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         Les travaux de recherche réunis dans cette thèse de doctorat ont été effectués 
dans l’unité de recherche de Chimie Nucléaire Analytique et Bio-environnementale 
UMR CNRS 5084 CNAB, et plus particulièrement au sein du Groupe de Chimie Bio-
organique situé sur le campus de l’université Victor Segalen Bordeaux 2. Les trois 
thèmes essentiels de recherche de cette unité sont : Chimie pour le Vivant, 
Cosmochimie/Géochimie Environnementale, et Environnement/Chimie Nucléaire. 
L’équipe de Chimie Bio-organique conçoit et applique de nouveaux outils chimiques 
pour aborder l’imagerie cellulaire et tissulaire (analyses par spectro-imagerie 
Infrarouge et par faisceaux d’ions), et la synthèse de molécules permettant le ciblage 
biologique. Un processus biologique est plus particulièrement privilégié, 
l’angiogenèse qui est capitale pour le développement des tumeurs solides tels les 
gliomes.  
 
         Les gliomes sont les tumeurs cérébrales primaires les plus fréquentes, 
classifiées en quatre grades cliniques (I à IV, selon l’OMS). Cette classification 
histologique est basée sur des critères de densité cellulaire, d’atypies nucléaires, de 
mitose, de prolifération microvasculaire et de nécrose. Les gliomes de grade I 
correspondent essentiellement à l'astrocytome pilocytique, circonscrit, bénin. Les 
gliomes infiltrants sont de bas grade (II) ou de haut grade (III ou IV). Les 
astrocytomes de grade IV, appelés glioblastomes multiformes (GBM), forment des 
tumeurs richement vascularisées, plus agressives et présentant une organisation 
hétérogène avec des zones nécrotiques et hémorragiques. En plus de leur 
dimension réduite, de quelques mm3 en général, leur forte propension infiltrante rend 
difficile l’exérèse complète de la tumeur. D’ailleurs, les solutions d’imagerie 
actuellement utilisées en clinique souffrent d’une sensibilité et/ou d’une résolution 
trop faibles pour espérer en délimiter les contours exacts. Un examen 
anatomopathologique est donc nécessaire mais il ne repose actuellement que sur 
l’étude visuelle des coupes histologiques de la tumeur et donc sur l’expérience des 
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praticiens. 20 à 30% des analyses extemporanées de glioblastomes restent ainsi 
sans résultat pour le neurochirurgien, ce qui limite fortement la prise en charge des 
patients. 
 
         Nous proposons donc d’utiliser la spectro-imagerie Infrarouge à Transformée 
de Fourier (IRTF) comme une imagerie fonctionnelle permettant de déterminer des 
marqueurs chimiques de la progression tumorale, la finalité étant d’en faire une aide 
au diagnostic. Cette technique apporte une information moléculaire globale des 
contenus d’un échantillon avec une résolution par pixel de l’image visible de 6*6 µm 
environ, ce qui en fait une modalité d’imagerie ex vivo très performante et à même 
d’améliorer l’examen pathologique des tumeurs. Nos travaux ont été basés sur la 
recherche de paramètres moléculaires permettant de discriminer les vaisseaux 
sanguins sains et tumoraux, notamment sur la base des contenus moléculaires de 
leur membrane basale, laquelle subit des altérations liées aux facteurs 
angiogéniques de la tumeur. 
 
         La première partie de ce travail de recherche est une synthèse bibliographique 
sur la pathophysiologie des gliomes, l’angiogenèse physiologique et pathologique et 
le rôle de l’angiogenèse dans les gliomes. Les moyens analytiques actuels sont 
ensuite abordés, plus particulièrement pour ce qui concerne les différentes 
techniques d’imagerie, et l’exposé bibliographique se termine sur la place que 
pourrait y prendre la spectro-imagerie IRTF. La seconde partie du document est 
consacrée aux différents résultats obtenus lors de ce travail qui sont présentés sous 
la forme de trois articles et deux rapports d’activités, et sont discutés globalement 
dans une conclusion générale. Nous avions tout d’abord utilisé la spectroscopie IRTF 
pour déterminer les différences de structure secondaire entre les collagènes des 
types I et IV, qui sont les principaux constituants des membranes basales des 
capillaires sanguins. Nous avons ensuite voulu vérifier si ces différences de structure 
secondaire pouvaient être utilisées pour discriminer les capillaires sanguins sains et 
tumoraux, aussi bien sur modèles animaux que sur des gliomes humains. Nos 
résultats ont alors été comparés à ceux de l’immunohistochimie utilisée lors de 
l’examen anatomopathologique. D’autres marqueurs spectraux ont aussi été 
envisagés, concernant notamment les contenus lipidiques et glucidiques des cellules 
de la membrane vasculaire, pericytes et cellules endothéliales. 
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         This work was conducted in the research unit of “Chimie Nucléaire Analytique 
et Bio-environnementale” UMR CNRS 5084 CNAB, in particularly within the Bio-
organic Chemistry Group situated at the campus of the University of Victor Segalen 
Bordeaux 2. The three main themes of this research unit are: Chemistry in Life 
Science, Cosmochemistry/Environmental Geochemistry, and Environment/ Nuclear 
Chemistry. The Bio-organic Chemistry team designs and implements new chemical 
tools addressed to the cell and tissue imaging (analyses by Infrared spectro-imaging 
and ion beams), and to the synthesis of molecules for biological targeting. A 
biological process is particularly privileged, angiogenesis, which is vital for the 
development of solid tumors such as gliomas. 
 
         Gliomas, the most frequent primary brain tumors, are classified according to the 
World Health Organization (WHO) classification into four grades with increasing 
malignancy: pilocytic astrocytoma (grade I), diffuse astrocytoma (grade II), anaplastic 
astrocytoma (grade III), and glioblastoma multiforme (grade IV). The histological 
classification is based on some criteria such as: cellular density, nuclear atypia, 
mitotic activity, necrosis and microvascular proliferation. Glioblastoma multiforme 
(GBM) are the most aggressive and present a high heterogeneity with hemorrhagic 
and necrotic areas. Besides their small size, generally a few mm3, their high degree 
of infiltration and invasiveness makes it difficult to complete excision of the tumor. 
Moreover, the current imaging techniques used clinically suffer from a sensitivity and 
/ or resolution too much weak to expect defining the tumor margins. A classical 
pathological examination is thus necessary but it is currently based on the visual 
study of histological sections of the tumor and therefore the experience of 
pathologists. As a consequence, 20 to 30% of extemporaneous analyses of 
glioblastomas are not sufficiently informative and remain without result for the 
neurosurgeon, which severely limits the care of patients.  
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         In this project we have proposed the use of Fourier Transform Infrared (FTIR) 
spectro-imaging as a functional imaging to identify chemical markers of tumor 
progression in order to help neurosurgeons in the diagnosis during surgery. This 
technique provides comprehensive molecular information of sample content with a 
resolution per image pixel of 6*6 µm approximately, making it a powerful modality of 
ex vivo imaging which may be able to improve the pathological examination of 
tumors. Our work was based on research of molecular parameters to discriminate 
between healthy and tumor blood vessels, especially on the molecular basis of the 
contents of their basement membrane, which undergoes alterations related to 
angiogenic factors of the tumor.  
 
         In the first part of this study, the statement literature addresses generalities on 
gliomas, the physiological and pathological angiogenesis and the role of 
angiogenesis in gliomas. Then, the current analytical techniques are discussed, 
especially for the various imaging techniques to end with FTIR spectro-imaging. The 
second part is devoted to the different results of this work which are presented in the 
form of three publications and two research reports, and are globally discussed in a 
general conclusion. First, we used the FTIR spectroscopy to determine the 
differences between the secondary structure of types I and IV collagen, which are the 
main constituents of basal membranes of capillary blood vessels. We then wanted to 
check whether these differences in secondary structure could be used to discriminate 
between healthy and tumor capillary blood vessels, in animal models as well as in 
human gliomas. Our results were then compared with those of the 
immunohistochemistry used in the pathological examination. Other spectral markers 
were also considered, including fat and carbohydrate contents of cell vascular 
membrane, pericytes and endothelial cells. 
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I – GLIOMAS 
 
       I.1. Generalities  
 
        Tumors of the central nervous system (CNS) have specific criteria that make 
them different from other neoplasms in the body. We can cite: the distinction between 
benign and malignant tumors which is less evident in the CNS; and that they rarely 
metastasize outside the CNS, although their infiltration into the surrounding brain 
parenchyma. The incidence of intracranial neoplasms is ~10–20 per 100,000, and 
they account for ~2% of deaths in Western countries. In adults, 50% of the brain 
tumors are primary and the other 50% are metastatic, also called secondary brain 
tumors. The majority of these tumors appear after the fifth decade of life, and they 
are slightly predominant (55%) in males with the exception of meningiomas, which 
are twice as common in females [1]. 
 
       I.2. Classification  
  
         Primary brain tumors are classified according to their predominant cell type. 
Tumors arising from glial cells, called gliomas, represent the most common group of 
primary brain tumors, and are among the two most lethal cancers for the human body 
with pancreatic tumors. They are classified by their cell type, their grade, and their 
location. The main types of gliomas are ependymomas (ependymal cells), 
astrocytomas (astrocytes), and oligodendrogliomas (oligodendrocytes). Four 
malignancy grades are recognized by the World Health Organization (WHO) grading 
system, with grade I tumors being the least aggressive and grade IV the most 
aggressive tumors. Astrocytic tumors are classified into pilocytic astrocytomas (grade 
I), diffuse or low-grade astrocytomas (grade II), anaplastic astrocytomas (grade III), 
and glioblastomas (grade IV). Grade I astrocytomas are most commonly seen in 
children and are not considered to be malignant. To the opposite, grades II to IV 
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tumors are malignant. More than 50% of the primary neoplasms are gliomas and 
65% of these gliomas are the most malignant variety, glioblastoma (GB) [1-3]. 
 
       I.3. Etiology and Clinical presentation 
 
        The etiology of primary brain tumors is unknown and data on risk factors is 
unclear. Several molecular mechanisms may be involved in the development of 
gliomas and their progression to more malignant tumors. The progression to high 
grade glioma is associated with inactivation of the p53 tumor suppressor gene, as 
well as with the over expression of many growth factors such as platelet-derived 
growth factor (PDGF), epidermal growth factor receptor (EGFR) gene, and also 
angiogenic factors such as vascular endothelial growth factor (VEGF) [1, 4]. 
 
         The clinical presentation of brain tumors depends on the location of the tumor. 
Patients may present symptoms either due to focal tissue destruction or because of 
edema and raised intracranial pressure. Brain gliomas can cause headaches, 
nausea and vomiting, epilepsy, and intracranial pressure. Glioma of the optic nerve 
may cause visual loss. Glioblastoma is usually centered in the deep white matter of 
the cerebral hemispheres, most frequently in the frontal lobe. The frontal lobe tumors 
commonly manifest with mental and personality changes as an early symptom [1, 5].  
 
       I.4. Prognosis and survival 
 
        The infiltrating adult astrocytic tumors occur commonly in the cerebral 
hemispheres. The diffuse astrocytomas have a peak incidence between 25 and 50 
years, the glioblastomas have a peak incidence between 45 and 70 years, while the 
peak incidence for the anaplastic astrocytomas is in between, around the age of 45. 
Survival is generally related to tumor histopathology, anatomic location, and age of 
patient. Patients with grade II tumors typically survive more than 5 years [1, 5]. The 
median survival of patients with anaplastic astrocytomas (grade III) is about 2–3 
years after surgery. If the recurrent anaplastic astrocytoma is subjected to a second 
surgery, more than 50% of cases will show glioblastoma. Glioblastomas may develop 
de novo (primary glioblastoma) or through progression from the low-grade or 
anaplastic astrocytomas (secondary glioblastoma) [2, 3, 6]. Glioblastomas are highly 
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invasive, very aggressive, and often infiltrate critical neurological areas within the 
brain, thus their prognosis is very poor. The mean survival time after diagnosis of GB 
has remained unchanged during the last few decades, in spite of advances in 
surgical techniques, radiotherapy, and also chemotherapy; patients’ survival still 
ranges from 9 to 12 months after initial diagnosis [1, 5, 7]. 
 
       I.5. Diagnostic tools 
 
        While a careful history and physical examination are the first step in diagnosis of 
gliomas, imaging is the next important step. However, the management of gliomas is 
still a challenging task because current imaging techniques do not always 
differentiate them from non-tumoral lesions (such as inflammation) or high grade 
tumors from low grade lesions. Imaging techniques, such as magnetic resonance 
imaging (MRI), positron emission tomography (PET), and Single Photon Emission 
Computed Tomography (SPECT) used for the diagnosis of malignant gliomas have 
their limitations.  
 
         Although MRI is the imaging modality of choice for brain tumors and has 
improved visualization of these tumors, there are a number of areas where it fails to 
provide sufficient information. Some of these areas are: the inability of this 
conventional imaging to show tumor infiltration, the deficient classification of tumor 
grading, and insensitivity to detect subtle changes in tumors due to the effects of 
treatment. MRI has a spatial resolution between 0.5 and 1.5 mm. The most widely 
used contrast agent for MRI is Gadolinium diethyltriamine pentaacetetic acid (Gd-
DTPA). Because Gd-DTPA leaves the vasculature and rapidly extravasates into the 
tissue, the changes in signal intensity do not adequately reflect tumor perfusion [8-
10].  
 
        PET has a spatial resolution limited to 3-4 mm. PET uses positron-emitting 
radionucleides to label molecules, which can then be imaged inside the body. 
Although its spatial resolution is lower than that of MRI, it has better specificity and 
sensitivity in the field of in vivo imaging modalities. Fluoro-deoxy-glucose (FDG) 
labeled with the positron emitter 18F (half life of 110 minutes) can be used to localize 
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primary tumors. SPECT (with a resolution of 5-6 mm) is another nuclear imaging 
modality sensitive to very low concentrations of tracer molecules, although one order 
of magnitude less sensitive than PET. However, the radionucleides used for SPECT 
are easier to prepare and present longer periods than those used for PET (e.g. 13.2 
hours for 123I) [10-13].  
          
         If diagnosis is unsuccessful by using in vivo imaging techniques, biopsies are 
necessarily performed to provide more information. Stereotactic biopsy is one of the 
safest methods [14]. Furthermore, during brain tumor surgery, since imaging 
modalities are not sufficiently efficient for determining the tumor margin accurately, 
rapid assessment of cryostat sections of biopsies are performed to obtain 
pathological diagnoses and to help determining tumor margins. Microscopic 
examination relies on these histological tissue sections from tumor biopsies to 
identify the morphological aspects in gliomas and to help determine the grade of the 
tumor which is not evident in most of cases. (Microscopic techniques will be further 
detailed in section IV). Moereover, cytotoxic or radiation therapy prior to histological 
diagnosis may make classification and malignancy grading extremely difficult or 
impossible. 
 
       I.6. Treatments 
 
         Surgery, radiotherapy and chemotherapy are the main treatments for malignant 
or high grade gliomas but they are limited for many reasons. Even when treated with 
combined surgery, chemotherapy, and radiotherapy, patients with high-grade 
malignant glioma present cancer recurrence between 6 and 12 months, and for 
anaplastic astrocytoma between 18 and 36 months. Surgery involves removing as 
much of the glioma as possible, while trying to minimize damage to healthy tissue. 
Several reports have assessed the effect of surgery on survival, showing that to a 
more extensive resection was associated a longer survival. However, glioblastoma 
tumors can be difficult to resect due to the lack of a defined tumor edge as the tumor 
may extend into normal brain tissue. It is thought that even a partial resection is 
beneficial to the patient, as it improves body functions and diminishes the pressure in 
the brain. The goal is to maximize tumor removal and, where possible, remove a 
margin of surrounding brain without removing tissue that would cause a new deficit 
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[1, 14]. External beam radiation is often administered after surgery to destroy any 
remaining tumor cells, but unfortunately this exposes the healthy brain tissue to 
damage. Chemotherapy may not be efficient because of the high heterogeneity of 
these tumors which may have more than one kind of cells. Moreover, the 
effectiveness of chemotherapy critically depends upon the successful transvascular 
delivery of small and large molecules through the blood brain barrier.  
 
       I.7. Notions on the blood brain barrier 
 
         The blood brain barrier (BBB) separates the brain from blood to help regulating 
brain functions and metabolism. It is composed of continuous tight junctions of 
endothelial cells lining blood vessels in the brain and forms a barrier between the 
circulation and the brain parenchyma (astrocytes, microglia) (Figure 1). A basement 
membrane composed of proteins, surrounds the endothelial cells and associated 
pericytes, and provides mechanical support and a barrier function. This physical 
barrier restricts the passage of various chemical substances and protects the brain 
from bacterial infections. BBB is less intact in brain tumors compared with the normal 
brain vasculature. BBB at sites of tumor undergoes alterations such as increased 
level of permeability. (More details in section III paragraph III.1.1). 
 
Figure 1. The blood brain barrier (BBB). (Modified, based on Francis et al 2003) [15] . 
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       I.8. The vascular microenvironment in gliomas 
 
         Like any other neoplasic tissue, gliomas are constituted of three compartments, 
classified as cellular, interstitial, and vascular in nature. Normal brain vasculature is 
highly specialized. It is composed of three cell types: endothelial cells, pericytes, and 
astrocytes (Figure 2) [16].  
 
 
 
Figure 2. A global view and a cross section of a CNS blood vessel. The pericyte is 
located at the abluminal side of the microvessel. A duplicature of the basement membrane 
(BM) separates the pericyte from the endothelial cell and the astrocyte footpads. (Based on 
Kacem et al. 1998 [17] and Balabanov et al. 1998 [18]) 
 
 
 
 
         The microvascular micro-environment determines the pathophysiological 
characteristics of gliomas, such as edema formation, tumor cell invasiveness, or 
selective permeability for large molecules. Clinically, the vascular microenvironment 
in gliomas is of diagnostic, therapeutic, and prognostic significance. Today, the 
radiological diagnosis and detection of gliomas is primarily based on its vascularity 
and permeability. Since the tumor causes alterations in tight junctions, BBB in tumor 
sites has higher permeability than into the normal brain tissue. As a consequence, 
endothelial cells, pericytes, and the basement membrane of tumor vessels reveal 
significant abnormalities when compared to cerebral vessels [1, 19].  
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II – ANGIOGENESIS 
 
 
       II.1. Angiogenesis and vasculogenesis  
 
                 II.1.1. Blood vessel formation 
 
         Growth of a vascular system is one of the earliest events in organogenesis. 
Development of new blood vessels occurs during embryonic development and during 
normal and pathologic periods of tissue growth. New vessels can form via distinct 
processes, namely vasculogenesis and angiogenesis. Angiogenesis, defined as the 
development of new blood vessels from preexisting vascular network, is one of 
several mechanisms that build and maintain the blood supply in the body’s tissues. 
As such, it can be distinguished from arteriogenesis and vasculogenesis. 
Arteriogenesis is a repair mechanism whereby bridging collateral arterioles are 
remodeled and grow to compensate for arterial occlusions in major vessels [20-23].  
 
         Vasculogenesis, which involves the differentiation of vascular cells from 
undifferentiated precursors, forms the initial vascular network during early embryonic 
development and contributes to the vascularization of tissues. In this process, 
mesodermal cells differentiate into angioblasts which then give rise to the endothelial 
cells assembling into a first vascular network. Because vasculogenesis only leads to 
an immature, poorly functional vasculature in the embryo, angiogenesis is essential 
for the subsequent development of the vascular network of arteries, veins, arterioles, 
venules and capillary blood vessels (Figure 3) [22, 24].  
 
         During the angiogenesis phase, the vascular plexus progressively expands by 
means of vessel sprouting and remodels into a highly organized and stereotyped 
vascular network of larger vessels ramifying into smaller ones [25]. Angiogenesis is 
responsible for the vascularization in the embryo and growing tissues. This process is 
generally suppressed in healthy adult organisms and is turned on temporarily in 
settings such as the female reproduction cycle (ovarian and uterine cycles) or during 
tissue repair processes (wound healing and restoration of capillary blood network into 
injured tissues) [26]. Otherwise, while angiogenesis is essentially a rare event in the 
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adult, it can occur in a number of relevant pathologies, such as cancer, various 
retinopathies, blinding ocular disorders, rheumatoid arthritis, psoriasis [20, 22]. 
 
 
 
Figure 3. Formation of blood vessels. Development of the vascular systems: during 
vasculogenesis, endothelial progenitors give rise to a primitive vascular labyrinth of arteries 
and veins; during subsequent angiogenesis, the network expands, pericytes (PC) and 
smooth muscle cells (SMC) cover nascent endothelial channels, and a an organized vascular 
network emerges. (Modified based on Carmeliet 2005) [25]. 
 
 
                 II.1.2. Maturation of vasculature 
 
         The maturation of nascent vasculature, formed by vasculogenesis or 
angiogenesis, requires recruitment of mural cells (pericytes in medium-sized and 
vascular smooth muscle cells in larger vessels), generation of an extracellular matrix, 
and specialization of the vessel wall for structural support and regulation of vessel 
function. The vascular network is spatially organized to provide adequate oxygen and 
nutrients to the cells of all organs. The walls of vessels are composed of endothelial 
cells (ECs) and mural cells (MCs), which are embedded in an extracellular matrix 
(ECM) (Figure 4) [21, 27]. The origin, number, type and organization of mural cells, 
the composition of the associated matrix, and the connection between the vascular 
system and the nervous system depend on the location of the vessel and its function. 
This is called organ-specific specialization of vessel wall (such as inter endothelial 
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junctions, fenestrations, apical-basal polarity, surface receptors and foot processes) 
[27]. 
 
         Capillaries are tubes formed by endothelial cells, which are supported by 
vascular pericytes and a basement membrane. Arteries and veins are tubes that 
consist of multiple layers: first, the intima, which is composed of ECs, pericytes and a 
basement membrane; second, the media, which is composed principally of smooth 
muscle cells and their ECM; and third, in the largest vessels, the adventitia, which is 
composed principally of fibroblasts and their ECM [23]. 
 
 
 
Figure 4. Wall composition of nascent versus mature vessels. (a) Nascent vessels 
consist of a tube of ECs. These mature into the specialized structures of capillaries, arteries 
and veins. (b) Capillaries, the most abundant vessels in our body, consist of ECs surrounded 
by basement membrane and a sparse layer of pericytes embedded within the EC basement 
membrane.  Depending upon the organ or tissue, the capillary endothelial layer is continuous 
(as in muscle), fenestrated (as in kidney or endocrine glands) or discontinuous (as in liver 
sinusoids). The endothelia of the blood-brain barrier are further specialized to include tight 
junctions, and are thus impermeable to various molecules. (c) Arterioles and venules have 
an increased coverage of mural cells compared with capillaries. (d) The walls of larger 
vessels consist of three specialized layers: an intima composed of endothelial cells, a media 
of SMCs and an adventitia of fibroblasts, together with matrix and elastic lamina. (Modified, 
based on Jain 2003) [27]. 
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       II.2. Angiogenesis process 
 
         Angiogenesis involves a variety of coordinated events, including: 1- production 
and release of angiogenic factors, 2- proteolytic degradation of the extracellular 
matrix surrounding the parent vessel, 3- migration and proliferation of the endothelial 
cells and mural cells to assemble the new vessel, 4- lumen formation, and 5- 
construction of the mural cell layer of the vessel wall with associated pericytes and/or 
smooth muscle cells. Angiogenesis is regulated by multiple stimulatory and inhibitory 
factors that are able to modulate the migration and/or proliferation of microvascular 
cells. Of the angiogenic factors, Vascular Endothelial Growth Factor (VEGF) and 
Fibroblast Growth Factors (FGF-1 and FGF-2) have been studied the most 
intensively. The mitogenic activity of VEGF has been shown to be restricted to ECs, 
while FGF is mitogenic for a spectrum of cells, including vascular smooth muscle 
cells (VSMCs) and ECs. The VEGF expression appears to be upregulated by 
hypoxia [20, 28].   
 
                 II.2.1. Endothelial cell functions relating to angiogenesis 
  
         Endothelial cells are the primary physical barrier in microvessels for delimitating 
between blood and tissue. As stated before, many endothelial cell functions are 
required for angiogenesis, including matrix degradation, migration, proliferation, and 
morphogenesis.  
 
a. Matrix degradation 
 
         Vessel sprouting requires both the degradation of the laminin-rich basement 
membrane surrounding the endothelial cells and the proteolysis of the collagen-rich 
extracellular matrix of the surrounding connective tissue. Matrix degradation can 
facilitate angiogenesis by activating angiogenic proteins or releasing matrix- or 
membrane-bound growth factors. This process can also release anti-angiogenic 
matrix fragments, including endostatin, angiostatin, and tumstatin. Families of 
proteases responsible for matrix degradation during angiogenesis include matrix 
metalloproteinases (MMPs), serine proteinases (plasminogen activators), cathepsins, 
and aminopeptidases. Of these, the MMPs are most frequently assessed as 
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contributors to angiogenesis. Upon activation, MMPs digest matrix components such 
as collagen, fibrin, laminin, and fibronectin [28-31].  
 
b. Migration 
 
         Following matrix degradation, ECs migrate into the surrounding tissue in 
response to angiogenic growth factors (VEGF) and chemokines (e.g. Interleukine-8 
(IL-8)). These factors can contribute to endothelial cell motility by causing random cell 
movement (chemokinesis) or by directing migration towards a stimulatory factor 
(chemotaxis) [32, 33]. By definition, the formation of functional vascular sprouts 
depends on directional migration of microvascular cells in the surrounding tissue. The 
mechanisms for migration of these cells are comparable with those involved in 
invasion of tumor cells. Migration is facilitated by the binding of tumor cell to a 
basement membrane rich in laminin, collagen IV, and tenascin [19]. Directional 
endothelial migration is controlled by the ability of these cells to exert mechanical 
forces on the ECM of the surrounding tissue. Most of the identified ECM-receptors on 
ECs are of the integrin type [28].  
 
c. Proliferation and Morphogenesis 
 
        Endothelial cell proliferation supplies the cells that build the new vessel. Many 
angiogenic factors increase the number of endothelial cells by enhancing both their 
proliferation and survival [34]. During angiogenesis, vascular endothelial cells can 
proliferate as rapidly as bone-marrow cells. This increase in proliferation is one of 
many events that are required for the formation of a new capillary blood vessel. 
When the detached endothelial cells are in contact with interstitial provisional matrix 
components, such as vitronectin, fibronectin, type I collagen, and thrombin, they 
mediate the formation of a new blood vessel with the vascular basement membrane 
(VBM) (Figure 5) [35].  
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Figure 5. Matrix transitions during angiogenesis. Angiogenesis is associated with 
degradation and reformation of the VBM. a. In response to growth factors and MMPs, the 
VBM undergoes degradative and structural changes. This transition from mature VBM to 
provisional matrix promotes the proliferation and migration of vascular endothelial cells. 
Growth factors, such as VEGF, FGF-2 (b FGF) and platelet derived growth factor (PDGF), 
are released from the BM, and are also produced by tumor cells, fibroblasts and immune 
cells. b. This induces formation of an intermediate, and then a mature VBM. Together with 
the vascular endothelial cells and pericytes, the VBM mediates formation of a new blood 
vessel. The degraded VBM during this process has a crucial role in regulating angiogenesis. 
(Based on Kalluri 2003) [35]. 
 
                 II.2.2. Role of the vascular basement membrane 
 
         The VBM is a self-assembled layer of proteins, glycoproteins and proteoglycans 
produced by endothelial cells, pericytes and smooth muscle cells (SMCs). Type IV 
collagen, laminin, fibronectin, nidogen (entactin) and the heparan sulfate 
proteoglycan (HSPG / perlecan) are among the main components. Basement 
membrane of normal blood vessels tightly envelops and covers most endothelial 
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sprouts and pericyte processes. Redundant layers of VBM, visible under conditions 
where blood vessels undergo regression and regeneration, may provide a scaffold for 
vascular re-growth [35]. When vascular cells migrate to form new sprouts, the 
composition of the matrix network is altered. Proteinases expose new cryptic 
epitopes in ECM proteins (such as in collagen IV) or change their structure (fibrillar 
versus monomer collagen), which induce ECs and SMCs migration. In addition, a 
provisional matrix of fibronectin, fibrin and other components provides a support 
scaffold, guiding ECs to their targets [21, 35].  
 
                 II.2.3. Role of pericytes 
 
         Cellular components of small blood vessels consist only of ECs, whereas larger 
vessels are surrounded by mural cells. Pericytes, also known as Rouget cells, peri-
endothelial cells, or mural cells, are adventitial cells located within the basement 
membrane of capillaries and postcapillary venules. Because of their multiple 
cytoplasmic processes, distinctive cytoskeletal elements, and envelopment of 
endothelial cells, pericytes are generally considered to be contractile cells that 
stabilize vessel walls and participate in the regulation of blood flow in the 
microcirculation. Pericytes may also influence endothelial permeability, proliferation, 
survival, migration, and maturation. They are extensively involved in the angiogenic 
process as well as ECs and participate in vascular remodeling in vivo. In vitro studies 
demonstrated that pericytes can inhibit proliferation of ECs by a mechanism that 
requires contact or close proximity between the two cell types, the inhibition being 
mediated by Transforming Growth Factor-β1 (TGF-β1). Under hypoxic conditions, 
however, cultured pericytes were shown to produce VEGF and thus may promote 
ECs growth in a paracrine way. In cultured human brain pericytes the increased 
expression of α-smooth muscle actin (α-SMA) suggests a contractile role of these 
cells and has been shown to be mediated by TGF-β1 [36-38]. 
 
                 II.2.4. Angiogenesis regulators 
 
         Angiogenesis is a physiologic process that is tightly regulated and involves a 
balance between pro-angiogenic and anti-angiogenic factors [39]. The “angiogenic 
switch” is determined by the opposing faces of pro- and anti-angiogenic factors, it is 
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turned “Off”, “On”, or is in a balance depending on the activity on each end of the 
balance. It is likely turned “On” in several diseases such as psoriasis, rheumatoid 
arthritis [40], diabetic retinopathy [41], and cancer [20, 21, 42]. Switching to an 
angiogenic phenotype likely requires both up-regulation of angiogenesis activators 
and down-regulation of angiogenesis inhibitors. The exact molecular mechanisms 
controlling the “angiogenic switch” are not completely understood, and so far, more 
than 20 stimulators (including notably VEGF, PDGF, FGF and some integrins), as 
well as inhibitors of angiogenesis have been identified (More details in section 
III.1.2.). Among the large number of angiogenesis inhibitors, there is a subset of 
endogenous matrix-derived angiogenesis inhibitors, (e.g. Arresten, Canstatin, 
Endostatin, and Tumstatin) [43].  
 
                 II.2.5. Mechanisms of angiogenesis 
 
         The growth, expansion and remodeling of the primary vascular plexus in a 
mature vasculature occur by two mechanisms: sprouting and intussusception. 
 
a. Sprouting angiogenesis 
         Sprouting angiogenesis was the first identified form of angiogenesis. Sprouting 
consists of a number of steps: degradation of the vascular basement membrane, 
endothelial cell proliferation in response to angiogenic factors, formation of sprouts of 
endothelial cells reaching out to connect to a neighbouring vessel, and finally 
formation of a lumen connected on both ends of the tube to the original vascular 
network [34, 44].  
b. Intussusceptive angiogenesis 
 
 
         Non-sprouting angiogenesis, also known as splitting angiogenesis or 
intussusception, occurs as a longitudinal division of an existing vessel. In this type of 
vessel formation, the capillary wall extends into the lumen to split a single vessel in 
two. There are four phases of intussusceptive angiogenesis. First, the two opposing 
capillary walls establish a zone of contact. Second, the endothelial cell junctions are 
reorganized and the vessel bilayer is perforated to allow growth factors and cells to 
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penetrate into the lumen. Third, a core is formed between the two new vessels at the 
zone of contact that is filled with pericytes and fibroblasts. These cells begin laying 
collagen fibers into the core to provide an extracellular matrix for the extension of the 
vessel lumen. The addition of collagen fibrils to the pillar core will stabilize the pillar 
mechanically. Finally, the core is fleshed out with no alterations to the basic structure. 
Intussusception is important because it is a reorganization of existing cells. It allows a 
vast increase in the number of capillaries without a corresponding increase in the 
number of endothelial cells. This is especially important in embryonic development 
since there are not enough resources to create a rich microvasculature with new cells 
every time a new vessel develops. After the formation of the primitive capillary plexus 
by vasculogenesis and/or sprouting, early developmental vascular growth and 
remodeling occur predominantly by intussusception. Thus blood vessel formation by 
intussusception is much faster than by sprouting since extensive cell proliferation, 
basal membrane degradation and invasion of the surrounding tissue are not required 
as is the case for sprouting [34, 44].  
 
 
       II.3. Angiogenesis in tumors 
 
         Angiogenesis is essential for the development and progression of many human 
solid tumors. It has been suggested that an outstanding characteristic of tumor cells 
is their capacity to elicit continuously the growth of new capillary endothelium from 
the host. The switch from an avascular tumor to an angiogenic phenotype represents 
a distinct step in the multistep pathogenesis of cancer.  
  
                 II.3.1. Tumor angiogenesis 
 
         The diffusion capacity for oxygen and nutrients in tissues is limited to about 
150–200 μm, therefore progressive growth of solid tumors beyond a diameter of 2 to 
3 mm3 is not optimally possible without neo-vascularization. It is thus dependent on 
the recruitment of angiogenic vessels and an expansion of the tumor vasculature to 
meet the metabolic requirements of the neoplasic tissue. Tumor metabolism varies 
with the function and architecture of these new blood vessels [45].  The formation of 
new tumor microvessels from preexisting vasculature requires a complex interaction 
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between tumor cells, endothelial cells, stromal cells, and matrix components [46]. 
Tumor cells have been shown to express angiogenic factors in order to stimulate 
expansion of the vascular bed. VEGF is expressed by tumor cells, such as glioma 
cells, and is the only known mitogen acting specifically on endothelial cells [47]. 
VEGF signaling initiates the formation of new vessels by recruiting ECs to form 
tubes. It also triggers a chain of molecular and cellular events that stabilize the EC 
tubes by recruiting mural cells and generating an extracellular matrix. It has been 
previously demonstrated that paracrine signaling via platelet derived growth factor B 
(expressed by ECs) and its receptor PDGFR-β (expressed by MCs) plays a central 
role in mural cell recruitment and blood vessel maturation and stabilization [48].  
          
                 II.3.2. Tumor vasculature  
 
         The tumor vasculature is structurally and functionally abnormal. Tumor blood 
vessels are leaky, tortuous, dilated, and saccular and have an arbitrary pattern of 
inter-connections. Most tumor vessels do not fit into the conventional hierarchy of 
arterioles, capillaries, and venules. Their abnormalities involve all components of the 
vessel wall structure and branching patterns: endothelial cells, pericytes and 
basement membrane. Despite the abnormalities, most tumor vessels do have 
endothelial cells and pericytes [27, 49-51]. Collectively, these vascular abnormalities 
lead to an abnormal tumor microenvironment characterized by interstitial 
hypertension (elevated hydrostatic pressure outside the blood vessels), hypoxia, and 
acidosis. Impaired blood supply and interstitial hypertension interfere with the delivery 
of therapeutics to solid tumors. Hypoxia and low pH compromise the cytotoxic 
functions of immune cells that infiltrate a tumor rendering tumor cells resistant to both 
radiation and several cytotoxic drugs. Unfortunately, cancer cells are able to survive 
in this abnormal microenvironment. When normal tissues are subjected to hypoxia 
(oxygen starvation) - because of a reduction either in blood flow or in the oxygen 
content of the blood - the eventual result is cell death. To ensure survival, tumor 
tissues switch into a protective mode by using a specific set of hypoxia-sensing 
proteins called hypoxia-inducible factors (or HIFs); and they produce angiogenic 
factors that will attract new blood vessels to restore local blood flow [52]. 
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a. ECs and BM abnormalities in tumor angiogenesis 
 
         In tumor blood vessels, ECs have aberrant morphology and form an imperfect 
lining, with wide junctions at some locations and stacked layers at others. The ECs 
may contain a large number of fenestrations, vesicle vacuolar organelles or both. The 
expression of adhesion molecules is also more heterogeneous than in normal tissue, 
for instance some ECs do not express common endothelial markers (such as CD31) 
and may undergo apoptosis, thus exposing cancer cells to the lumen (this is called 
mosaic vessels) (Figure 6). Basement membrane of tumor vessels is often 
abnormal, loosely associated with ECs and pericytes, varies in thickness (unusually 
thick at some locations, entirely absent at others) and has multiple layers in some 
regions. Vessel diameters are increased, due in part to compression of the immature 
wall by proliferating tumor cells [20, 27, 50].  
 
b. Pericytes 
     
         In tumor blood vessels, pericytes are generally loosely attached to endothelial 
cells, have multiple layers and extend cytoplasmic processes away from the vessel 
wall. The data on the mural-cell coverage of tumor vessels is a little controversial, 
with some studies showing a paucity of mural cells and others showing their 
abundance. Mural cells are either absent or loosely associated with the tumor 
endothelium. This abnormality contributes to the leakiness of the vessels, rendering 
them vulnerable to anti-angiogenic therapies [27, 38].  
 
                 II.3.3. Mechanisms of tumor angiogenesis 
 
         To obtain nutrients for their growth and to metastasize to distant organs, cancer 
cells coopt host vessels, sprout new vessels from existing ones (sprouting and 
intussusceptive angiogenesis: mechanisms previously described in II.2.5), and/or 
recruit endothelial cells from the bone marrow (de novo vessel formation or 
vasculogenesis from angioblasts or stem cells) (Figure 6) [50, 53].  
 
         Many tumors when developed in highly vascularized tissues, such as brain and 
lung, can use another mechanism for vascularization, named “cooption”. Tumor 
cells rapidly coopt existing host vessels to form an initially well-vascularized tumor 
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mass. Vessels are surrounded, coopted by tumor cells and no sprouts are observed 
[54, 55].  
 
         Tumor cells may localize into the wall of tumor blood vessels. They may form 
blood vessels in association with endothelial cells; this mechanism is named 
“mosaic blood vessels”. Tumor cells in mosaic vessels are undergoing 
intravasation into the lumen and stay temporarily in the capillary vessel wall [56]. 
 
         Tumor cells may also form tumor blood vessels instead of endothelial cells such 
as in skin and ovarian cancer. This process called “vasculogenic mimicry” seems 
to be driven by the acquisition, by these tumor cells, of phenotypic characteristics of 
endothelial type [57].  
 
 
 
Figure 6. Mechanisms of tumor vascularization. The different mechanisms of tumor 
vascularization are shown in this figure. These include: (A) sprouting angiogenesis; (B) 
intussusception; (C) recruitment of circulating endothelial precursors; (D) cooption; (E) 
mosaic vessels; (F) vascular mimicry (Based on Auguste et al. 2005) [53]. 
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III – ROLE OF ANGIOGENESIS IN GLIOMAS 
 
 
         Malignant gliomas are in general among the most vascularized human tumors.  
Glioblastoma multiforme (GBM) is one of the most highly vascularized classes of 
these tumors. The fact that microvascular proliferation cannot be observed in low 
grade glioma and is frequently present in GBM has led to the assumption that both 
the development as well as the progression of malignant glioma largely depend on 
angiogenesis. Thus, angiogenesis represents a crucial patho-physiological step in 
this tumor entity and antiangiogenic therapy might be especially useful [19, 58-61]. In 
animal models the growth of glioma xenografts can be inhibited by targeting the 
angiogenic process. However, unlike many glioma xenografts, human infiltrating 
gliomas such as GBM have a diffuse infiltrative growth pattern, and preexistent 
vessels  provide many tumor cells with much of their blood supply, particularly in the 
critical peripheral infiltrative margins [28].  
 
       III.1. Pathogenesis of brain tumor angiogenesis 
 
         Many of the characteristic features of the vascular microenvironment in gliomas 
are related to abnormal expression patterns of vasoactive molecules. The high 
angiogenic activity of the tumor results from a high expression of pro-angiogenic 
growth factors and their receptors. 
 
                 III.1.1. Characteristic features of brain tumor microvasculature  
 
         The glioma vessel morphology is highly heterogeneous and does not conform 
to the physiologic microvasculature in brain tissue. As a result, endothelial cells, 
pericytes, and the basement membrane of glioma vessels reveal significant 
abnormalities when compared to cerebral vessels. In contrast to cerebral capillaries 
(~3–5 µm in diameter), gliomas contain tortuous and sinusoidal vessels with 
diameters ranging between 3 and 40 µm. All morphologic analysis on the glioma 
microvasculature demonstrated that glioma endothelial cells were surrounded by a 
continuous basement membrane, although this one was found to be quite thin when 
compared with that seen around normal vessels. An increase in vessel wall thickness 
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is one common feature of the glioma vasculature and is attributed to endothelial cell 
hyperplasia (endothelial wall thickness in glioma ~0.5 µm vs. 0.26 µm in cerebral 
vessels) reflecting an increase in non-selective transendothelial transport [19, 62-64]. 
 
         In normal human brain as well as in most glial neoplasms ECM proteins such 
as fibronectin, laminin, and the different types of collagen are essentially confined to 
the vessel walls. In GBM, the migration of microvascular cells into the glial tumor 
tissue during angiogenesis may have been facilitated by an altered expression of 
ECM components by tumor cells. For migration along blood vessels, interactions 
between integrins on tumor cells and vascular ECM components are considered to 
be important. Within the glial compartment, such ECM components are generally 
lacking, and diffuse infiltrative growth may be facilitated by other molecules like 
adhesion molecules of the CD44 family, especially since the glial ECM is rich in 
hyaluronic acid, a potent ligand of CD44 [28, 65]. ECM components such as laminin, 
fibronectin, collagen type IV, vitronectin, tenascin and hyaluronic acid, have all been 
shown to be key compounds for glioma cell migration and invasion in experimental 
model systems. Most of the components expressed within glioma tumors, e.g., 
laminin, fibronectin and collagen types (I, II, IV and V), are predominantly localized 
within the basement membrane of existing and newly formed hyperplastic blood 
vessels. The distribution of laminin, fibronectin and collagen type IV varied regionally 
within the tumors. These ECM components were found to be strongly associated with 
the basal lamina of blood vessels, but with deposits also present in the parenchyma 
of tumors, suggesting a possible role for these proteins during tumor cell invasion. 
These changes in the expression of ECM molecules indicate that this is a normal 
host response to environmental changes. The tumor cells may use these molecules 
either as stimulating or guiding molecules for their migration into the host tissue [66].  
 
         Regarding blood vessel maturity, many studies revealed some differentiations 
because heterogeneity is a common feature of tumor vasculature. Not all tumor-
associated vessels have the same structural or functional defects and not all of them 
exhibit the same organization. Tenascin C, an extracellular matrix molecule, has 
been described previously to be absent in mature non-pathological brain tissue and 
to accumulate in the basal lamina of tumor vessels in high grade astrocytomas. It has 
been suggested that tenascin C may be correlated with the grade of malignancy in 
27
astrocytic tumors [22, 67, 68]. Also, CD105 (endoglin) is expressed in the newly 
formed blood vessels of the tumor, but not in the mature vessels, either intra- or peri-
tumoral [69]. Bian et. al [70] in their study for distinction between tumor microvessel 
endothelial cells from those derived from normal tissues, have revealed several 
characteristic features of GDMEC (Glioblastoma derived microvessel endothelial 
cells). GDMEC expressed high levels of CD105, a proliferation-associated cell 
membrane antigen and a defined endothelial cell marker present on newly formed 
preliminary capillaries of tumor tissues.  
 
         Electron microscopic studies of the blood brain barrier comprising endothelial 
cells and perivascular astrocytes have identified at least three structural 
abnormalities of the endothelial lining which all form the basis for an increased 
microvascular permeability and loss of BBB function in glioma tumors: open 
endothelial gaps (as inter-endothelial junctions and trans-endothelial channels), 
cytoplasmic vesicles (as vesicular vacuolar organelles), and fenestrations. Astrocytic 
alterations include abnormal junctions between astrocytic processes in certain 
gliomas [19, 71, 72].  
 
         Pericytes and vascular smooth muscle cells also contribute to the vascular 
microenvironment in gliomas. They have been implicated in all stages of neo-
vascularization, guiding the migration of endothelial cells, regulating their 
proliferation, and connecting individual vascular sprouts [18]. Furthermore, they have 
also been linked to the process of glioma vessel maturation which identified them as 
regulators of glioma vascularization and of microvascular remodeling and survival 
[73]. The frequency of pericytes within the glioma microvasculature is a matter of 
debate since different techniques to identify pericytes have revealed controversial 
results. Conventional electron microscopy and immuno-electron microscopy have 
clearly identified a significant number of pericytes or VSMCs in direct contact to 
endothelial cells within the glioma microvasculature (3- to 5-fold compared with 
normal brain tissue) [64, 73]. Other results have shown that microvessel pericyte 
coverage ranges from 10–20% in human glioblastoma specimens [74, 75]. 
 
         As abnormalities involve all components of the vessel wall structure: endothelial 
cells, basement membrane and pericytes, all markers used for these patterns might 
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help to understand the structural and functional alterations during tumor growth and 
might provide novel therapeutic targets. (More markers will be further detailed in 
section IV.2). 
 
                 III.1.2. Mediators of glioma angiogenesis 
 
         Glioma microvessels appear to have three principal origins: angiogenesis, 
cooption, and intussusception. Although the exact biomolecular mechanisms 
responsible for these distinct vascularization mechanisms are still ambiguous, there 
is strong evidence that they are mediated by similar growth factors. Glioma 
angiogenesis is mediated by the release of angiogenic cytokines by the tumor cells. 
The VEGF and its receptors seem to be the central signaling pathway of glioma 
angiogenesis [16, 19, 76]. But there are many other important molecules which act 
angiogenically by stimulating endothelial cell migration and tumor invasiveness, such 
as PDGF, fibroblast growth factors (FGF-1 and FGF-2), hepatocyte growth factor / 
scatter factor (HGF / SF) and the angiopoietins (Ang-1 and Ang-2) [77-79]. Also 
some integrins have a role in glioma associated angiogenesis. Here we will develop 
two of these mediators:   
 
a.  VEGF and its receptors 
 
         VEGF acts not only as a growth factor but also as a survival factor for 
endothelial cells. It plays a central role in mediating the differential steps of tumor 
angiogenesis and is responsible for many pathological characteristic of the tumor 
vascular compartment. VEGF is a multifunctional angiogenic cytokine that induces a 
series of protein phosphorylations, beginning with the autophosphorylation of its main 
receptor tyrosine kinases VEGFR-1 (known as Flt-1) and VEGFR-2 (known as Flk-
1/KDR). These receptors mediate their signals intracellularly via the MAP-kinase 
pathways. In the normal brain, VEGFR-1 and VEGFR-2 are expressed at very low 
levels, but become elevated after ischemia and in malignant gliomas. The expression 
of VEGF is mainly triggered by hypoxia, but also promoted by other vascular 
cytokines, such as FGF, PDGF, EGF, TNF-α, IL-1β, IL-6 and nitric oxide. In addition, 
upregulation of VEGF is, at least in part, responsible for the loss of blood brain barrier 
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function and increased microvascular permeability in gliomas, mediated by the 
VEGFR-2 [61, 78].  
 
b. Integrin signaling 
 
         Integrins are cell-surface receptors of specific ECM molecules, responsible for 
the interaction of endothelial and tumor cells with the extracellular matrix, mediating 
cell migration and invasion. The αvβ3 and αvβ5 integrins are considered to positively 
regulate angiogenesis, because their pharmacological antagonists suppress 
pathological angiogenesis. Integrin ανβ3 is of special interest in gliomas, because its 
expression correlates with the histological grade and it is upregulated especially in 
the proliferating parts of malignant glioma, thus, playing a role in tumor invasion and 
angiogenesis [21, 80].  
 
       III.2. Anti-angiogenesis strategies 
 
         Two main anti-angiogenic approaches currently in development are the 
inhibition of the angiogenic process and vessel formation by the delivery of anti-
angiogenic agents or direct targeting and destruction of the tumor vasculature. 
Inhibition of angiogenesis would represent an approach for blocking tumor growth, 
possibly circumventing the multidrug resistance problem [22]. Furthermore, 
angiogenesis inhibitors may help chemotherapy and radiotherapy when given in 
combination. In this way, cytotoxic agents would kill cancer cells directly, and anti-
angiogenic agents would kill them indirectly by depriving them of nutrients [50].  
 
         Under physiological conditions angiogenesis in the CNS is tightly down-
regulated. Recently a number of endogenous angiogenic inhibitors have been 
described [81-83], between them tumstatin, endostatin, and angiostatin (proteolytic 
fragments of collagen IV, XVIII and plasminogen, respectively) that inhibit endothelial 
cell migration and proliferation; and protease inhibitors that prevent degradation of 
the basal lamina of blood vessels. There are also some compounds that interfere 
with the adherence of endothelial cells to matrix proteins (e.g., via blockade of αvβ3 
integrin), such as PEX (hemopexin fragment), which regulates the interaction of 
metalloproteinase-2 (MMP-2) and integrin αvβ3 and it is a potent inhibitor of glioma 
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angiogenesis [84-86]. Other molecules have been also developed such as protein 
tyrosine kinase inhibitors which prevent phosphorylation in cell signaling by blocking 
access of ATP [87].     
 
         Other targets are vascular endothelial growth factor VEGF/VEGF-receptor 
complex. Antagonizing VEGF (such as using dominant-negative mutants of the 
VEGFR-2, or anti-VEGFR2 antibodies) can inhibit the growth of human malignant 
gliomas in animal models [88, 89]. Furthermore, this inhibition can also be achieved 
by simultaneous administration of molecules that target both tumor and endothelial 
cells and acting by separate mechanisms (as PF-4/CTF, CBO-P11) [86, 90]. CBO-
P11 is a cyclic peptide (synthesized in our laboratory) derived from VEGF. It 
significantly blocks the growth of intracranial glioma in nude and syngeneic mice and 
improves survival. 
 
         Antiangiogenic therapies should destroy the tumor vasculature, thereby 
depriving the tumor of oxygen and nutrients. Jain has stated that certain 
antiangiogenic agents can also ‘‘normalize’’ the abnormal structure and function of 
tumor vasculature to make it more efficient for oxygen and drug delivery [91]. 
Targeting the VEGF signaling pathway can be a potential strategy to reverse some of 
the abnormalities. Anti-VEGF antibody (Bevacizumab) and anti-VEGFR2 antibody 
(DC101) prune some tumor vessels and remodel the remaining vasculature in human 
colon cancer and glioma xenografts as well as murine breast cancers so that it more 
closely resembles the normal vasculature. The anti-VEGF treatments reduce the size 
and length as well as permeability of these abnormally dilated and tortuous vessels 
[92-94].  
 
 
 
 
 
 
. 
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IV – EX VIVO IMAGING OF ANGIOGENESIS 
  
 
         To be useful tools for studying angiogenesis, imaging methods should be able 
to locate sites of angiogenesis, determine level of blood vessel growth, characterize 
functional abnormalities of vessels, assess vascular heterogeneity and elucidate 
features that distinguish between tumor-mediated (angiogenic) and normal blood 
vessels. They should also have potential utility in assessing the efficacy of 
angiogenesis inhibitors used in the treatment of cancer. Current angiographic 
methods for visualizing blood vessels in clinics are usually able to evaluate larger 
arteries and veins but not the microvasculature of tumors or even the sites of 
angiogenesis. The poor resolution of in vivo imaging techniques such as MRI, PET 
and SPECT (described before in section I.5) does not allow imaging of angiogenic 
areas in the case of small-size tumors such as gliomas. For this purpose, 
microscopic methods or ex vivo imaging modalities may be of some help. 
 
         A few microscopic techniques have been developed for image analysis of the 
microvasculature in glial tissue. These methods are used to compare several 
vascular parameters in histological tumor sections of human glioblastoma with those 
in normal cerebral cortex. They are in part based on a significant increase in mean 
number, area, and perimeter of blood vessels per microscopic field in glioblastoma 
compared to normal cerebral area. However, each of the methods being potentially 
used for this diagnosis presents advantages and limits.  
 
 
       IV.1. Imaging morphological abnormalities of blood vessels 
 
         Imaging studies by conventional, UV-Vis, fluorescence, and electron 
microscopy have identified several cellular and molecular abnormalities that 
distinguish tumor vessels from their normal counterparts and help to explain their 
unusual appearance, disturbed blood flow, and leakiness.  
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                 IV.1.1. Classical histological examination 
 
         Traditionally, the diagnosis of tumors is based on visual inspection of stained 
tissue sections by an experienced pathologist. The standard histopathological 
procedures have in common that they “tag” and visualize the distribution and 
structure of cellular components in tissue sections using standard light microscopy-
based techniques. Distinction between tumor and normal brain tissue is particularly 
important in neurosurgery in order to maximally resect tumor cells and to minimally 
affect brain function.  
 
         The diagnosis and grading of individual gliomas is based primarily on 
morphological pattern recognition. Cryostat sections for intraoperative diagnosis are 
prepared from fresh frozen samples. They are fixed, stained by hematoxylin and 
eosin (H&E), and evaluated by a neuropathologist. However, in 20 to 30% of cases 
there is an inability to provide diagnostic answers due to the high heterogeneity of 
tumors. Furthermore, the quality and quantity of tissue specimens constitute in some 
cases a problem for an accurate diagnosis. The histological classification of human 
gliomas nowadays remains a challenge. The aim is to define the histological type of 
glioma (astrocytic, oligodendrocytic, or mixed) and the grade in order to classify the 
patients and give them an accurate treatment. Although the standard remains the 
WHO classification, this classification suffers from a lack of reproducibility between 
pathologists. It is based on cell density, atypical nuclei, mitoses, endothelial cell 
hyperplasia, microvascular density and proliferation and necrosis. In particular this 
classification does not take into account the intrinsic morphological heterogeneity of 
infiltrative gliomas and does not discriminate the tumor cells from the residual brain 
parenchyma. The classification is not trivial, since the morphology used to classify 
the tumors forms a histological continuum and a single tumor may encompass 
regions of different morphology and cellularity with the highest grade of malignancy 
being relevant for the final classification of the tumor and the resulting therapy [95, 
96]. 
                 IV.1.2. Electron microscopic examination 
 
         A key indicator emerged from the examination of blood vessels in different 
organs by transmission electron microscopy in the 1950s. These studies identified 
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three general types of capillaries: continuous, fenestrated, and discontinuous. Blood 
brain barrier was recognized as an example of specialized capillary endothelial cells 
joined by tight junctions. Three microvessel populations may occur in brain tumors: 
continuous nonfenestrated, continuous fenestrated and discontinuous (with or 
without fenestrations) [62].  
 
         Transmission and scanning electron microscopic analyses have gained further 
insight into ultrastructural alterations of the glioma vessel wall and potential 
transvascular transport mechanisms. Many articles describe and illustrate ultra-
structural abnormalities in brain tumors such as fenestrations, endothelial gaps, 
pinocytotic vesicles, and transendothelial channels [19, 62, 63, 71, 97].  
 
         Electron microscopic studies may help for the understanding of structural and 
functional abnormalities of tumor blood vessels and analyzing at a submicroscopic 
level the morphological changes in vascular microenvironment of astrocytic tumors. 
The attempt is to understand the pathological aspects that may help researches for 
the design of future therapeutic strategies since current brain tumor treatment 
protocols are based on the histological and the vascular phenotype of the tumor 
microenvironment.  
 
       IV.2. Imaging molecular markers of blood vessels 
 
                   Immunohistochemical markers and molecular approaches have also 
been integrated into the classification of gliomas with respect to their glial lineage 
(e.g., whether astrocytic or oligodendroglial), their clinical behavior, and their 
response to treatment [6]. Markers used to understand the structural and functional 
alterations during tumor growth highlight all components of the vessel wall structure: 
endothelial cells, basement membrane and pericytes. Immunohistochemistry (IHC) is 
widely used in basic research to understand the distribution and localization of 
biomarkers and differentially expressed proteins in different parts of a biological 
tissue.  
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         The current standard marker of angiogenesis in cancer is the intra-tumor 
microvessel density (MVD). This is measured as the number of immunostained blood 
vessels per high power microscopic field on a few micrometers thick histological 
section, counted in an area of high vascular density [98].     
 
         Blood vessel detection by UV-Vis means on tissue sections is improved by 
immunohistochemical staining of endothelial cell markers, most commonly CD31 
(Platelet endothelial cell adhesion molecule or PECAM), CD34, factor VIII-related 
antigen (von Willebrand factor) and Ulex europaeus lectin [51, 56, 99]. Vessels are 
also identified by their binding of intravascularly injected fluorescent probes (such as 
cationic liposomes which are positively charged lipid vesicles used as drug delivery 
vehicles) [100] and Lycopersicon esculentum lectin [51]. 
 
         Because vascular endothelial cells are present in much smaller numbers than 
tumor cells, the density of angiogenic markers is low. Not all markers have the same 
specificity and they should be detectable at low concentrations. CD31 is an 
endothelial marker that is commonly used to identify tumor vessels [101]. Like the 
lectin, CD31 immunoreactivity defines the luminal surface of tumor vessels, but, 
unlike the lectin, it is also present on sprouts radiating from the vessel lining into the 
tumor [51, 101].  
 
         Blood vessels can also be marked by antibodies to basement membrane 
proteins. Regardless of the marker, the appearance of blood vessels in histological 
sections is greatly influenced by section thickness. Only short segments of vessels 
are visible in thinner sections, but the vascular network can be seen in thicker 
sections [99, 102]. Membrane proteins selectively expressed by angiogenic blood 
vessels provide potential markers for imaging tumors. Reported examples include 
αvβ3, αvβ5, and α5β1 integrins [80, 103] CD105 (endoglin) [104] , complexes of 
vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 [105], CD36 
(thrombospondin-1 receptor) [106], Thy-1 [107], prostate-specific membrane antigen 
[108] and tumor endothelial markers [109].  
 
          As a key cellular component of the microvasculature, pericytes are a potential 
target for vascular imaging agents, but the cells are located outside the endothelial 
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barrier. Reports that pericytes are an inconsistent component of tumor vessels and 
that their absence is a sign of vessel immaturity raise additional questions. Pericytes 
are identified by their distinctive location within the vascular basement membrane or 
by selective markers. Immunohistochemical markers of pericytes mostly known are 
α-SMA [36, 73, 110], platelet-derived growth factor receptor (PDGFR)-β [48, 111], 
desmin [112], nestin [113], aminopeptidase A, aminopeptidase N (CD13) [113], 
matrix metalloproteinase-9 (gelatinase B) [114], and regulator of G-protein signaling-
5 [115].  
 
         Unfortunately, none of these markers is unique to pericytes. Moreover, 
pericytes are heterogeneous and may not express all markers. The most commonly 
used marker, α-SMA, is expressed by the mural cells of most arterioles and venules 
but not by capillaries, and has variable expression in tumors and other sites of 
angiogenesis [110, 112, 114]. Therefore, the absence of immuno-reactivity for α-SMA 
does not indicate an absence of pericytes. Nevertheless, when multiple markers are 
used for identification, pericytes are consistently found on tumor vessels and growing 
blood vessels at a stage when they do not express α-SMA [36, 111]. Marker 
expression can also vary in different organs and with pathological conditions. 
Because no single commonly used marker identifies all pericytes with certainty, 
pericytes identification is not systematic in pathological conditions, as for cancers, 
i.e., when the cells change their expression of marker proteins. Other limits result 
from differences in the markers used to identify pericytes or differences in section 
thickness, where partial pericyte coverage is missed in thin histological sections [36, 
38].  
 
 
         The use of labeled probes, which can be visualized by fluorescence 
microscopy, confocal microscopy, scanning electron microscopy and transmission 
electron microscopy, is helping to define organ-, vessel- and cell-specific differences 
in the vasculature of normal organs, and of disease sites such as tumors. But it is 
very limited since actually, and in the best conditions, no more than three labels may 
be used on a same sample at once. Moreover, there may be interference between 
antibodies used to highlight blood vessels ultrastructure. Besides, the routine use of 
molecular related markers is laborious, requires suitable technical means, and is thus 
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time and money consuming. Furthermore, the high level of heterogeneity frequently 
encountered in gliomas (at histological, biological and molecular levels) does not 
facilitate the use of such markers [5, 116, 117]. In addition, these global profiling 
approaches have not adequately represented intra-tumor heterogeneity, which could 
be a critical issue if sub-populations of tumor cells had differential growth or migratory 
properties. 
 
 
 
         In conclusion, the most popular methods for imaging gliomas in vivo or ex vivo 
in humans still suffer from a number of important limitations. Angiographic methods 
have a poor resolution to spatially resolve the microvasculature. Ex vivo techniques 
such as microscopic methods ranging from fluorescence, confocal and multiphoton 
microscopy to electron microscopic imaging have not been demonstrated for 
elucidating systematically the structural and functional abnormalities of angiogenic 
blood vessels. Microscopic methods provide their highest resolution on preserved 
tissue specimens, whereas clinical methods give images of living tissues deep within 
the body but at much lower resolution and specificity, and generally cannot resolve 
vessels of the micro-circulation neither small size tumors as metastases. Future 
challenges include developing new imaging methods that can bridge this resolution 
gap and specifically identify angiogenic vessels.  
 
         On the other hand, glioma cell invasion and angiogenesis, today, can only be 
addressed by histological means. These ones are performed in vitro, require 
chemical reagents and staining, and limit the examination to a single observation 
time point. Any fixation and embedding procedure always change the morphology 
and the molecular contents of tissues and may distort the structure of cells. For 
example, immersion of tissues in lipid solvents, such as xylene, dissolves the tissue 
lipids. This treatment causes alterations for any further analysis. 
 
         A convenient technique to study glioma tissues should permit a direct, 
quantitative, sequential, and reproducible assessment of both the tumor cell as well 
as the microvascular compartment. Thus, it is still and crucially required to develop 
other molecular imaging modalities. 
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Chapter II 
 
Vibrational Spectro-Imaging 
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I – INTRODUCTION 
 
         Among the several methods that may be employed for the diagnosis of tumors, 
vibrational spectroscopies and spectro-imaging have been applied successfully, 
owing the possibility of performing analysis of the different chemical compositions 
and molecular structures of healthy and pathological tissues. Vibrational 
spectroscopy belongs to techniques which benefit from the interaction of light with 
matter. Photons that interact with a sample are either absorbed or scattered; photons 
of specific energy are absorbed, and the pattern of absorption provides information, 
or a fingerprint, on the molecules that are present in the sample. 
 
         Two vibrational spectroscopy techniques are available, infrared (IR) 
spectroscopy and Raman spectroscopy, and may be considered as fast analytical 
tools for providing reproducible information about the organic contents of biosamples. 
Moreover, they allow analyzing samples with no need of laborious and invasive 
sampling procedures, or the use of chemical reagents to obtain a result. In particular, 
IR spectroscopy provides the possibility to perform a qualitative and quantitative 
analysis at a molecular level.  
 
         Over the last decade, major technological advances occurred for many 
components of vibrational spectroscopy instruments, including the introduction of 
microscopes, new multi-channel detectors, tunable diode lasers, and optical fibers. 
One of the big advantages of vibrational spectroscopy, especially IR, is that it is not 
limited to a particular state of the sample. Spectra can be obtained from liquids, 
solids (pellets, powders, films), emulsions, suspensions, gases and tissues. In 
principle, the Raman technique has also a distinct advantage over IR for the analysis 
of biofluids, due to the weak scattering of water [118, 119]. 
 
Vibrational Spectro-Imaging 
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II – PRINCIPLES OF VIBRATIONAL SPECTROSCOPY 
 
       II.1. IR spectroscopy 
 
         IR spectroscopy deals with the mid-infrared region (2.5-25 µm) of the 
electromagnetic spectrum (Figure 7), which is the most informative for biosamples 
since these ones contain mainly organic compounds, although the far (25-1000 µm) 
and near IR (0.75-2.5 µm) have proved some benefits.  
 
 
 
 
Figure 7. Electromagnetic spectrum with wavelength and frequency: It shows IR region 
divided in near, mid and far IR regions with their appropriate wavelength limits. 
 
 
 
          This vibrational spectroscopy is considered as a nondestructive photonic 
technique that provides a rapid measure of sample chemistry. Moreover, infrared 
spectral analyses have been widely used to study a variety of samples in different 
chemical and biological fields. IR spectroscopy is based on the absorption of infrared 
radiation by the material analyzed. It allows performing a chemical analysis via the 
detection of vibrations that are characteristic of chemical bonds. When the 
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wavelength (energy) provided by the light beam is close to energy vibration of the 
molecule, this one absorbs the radiation and a decrease in the reflected or 
transmitted intensity occurs. 
 
         Vibrations that result in a change of the dipole moment of the molecule are 
observed in the IR. The frequency or wavelength of absorption depends on the 
relative masses of the atoms and the force constants of the bonds. In general, 
functional groups that have a strong dipole give rise to strong absorptions in the IR 
(Figure 8). The number of normal frequencies of a molecule consisting of n atoms 
can be determined by the following calculations based on the theory of Groups: A 
nonlinear molecule with n atoms has 3n−6 normal modes of vibrations, whereas a 
linear molecule has 3n−5 normal modes of vibration. For organic compounds, the 
observations of the wavenumbers with the relative intensities are sufficient to identify 
a chemical component or a specific chemical bond. Therefore, mid-infrared 
spectroscopy is a global analytical method for biosamples, and an infrared spectrum 
of a molecule may be considered as the fingerprint of that one [120]. 
 
 
Figure 8. Summary of absorptions of bonds in organic molecules in the mid infrared 
region (4000-1000 cm-1).  
 
 
         In the mid-infrared range are revealed mainly two types of molecular vibrations: 
stretching and bending. A stretching vibration (ν) is a rhythmical movement along the 
bond axis such that the interatomic distance is increasing or decreasing. A bending 
vibration (δ) (e.g. scissoring, rocking, wagging, and twisting vibrations) consists of a 
change in the bond angle between bonds. The bond axis (defined as the line directly 
joining two bonded atoms) may rock back and forth within the plane it shares with 
another bond or bend back and forth outside the plane (Figures 9).  
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 Figure 9. Types of vibrations bonds. The bonds between atoms in the molecule stretch 
and bend, absorbing infrared energy and creating the infrared spectrum. A molecule will 
absorb infrared light when the vibration (stretch or bend) results in a molecular dipole 
moment change.  
 
       II.2. Raman spectroscopy 
 
         Raman spectroscopy relies on inelastic scattering, or Raman scattering, of the 
monochromatic light. Excitation of light may range in the ultraviolet (UV), visible or 
near infrared domains of light [118]. When samples are illuminated with a laser beam, 
this latter interacts with the excitations in the sample, resulting in a variation of the 
energy of the laser photons being shifted up or down; this is called Raman scattering 
(Figure 10). Light from the source is collected with a lens and sent through a 
monochromator. Wavelengths close to the laser line, due to elastic Rayleigh 
scattering, are filtered out while the rest of the collected light is directed onto a 
42
detector. The Raman effect occurs when the light hits a molecule, interacts with the 
electrons of its bonds and the incident photon excites one of the electrons in a virtual 
energy state. Two types of scattering may occur: Stokes Raman scattering when the 
molecule relax into a higher vibrational excited state than the original excitation 
energy state; and anti-Stokes Raman scattering occurs if the molecule was already in 
a high vibration energy state and thus returns to a lower state (Figure 11). 
 
Figure 10. Principle of Raman scattering. 
 
 
 
Figure 11. Energy level diagram showing the state involved in Raman signal. 
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         Raman spectroscopy is a non-destructive technique that does not require 
previous sample preparation, allowing data collection, repetition, or complementation. 
Recently, it has been extensively developed to show its potential for the diagnosis of 
pathogens, the analysis of blood components, and for the study of tissue lesions, 
tumors…etc. [121-129]. The advances in optical-electronic devices, mainly in 
detectors and lasers, have increased the number of potential applications and thus 
active research groups in this field.  
 
          Until recently, most Raman spectrometers combined the spectral and the 
lateral information using serial registration procedures. Consequently, data 
acquisition was really time-consuming [130]. Another major disadvantage remains: it 
is that Raman light scattering of a biological sample is an inherently weak effect since 
only one photon over 106 is scattered and thus provides the Raman signal. The 
consequence of this weak sensitivity is that applicability of Raman spectroscopy to 
biological studies remains limited, notably for quantitative studies [131]. An 
alternative would be the utilization of the coherent anti-stokes Raman spectroscopy 
(CARS) technique. It is sensitive to the same vibrational signatures of molecules as 
seen in Raman spectroscopy, typically the nuclear vibrations of chemical bonds. 
However, unlike Raman spectroscopy, CARS employs multiple photons to address 
the molecular vibrations, and produces a signal in which the emitted waves are 
coherent with one another. As a result, CARS is orders of magnitude stronger than 
spontaneous Raman emission. This technique is actually under development, but in 
the future it should be able to fight with IR spectroscopy in terms of sensitivity and 
information level obtained from sample chemical contents. 
 
         Nevertheless, other limits strongly affect the applicability of Raman-related 
techniques to biology; as an example, biological tissues exhibit strong auto-
fluorescence due to the presence of cellular components, and this may obscure the 
Raman spectra obtained when visible excitation is used. Alternatively, it is possible to 
use UV light at wavelengths below 270 nm to circumvent the fluorescence 
interference problem. However, with UV resonance excitation, the tissue penetration 
depth is about a few micrometers. Thus, this technique might be found suitable for 
analyzing surface layers although damages may occur on biosamples when using 
UV light [118].  
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          Although water is a weak scatterer in the Raman, not all fluids can be 
measured with all available excitations. For example, analysis of intact blood is not 
possible with an excitation in the visible because the main component of blood is the 
protein hemoglobin, and the associated heme group has strong absorption bands in 
the 400–520 nm region. Dilution of blood with a buffer or the alternative use of near-
infrared excitation can overcome this limit. However, the use of high intensity lasers 
induces heating of the sample, thus damaging his organic contents [132]. This is 
probably the major limit of actual Raman spectrometers for biosample analyses. 
  
         Raman spectroscopy offers several advantages for microscopic analysis. A 
Raman microscope consists in a standard optical microscope, an excitation laser, a 
monochromator, and a sensitive detector such as charge coupled device (CCD) or a 
photomultiplier tube (PMT). Although Raman microspectroscopy is not highly 
sensitive and may be interfered by laser-induced fluorescence, it allows for confocal 
analyses, less water interference, and higher spectral resolution than IR. 
Nevertheless, the heating destruction of the sample is due to his prolonged exposure 
to the laser beam for obtaining high signal-to-noise (S/N ratio) Raman spectra [119]. 
This makes Raman spectroscopy and imaging unsuitable for small size samples, 
such as single cells or thin tissue sections, where the small amount organic contents 
in presence will require high intensity lasers and/or long acquisition times for 
obtaining a signal. 
 
        All these characteristics and factors that we stated above might explain why 
there are twice as many biomedical applications of IR spectroscopy as Raman 
spectroscopy. That’s also why we were further interested in the biomedical 
applications of IR spectroscopy.  
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III – IR SPECTROSCOPY TECHNIQUES AND APPLICATIONS 
 
       III.1. IR spectroscopy Techniques 
 
      III.1.1. Sample processing 
 
         IR spectroscopy allows analyzing organic materials mainly. The vast diversity of 
experimental applications allows many types of samples, whatever their physical 
condition. There are several types of experimental procedures:  
 
a. Transmission 
 
         Transmission is the property of a substance to allow the passage of light, with 
some or none of the incident photons being absorbed in the process. During the 
process, layers are deposited on an IR transparent substrate. Examples of 
substances tested in transmission: Powder that should be dispersed in a KBr pellet, 
Polymer films if their thickness is <10μm, or substances that should be dissolved in a 
solvent by using liquid cells. Examples of materials that transmit infrared: KBr, CaF2, 
ZnSe, Si. 
 
b. Reflection 
 
         Reflection techniques occur by collecting light reflected from an interface 
air/sample, solid/sample, or liquid/sample. In internal reflection also called attenuated 
total reflection (ATR) technique, the beam of infrared passes through the ATR crystal 
(e.g. Germanium, ZnSe, Diamond, etc.…) in a manner that it reflects the internal 
surface of the sample. This reflection forms the evanescent wave which extends into 
the sample (on < 1 micrometer). Then the beam is collected by a detector when exits 
the crystal. The ATR technique is used for a variety of materials and requires minimal 
or no sample preparation, but it has a sensitivity 3-4 orders of magnitude lower than 
for transmission measurements. There are also other types of reflection techniques 
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such as: external reflection or specular reflection used for smooth surfaces, and 
combination of the two types or diffuse reflection used for rough surfaces.  
 
 
      III.1.2. IR spectra processing 
 
         The infrared spectrum of a sample is collected by passing a beam of infrared 
light through the sample. This can be done with a monochromatic beam which 
changes in wavelength over time, or by using a Michelson interferometer with Fourier 
Transform (FT) instrument to measure all wavelengths at once. From this, a 
transmittance or absorbance spectrum can be produced and shows at which IR 
wavelengths the sample absorbs. 
 
a. Michelson interferometer 
 
         The essential piece of optical hardware in a FTIR spectrometer is the 
interferometer.  The basic scheme of a Michelson interferometer is shown in Figure 
12A. The infrared beam from the source is directed towards the interferometer, when 
the IR light hits the beam splitter, half of the beam passes through it directed to a 
mobile mirror, while the other half is reflected and directed to the fixed mirror. When 
the two beams recombine again on the beam splitter, destructive or constructive 
interferences appear depending on the position of the mobile mirror. The modulated 
beam is then directed from the two mirrors to the sample, where absorptions are 
involved. Then the beam arrives on a detector to be transformed into an electrical 
signal. The signal detector appears as an interferogram (i.e. a signing of the intensity 
(I) depending on the position of the mirror). The interferogram (Figure 12B), which is 
the sum of all the frequencies of the beam, is then converted into an infrared 
spectrum by a mathematical operation called Fourier Transform. 
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 Figure 12. A) Schematics of a Michelson interferometer, S: source, D: detector, M1: fixed 
mirror, M2: mobile mirror, X: mirror displacement, B) Signal measured by detector D. This 
is the interferogram which will be converted into a spectrum by means of a mathematical 
operation called Fourier transform (FT). 
 
b. Final  spectrum 
 
         To obtain a final transmittance spectrum, three steps are necessary (Figure 
13): 
• An interferogram measured without sample in the optical path is Fourier 
transformed and yields a reference spectrum or background (B). 
• An interferogram measured with a sample in the optical path is Fourier 
transformed and yields a sample spectrum (S).  (S) is similar to (B) but has less 
intensity at the wavenumbers where the sample absorbs. 
• The final transmittance spectrum T is defined as the ratio T=S/B.  
 
 
Figure 13. Process to obtain a final spectrum 
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          The reference spectrum is used mainly to prevent fluctuations in the output of 
the source affecting the data. The final transmittance spectrum is the fraction of the 
incident light at a specific wavelength that passes through a sample: 
 
T= I / I0 
 
where (I0) is the intensity of the incident light and (I) is the intensity of the light coming 
out of the sample. Transmittance is related to absorbance by the equation: 
 
A= - log10T 
 
 
c. Detector properties 
 
          Two main types of IR detectors are available: thermal and photonic. The most 
commonly used are: The Deuterated triglycine sulfate (DTGS) detector which is a 
thermal detector that operates at room temperature. It is in thermal equilibrium with 
the environment. And the Mercury cadmium telluride (MCT) detector which is a 
photonic or photoconductive detector, it has to be cooled to cut thermal noise. It 
usually operates at the temperature of liquid nitrogen. 
 
         The detection limit of an IR detector is the number of photons necessary for a 
signal to be recorded. 
 
 
      III.1.3. Advantages of FTIR over conventional IR 
 
         Besides its high wavenumber accuracy, FTIR offers other advantageous 
features, which make it superior to conventional IR:  
 
• The circular apertures used in FTIR spectrometers have a larger area than the 
linear slits used in conventional spectrometers, thus enabling higher throughput of 
radiation. 
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• In conventional spectrometers the spectrum is measured directly by recording the 
intensity at different monochromator settings, one after the other. In FTIR, all 
frequencies emanating from the IR source hit simultaneously the detector.  
 
• The measuring time in FTIR is the time needed to move mirror M2 over a distance 
proportional to the desired resolution. As the mirror can be moved very fast, com-
plete spectra can be measured in fractions of a second.  
 
      III.1.4. IR microscopy and imaging 
 
         With IR microscopy (where a spectrometer is coupled to a microscope), the 
chemical information of a sample is obtained from a microscopic volume, which may 
be close to the cellular level or even below. This spatially resolved investigation of 
samples is useful for analyzing biological tissues. The major advantage of IR 
microscopy over microscopic methods in the visible / UV spectral region is its ability 
to monitor the chemical composition using the inherent spectral properties of the 
components [133].  
 
         The term infrared microscopy covers two main types of diffraction-limited 
microscopy. The first one uses a single detector and thus provides optical 
visualization plus IR spectroscopic data collection at one point of the sample. Point-
by-point mapping of a sample area is also possible, although IR spectra acquisition 
time may be very long. The second technique employs arrays (linear or focal plane) 
of detectors and thus provides optical visualization plus a spatially resolved IR 
mapping of a sample area. In this case, the term “FTIR imaging” may be used to 
discriminate with “FTIR microscopy”. One advantage of FTIR microscopy is the 
possibility to modulate the aperture, thus allowing a “confocal-like” microscopy of the 
sample. In this case, it becomes possible to obtain information from the sample at a 
spatial resolution below the diffraction limit, i.e., from a sample area smaller than the 
IR vibration length. As a consequence, the limit of this microscopy will be the level of 
signal obtained, which is usually very poor for apertures more than 50% smaller than 
the diffraction limit. On the other hand, FTIR imaging uses arrays of detectors without 
a physical control of aperture but with a magnification level. In other words, the 
spatial resolution of the image is determined by the size of the detectors and the 
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magnification level. As an example, a 6.25*6.25 µm pixel-size is obtained on the final 
IR image with FTIR imaging system using detectors of 25*25 µm and a 4X 
magnification level of the microscope. It means that a spectrum is collected every 
step of 6.25 µm (named “step-size” resolution), whatever the diffraction limit. 
Therefore, for spectral resolutions below 6.25*6.25 µm, i.e., below 1600 cm-1, there is 
overlapping of information from the adjacent pixels. This has to be taken into account 
for the interpretation of results. Nevertheless, the development of linear and focal 
plane arrays of detectors opened the way to the routine use of FTIR imaging for 
biosample analyses, which is mainly due to the enormous gain of time in FTIR image 
acquisitions with respect to FTIR micro-spectroscopy.  
 
a. Arrays of detectors 
 
         Spectra may be measured using only one detector (FTIR microscopy) or a 
series of detectors physicaly arranged as Linear Arrays (LA; typically 16 or 32 
detectors) or the two-dimensional Focal Plane Arrays (FPA; typically 64*64 = 4096 
detectors or 128*128 = 16384 detectors). With FTIR microscopy, a reconstructed 
FTIR image of a sample is obtained point-by-point by moving the sample in the x and 
y directions using a computer-controlled stage. For mapping a sample with LA or 
FPA detectors, sample movements are tremendously reduced, thus saving time in 
FTIR spectra acquisitions and reducing possible displacement errors. FPA imaging, 
with its ability to collect tens of thousands of spectra simultaneously is orders of 
magnitude faster than linear arrays which can typically collect 16 to 32 spectra 
simultaneously, which are in turn much faster than single-point mapping. However, 
the disadvantage at using FPA or LA detectors is that the photon flux produced by 
the IR source is divided by 16 to 16.103, thus necessitating longer acquisition time to 
obtain high quality spectra with appropriate S/N for further spectral data treatment 
and interpretation. In theory, the same S/N should be obtained by FTIR microscopy 
and imaging means as soon as a sample has absorbed the same count of photons. 
In the practice however, the FTIR spectroscopy technique is sensitive enough to 
obtain high S/N with a limited number of scans, over which the absorption of photons 
does not mean a higher quality of the spectrum obtained. One may also consider that 
long acquisition time is also affected by changes in the environmental conditions, 
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notably for CO2 and H2O in air, making the background spectrum lifetime quite 
limited. To overcome this limit, the N2 purge of the system must be optimized, which 
usually requires modifications of commercial IR instruments. Therefore, FTIR imaging 
maintains a significant advantage over FTIR microscopy in term of acquisition time 
for large sample areas. 
 
b. Data analysis  
 
         The data volume obtained in chemical imaging is called hyperspectral as many 
spectral wavelengths are collected and the data format is called a hypercube. It is 
visualized as a three-dimensional block: two spatial dimensions (x and y) and a 
series of wavelength (λ) making up the third spectral axis. Data analysis methods for 
chemical imaging data sets typically employ mathematical algorithms common to 
single point spectroscopy or to image analysis. The reasoning is that the spectrum 
acquired by each detector is equivalent to a single point spectrum; therefore pre-
processing, chemometrics and pattern recognition techniques are utilized with the 
similar goal to separate chemical and physical information and perform a qualitative 
or quantitative characterization of individual sample components. Spectral data 
processing is necessary regarding the complexity of biological spectra. Due to the 
composition of samples, containing hundreds to thousands of molecules in very 
different and variable concentrations, their absorptions are overlapped in small 
spectral regions, mainly 3050-2800 and 1750-900 cm-1, where the most useful 
spectral information is found for the mid-infrared range.  
 
 
       III.2. FTIR Bio-applications  
 
         FTIR spectroscopy is widely used and adaptable method for chemical analysis, 
which produces a spectrum with characteristic spectral absorption bands from a 
single molecular species at specific vibrational frequencies (Figure 14). The huge 
information found in IR spectra of biosamples grants itself to the operation of data 
bases and the “fingerprint” approach to chemical identification.  
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Figure 14. IR spectrum of β-D-Glucose (pure product). IR reveals the ν(C-O-C) at 1033 
cm-1. 
 
 
         For years, FTIR spectroscopy has been widely applied as an analytical 
technique in different fields as geology, material sciences, polymers, engineering, 
chemical and pharmaceutical industries…etc. for the study of molecular structure of 
compounds. However, it found also an application in biology since rapid advances in 
biomedical sciences required new chemical and structural information of biological 
materials. These include kidney stones [134, 135] and biological fluids such as 
synovial fluid [136] and plasma which was studied in our laboratory [137-139]. Due to 
its unique fingerprinting capabilities, infrared spectroscopy is a very valuable tool for 
biomolecular investigations.  
 
         Infrared spectra of tissues from various biological organs show similarities in 
main spectral features, and consist of several bands similar to those obtained from IR 
spectra of mixtures of extracellular and intracellular proteins and typical cell 
components, such as nucleic acids, lipids, and carbohydrates, which are the main 
constituents of biological tissues. The bands observed in the IR spectra of the 
samples revealed the various modes of the functional groups in the molecules of 
these constituents. Detailed assignments of the IR bands in various tissues have 
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been established by comparison of the IR spectra of proteins, nucleic acids, lipids, 
and carbohydrates isolated from tissues and cultured cells (Figure 15). 
 
 
 
Figure 15. FTIR spectrum of U87 cells (human glioblastoma) expressed as arbitrary units 
(a.u.). The main infrared absorptions belonging to cellular contents are the ν-(–CH) of fatty 
acyl moieties, the C=O and N–H of amides, the NH2 of amines, P–O and P=O of phosphate 
groups and C–O–C of sugars. (Based on Petibois et al. 2006) [140]. 
 
 
 
         In biological tissues, FTIR spectra reveal absorbances corresponding to their 
chemical components. As an example of band assignments in a biological tissue: 
brain tissue is mainly composed of lipids (6–16%), proteins (9–11%), and water (70–
83%) [141, 142]. FTIR spectra of brain samples are dominated by the amide I band 
at 1655 cm-1 and amide II band at 1545 cm-1 which arise from the C=O stretching and 
N–H bending vibrations, respectively, of the amide groups comprising the peptide 
linkages of proteins. Weaker protein absorptions include the amide III band at 1254 
cm-1 and a number of peptide side chain vibrations that occur in the range between 
1310 and 1470 cm-1. At 1080 and 1240 cm_1 occur absorption bands due to 
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deoxyribose C–O and PO2- groups of DNA [143]. White matter is known to have a 
high lipid and cholesterol content. Cholesterol exhibits IR bands at 1060 and 1382 
cm−1 [141]. Intense IR bands of lipids are found at 1234 cm−1 (phosphodioxy groups), 
1467 cm−1 (CH2 bend), 1740 cm−1 (C=O stretch), and 2851 and 2920 cm−1 (CH2 
stretch), owing to the phospholipids, sphingomyelin, and glycolipids of the major 
white matter constituent myelin [144]. 
     
         Several groups used infrared microscopy as a diagnostic tool to distinguish 
control from diseased cells or tissues. Numerous papers are devoted to the studies 
on cancerous disease, and subtle differences between normal and cancerous 
samples were detected. Infrared microscopy has also been applied in neuroscience. 
Several research papers to introduce the biomedical applications of FT-IR 
microscopy have been reported [133, 140, 141, 145-153]. Results obtained for 
various pathological states of human tissues are quite promising: changes in cell 
structure and composition can be visualized in the vibrational spectrum of a biological 
fluid or tissue even at an early stage of the disease. Thus, FTIR microscopy can join 
ex vivo clinical diagnostics, immunohistochemical analysis and histological 
determinations to set up a suitable protocol to study lesions in human tissues. 
 
      III.2.1. FTIR in cell biology 
 
         FTIR microscopy is becoming increasingly important for the study of cellular 
changes in various biological samples due to the molecular information provided. 
This powerful technique has been around for years but only now is becoming used in 
cell biology. Advances in high resolution FTIR microscopy may provide valuable new 
information on stem cells [154, 155]. It has been used to detect intracellular changes 
associated with diseases. It has also been used to study erythrocytes changes during 
exercise oxidative stress [138] and to analyze biochemical changes in tumor cells 
under stress conditions [150]. FTIR microscopy provides unique information about 
the structural and conformational changes of the molecules inside the cell in 
response to physiological or pathological stimuli. Studies of main biological molecules 
in individual cells with the use of FTIR means were previously applied to identification 
of changes that proceed during normal cell cycle or other processes like necrosis or 
apoptosis [156, 157]. Moreover, it has been proved that IR spectra is very informative 
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for taxonomical purposes concerning bacterial classification [158, 159], and other 
studies used FTIR spectroscopy for discrimination between diverse microbial species 
and strains on a routine basis [160, 161]. 
 
                 III.2.2. FTIR in histology 
 
         FTIR spectroscopy utilization may be envisaged as a tool for the detection of 
cancer over the traditional methods such as histopathologic analysis or others. The 
histological analysis of tissue samples by focusing on the bulk morphological features 
lacks quantitative accuracy and gives no account for the biochemical causality of the 
changes that occur during carcinogenesis. In comparison, IR spectroscopy may be a 
good alternative, being better than both of the histopathological or ultrasound 
examination (for ensuring high accuracy) and the computer tomography or X-ray 
transmission diagnosis (for being less expensive) [162]. Rather than using a stain- or 
immunoassay-based approach to histopathologic analysis, many researches focused 
to develop a spectroscopic imaging approach based on the chemical constitution of 
tissue.  
 
         As biological tissues contain same chemical components (proteins, nucleic 
acids, carbohydrates and lipids), their characteristic FTIR spectra are close but reveal 
small differences in specific absorbance features. Whereas chemical concentrations 
are quantified by spectral absorbance properties at specific vibrational frequencies, 
subtle molecular structural changes are indicated by spectral peak shifts, band 
shapes and relative intensity changes occurring across the vibrational spectrum 
[163]. Any changes in the body induced by diseases such as cancer are due to 
biochemical changes in one or all of these components. And since vibrational spectra 
are sensitive to the structure of these components, then they also change with the 
diseased state. For conventional methods, such as standard histological techniques, 
fluorescent probes and stains are required to display the spatial distribution of cellular 
and some biochemical components in tissue. Thus, quantification with these methods 
remains difficult. The use of FTIR imaging is exceptionally well suited for 
differentiating distinct tissue structures and for identifying tissue pathology. A series 
of works done by the group of Malins have demonstrated that highly sensitive 
statistical models of FTIR spectra are capable of identifying subtle differences in the 
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base and backbone structures of DNA in normal and abnormal tissues such as in 
prostate, ovary, and breast cancers [164-167]. Many other investigations have been 
focused on discriminating normal and malignant tissues at different sites such as 
stomach [168], cervical [169, 170], breast [146, 162], skin [171, 172], colon [148, 
173], prostate [174-176] and lung [177]; or for studying tissue changes in other 
pathological conditions such for bone [178, 179], osteomalacia [180], and 
osteoarthritis [181].  
 
         However, if the FTIR technique for molecular assessing of tissue diagnosis has 
still not become an everyday tool in the hands of pathologists, it is that surgery and 
treatment of these diseases have already benefited dedicated developments from 
other high performance methods. It appears that FTIR imaging might play a role only 
for clinical applications where all other imaging modalities have already failed to 
provide accurate diagnostic results. This is the case for brain gliomas or prostate 
cancer, which have in common to be lethal for most of occurrences and present small 
size dimensions, i.e., a few mm3 at early stage of the pathology. Since tissue 
composition is modified during carcinogenesis, the FTIR spectrum of cancerous 
tissue, as for glioma, will differ from that of the healthy tissue. Pathological changes 
associated with the development of brain tumor were investigated by FTIR imaging in 
many previous studies [143, 151, 182-184]. Most of these studies mentioned that 
structural changes were mainly related to qualitative and quantitative changes in 
lipids and they suggest that an increase in malignancy is accompanied by a reduction 
of total lipids relatively to other chemical species [151, 182, 184]. However, till now 
there is not a real clinical application of these studies that would allow help to define 
tumor edge during neurosurgery.  
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         In summary, vibrational infrared spectro-imaging is a nondestructive photonic 
technique that provides a rapid measure of sample chemistry. Consequently, infrared 
spectral analyses have been used to study a wide variety of biomedical samples. 
There are three major aspects to the implementation of such an approach: 1- the 
rapid acquisition of high-fidelity microspectroscopic imaging data; 2- the development 
of robust algorithms to provide statistical controls over the classification process; and 
3- the large-scale validation of the developed algorithms. The resultant FTIR 
vibrational microscopy or imaging can provide molecular information of samples with 
a high spatial resolution at microscopic level (e.g. the secondary structure of the 
proteins may be noninvasively measured in native environment). Thus, the use of this 
technique has extensively become a great potential over other diagnostic techniques 
for noninvasively investigating the chemical components of ultrastructual tissues at 
various disease states, due to the reagentless procedure and no dyes or labels 
addition for spectral determination. As compared with conventional histopathologic 
diagnosis, the micro-spectroscopic chemical information is supposed to be more 
objective and rapid. It not only provides more detailed spectral information of tissue 
(lipids, proteins, RNA/DNA, carbohydrates) for physicians, but also earlier predicts 
the diagnostic results of diseases. 
 
         FTIR imaging is a new tool for examining tissue sections, which does not 
require sample staining or fixation. In combination with advanced data processing 
techniques, this new approach has the potential to complement established 
strategies of tissue section diagnosis. Concordance between spectroscopic and 
clinical results opens the way for FTIR imaging to complement and support 
immunohistochemical and histological procedures, regarding the complexity of 
biological tissues. Nevertheless, chemical mapping by FTIR imaging may lead to an 
early and better understanding of chemical and morphological changes through the 
localization and characterization of pathological areas of a tissue. The possibility to 
detect molecular changes resulting from the initial pathological levels of a disease 
makes this technique a powerful tool for its accurate early diagnosis and prognosis. 
 
        In this research, Infrared spectro-imaging will be suggested as a tool in clinical 
and diagnostic analysis of glioma tissues to complement the existing methods 
because of its potential to probe tissue and cells at the molecular level. Compared to 
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routine imaging modalities, FTIR imaging advantages include that (i) it is rapid, as 
spectral data can be collected and interpreted within minutes by automated 
algorithms; (ii) it requires minimal sample preparation, as molecular vibrations probe 
the chemical composition and structural properties of tissue sections without external 
markers; and (iii) it is non-destructive, so the sample can be subjected to further 
analyses such as immunohistochemistry in order to confirm the findings.  
 
         Regarding the role of angiogenesis in gliomas, the limits of the imaging 
techniques for gliomas angiogenesis used nowadays, and the molecular information 
available through FTIR imaging data treatments, we performed this research to 
complement established histological techniques used for gliomas diagnosis. The 
most relevant parameters for discriminating between areas of tumor and healthy 
tissue are the following: (i) discriminating tumor versus healthy vasculature; (ii) 
determining changes in protein secondary structure of blood vessels during tumor 
growth; and (iii) evaluating oxidative stress effects on the fatty acyl chains of 
phospholipids. A combination of these parameters was envisaged to provide a more 
robust molecular histopathology prediction tool to study gliomas angiogenesis in 
different xenografted tumors as well as in human samples. After the review of the 
literature, it is noteworthy to precise that for the first time FTIR imaging was 
used to study angiogenic blood capillaries in glioma tumors.   
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- PAPER 1- 
 
Analysis of type I and IV collagens by FT-IR spectroscopy and 
imaging for a molecular investigation of skeletal muscle connective 
tissue 
  
 
Anal Bioanal Chem (2006) 386:1961–1966. 
 
 
Purpose: The aim of this study was to show that FT-IR spectroscopy and imaging 
are relevant techniques for studying biological tissue molecular contents, notably for 
its connective part. Type I and IV collagens (tI-C and tIV-C, respectively) were 
analyzed by FT-IR spectroscopy to determine the differences in secondary structure 
of these proteins. FT-IR imaging of skeletal muscle tissue sections was then used for 
comparing perimysium and endomysium collagen types, which are known to be 
mainly tI-C and tIV-C, respectively. This tissue model was chosen because of the 
ease morphological recognition of these connective tissue parts. 
 
Main results: Secondary structure of collagen types was determined by using their 
secondary derivative spectrum for determining the position of absorption bands within 
the amide I spectral interval (1700-1600 cm-1) and the curve-fitting of this one for 
determining every band absorption (spectral area, in squared a.u. of FTIR spectrum). 
Eight absorption bands could be determined on series of pure product FTIR spectra 
of types I and IV collagens, with α-helix (1,656 cm−1), β-sheet (added 1,691; 1,679; 
and 1,626 cm−1), β-turn (added 1,669 and 1,608 cm−1), triple helix (1,638 cm−1), and 
unordered structure (1,647 cm−1). Type I collagen could be differentiated from type IV 
by its higher amounts of triple helix and α-helix, and lower amount of β-sheets 
(P<0.01). FT-IR imaging was then used to determine structural features of 
perimysium and endomysium collagen network in bovine flexor carpi radialis muscle. 
Secondary structure of proteins contained in perimysium and endomysium was found 
to be highy correlated to type I and IV collagens, respectively. FT-IR spectroscopy 
77
and imaging are thus analytical tools that might be used for investigating 
biodistribution and assembly of collagen types in tissues. 
 
Conclusion: This study has shown that type I and IV collagens may be differentiated 
by using several secondary structure parameters revealed by the curve-fitting of the 
amide I spectral interval of FT-IR spectra. Moreover, FT-IR imaging allows 
differentiation of the main connective tissue compartments of skeletal muscle, 
perimysium and endomysium, on the basis of these collagen types secondary 
structure parameters. These perspectives open the route to a functional FT-IR 
imaging of tissues on the basis of molecular features considered as characteristic of 
a given physiological situation (e.g., pathology or necrosis), which may be named a 
molecular histopathology. 
 
Contribution to a “molecular histology of brain glioma”: The extracellular matrix 
(ECM) provides necessary contacts between endothelial cells (ECs) and the 
surrounding tissue, and thus prevents blood vessels from collapsing. At their native 
state, i.e., when vessels are quiescent, their basement membrane is mainly made of 
of collagen IV, laminin, and other components surround the vascular cells; pericytes 
and ECs are even embedded in the same basement membrane. An interstitial matrix 
of collagen I and elastin between vascular cells further provides visco-elasticity and 
strength to the vessel wall. The ECM also regulates the formation of new vessel 
sprouts. Thus, the idea is to study collagen type contents within the vascular 
basement membrane of healthy and tumor blood capillaries by FT-IR spectroscopy 
with the aim of determining the morphological limits of gliomas. 
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Abstract Many muscular diseases result from abnormal
organization of connective tissue and/or collagen network
formation. Only a few molecular imaging techniques are
able to analyze this collagen network by differentiating
collagen types. In this study, FT-IR spectroscopy was used
to analyze type I and IV collagens, the most important
compounds of which are perimysium and endomysium,
respectively. Secondary structure of collagen types was
determined by curve-fitting the 1,700–1,480 cm−1 spectral
interval. Type I collagen could be differentiated from type
IV by its higher amounts of triple helix and α-helix, but
lower amounts of β-sheets (P<0.01). FT-IR imaging was
then used to determine structural features of perimysium
and endomysium collagen network in bovine Flexor carpi
radialis muscle. Secondary structure of proteins contained
in perimysium and endomysium was found to be very close
to type I and IV collagens, respectively. FT-IR spectroscopy
and imaging are thus analytical tools that might be used for
investigating biodistribution and assembly of collagen types
in connective tissues.
Keywords FT-IR imaging . Skeletal muscle . Collagen .
Perimysium . Endomysium
Abbreviations
ECM extracellular matrix
FT-IR Fourier-transform infrared
IMCT intramuscular connective tissue
tI-C type I collagen
tIV-C type IV collagen
Introduction
Abnormal formation of skeletal muscle connective tissue is
presumed to initiate a wide range of debilitating diseases, such
as dystrophies [1], fibrosis [2], rhabdomyosarcoma [3], and
most myopathies [4]. In such pathologies, the extracellular
matrix (ECM) plays a fundamental role, both in structural
and functional aspects of skeletal muscle. The two main
components of the ECM are the endomysium and the
perimysium. The endomysium is made of a continuous sheet
covering the full length of myofibers until the myotendinous
junction. It is organized as a regular network of thin collagen
fibers composed mostly of type IV (tIV-C), as well as types
III, VI, and XII to a minor extent. This network attaches
myofibers sarcolemma to specific transmembrane proteins,
thereby forming a regular mosaic pattern. In contrast, the
perimysium is formed by an alveolar network of crimped
collagen fibers varying in diameter and composition,
including essentially type I collagen (tI-C) in conjunction
with small amounts of types III, VI, and XII. Thus,
perimysium and endomysium network formation within
skeletal muscle may be analyzed through the respective
biodistributions of tI-C and tIV-C [5, 6].
However, to date, only a few analytical methods are able
to provide information about collagen biodistribution,
assembly, and typology [5]. The spatial distribution of the
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intramuscular connective tissue (IMCT) is usually exam-
ined by using histology and magnetic resonance imaging,
but these techniques do not provide a spatial resolution
allowing the study of collagen network organization [7].
Among ex vivo diagnostic methods, Fourier-transform
infrared (FT-IR) spectroscopy and spectro-imaging emerged
and developed rapidly during the last decade [8]. The FT-IR
technique is based on the absorption of infrared light by
vibrational transitions in covalent bonds. The intensities
provide quantitative information about sample contents,
since frequencies relate to the nature of molecular bonds,
their structure, and their environment. In complex systems
such as cells, an infrared spectrum is the sum of the
contributions gathered from the proteins, lipids, nucleic
acids, and metabolic parameters present. The spectra can be
used as signatures if spectral patterns are correlated with
biological properties. Useful diagnostic information has
been extracted from infrared spectra in the case of different
pathologies [9–11], but this technique is not yet recognize
as a powerful diagnostic tool. Right now, the main
successes of FT-IR spectroscopy have been bacteria
identification [12], recognition of molecular structure [13],
and molecular concentrations determination within biolog-
ical fluids [14, 15]. One of the advantages of the FT-IR
spectroscopy approach is that a spectrum is representative
of all the cell constituents and may be recorded within a
few seconds. A recent technical advance has been the
development of imaging systems able to provide fast FT-IR
images of tissues, and only a few minutes are now required
to obtain a functional FT-IR image of a 1-mm2 tissue area.
Therefore, as a molecular probe of tissue composition, FT-
IR imaging may favorably help histopathology in detecting
and diagnosing diseases, notably small-sized and/or diffuse
tumors, which are undetectable using the MRI or PET
imaging techniques in vivo [16, 17].
The aim of this study was to show that FT-IR imaging may
be considered as a useful tool for the functional molecular
imaging of skeletal muscle connective tissue. tI-C and tIV-C
were analyzed by FT-IR spectroscopy to determine secondary
structure differences between proteins. FT-IR imaging of
skeletal muscle tissue sections was then used to determine tI-C
and tIV-C biodistribution within the connective tissue
collagen network.
Methods
Reference collagen FT-IR spectra
The tissue the most concentrated in type I collagen (>90%)
is the tail of male Wistar rat [18] and thus may be used to
analyze this protein secondary structure. A series of thin
fibers were removed from the rat tail for FT-IR spectra
acquisitions. Fibers were laid down flat on a ZnSe window
(25-mm diameter; 2-mm thickness) before desiccation in a
moderate drying vacuum to evaporate residual water (2 h).
Pure product (>95%) type IV collagen was purchased from
Sigma-Aldrich (Ref. product: C5533). Type IV collagen
solution was deposited on a series of ZnSe windows before
desiccation to obtain reproducible dry films. All spectra
were obtained by using a Spotlight 300 imaging system,
equipped with a Spectrum One spectrometer (Perlin-Elmer,
France). For FT-IR spectra acquisition, the imaging system
was used in spectroscopy point mode (aperture of 100×
100 μm), with a 4.0 cm−1 resolution, and acquisitions were
performed using 60 scans in transmittance mode. All
experiments were performed in triplicate and FT-IR spectra
were averaged before data treatments (n=10 averaged
spectra for each collagen type).
Tissue FT-IR imaging
All procedures were performed in accordance with institu-
tional guidelines for animal care. The Flexor carpi radialis
muscles of the foreleg were taken from different cows, just
after slaughter, and immediately frozen. Frozen tissue was
laid down flat on cooled glue (poly(vinyl alcohol) for
cryostat, −20 °C) to avoid tissue embedding. Tissue
deposition on sample holder was arranged in order that
fibers present vertically to the blade at sectioning. Additional
glue was used to homogenize the sample intended for
cryosections (Cryostat 3050-TM, Leica-Microsystems,
France). A series of 16-μm-thick sections were used for
FT-IR analyses using the Spotlight 300 FT-IR imaging
system (Perkin-Elmer, France). Transmittance FT-IR spectra
were obtained in image mode (6.25-μm pixels) and using
8 scans (4,000–700 cm−1) and a 4 cm−1 resolution. A total of
10 tissue sections were used for statistical data treatments.
Fig. 1 FT-IR spectra of type I and IV collagens. Maximal intensity
absorptions are revealed by the peak-picking sub-routine of Opus 4.2
software (Bruker, Germany) with a sensitivity of 1%
1962 Anal Bioanal Chem (2006) 386:1961–1966
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Spectral curve-fitting
Curve-fitting of collagen FT-IR spectra was performed as
previously described [19], using a sub-routine of Opus 4.2
software (Bruker, Germany). Briefly, the 1,750–1,400 cm−1
spectral interval was used to determine secondary structure
of collagen protein. To avoid the usual confounding effects
of self curve-fitting, where absorption band positions may
vary a lot, absorption bands were fixed for all FT-IR spectra
according to previous studies [13, 20–22]. The percentage
of Gaussian and Lorentzian functions for every absorption
band was first determined from the series of pure product
spectra of collagen. Thirteen absorption bands of amides I
and II were found in the 1,700–1,480 cm−1 spectral interval
of plasma FT-IR spectra. Secondly, bandwidth and absorp-
tion line shape fixed for these 13 bands were applied to
determine collagen absorptions on skeletal muscle tissue
FT-IR images. Free parameters in fitting procedure were
also added at 1,750 and 1,400 cm−1 to avoid anomalous
band additions at the limits of the selected spectral interval.
In this way, secondary structure absorption bands of
collagen were not modified by the bands that could not be
correctly determined at the limits of the spectral interval
selected. According to literature [8, 13, 19–21, 23, 24],
secondary structure calculation was performed using amide
I bands as follows: α-helix (ca. 1,656 cm−1), β-sheet
(added ca. 1,691, 1,679, and 1,626 cm−1), β-turn (added ca.
1,669 and 1,608 cm−1), triple helix (ca. 1,638 cm−1), and
unordered structure (ca. 1,647 cm−1). Secondary structure
parameters were expressed as percentage of total amide I
absorption.
Statistics
Results are presented as means±SD. Differences between
series of data were determined by using the Student t-test.
Confidence limit was set at 1 or 5% (P<0.01 or 0.05) as
indicated in text or tables.
Results and discussion
FT-IR spectra of type I and IV collagens
FT-IR spectra from tI-C and tIV-C are presented in Fig. 1.
Peak picking was performed on the 1,800–900 cm−1
spectral interval for comparison with literature [13, 20,
25–29]. Both types of collagen exhibited absorptions at
1,033, 1,059, and 1,083 cm−1, which arise from the C–OH
stretching vibrations of the carbohydrate moieties attached
to the protein [29]. Absorption features at 1,451, 1,399,
1,339, 1,282, 1,236, and 1,203 cm−1 are attributed to CH2
and CH3 wagging and deformation, and C–N stretching of
collagen [4]. Amides I and II absorptions were revealed at
1,658 and 1,555 cm−1 and the shoulder appearing at
1,637 cm−1 could be attributed to the triple helix absorption
of collagens [27]. Both tI-C and tIV-C exhibited very
similar absorptions although one could notice that tI-C
presented higher intensities for the 1,100–1,000 cm−1
spectral interval.
To analyze secondary structure of proteins, amide band
absorptions were determined by curve-fitting the 1,750–
1,480 cm−1 spectral interval (Fig. 2). All amide I absorption
bands could be determined on every spectrum (n=10 for
Fig. 2 Spectral curve-fitting of
type I (left) and IV (right)
collagens for the 1,750–
1,400 cm−1 spectral interval.
Absorption bands of amide I are
used for secondary structure
calculation (Table 1)
Table 1 Secondary structure calculation from tI-C and tIV-C FT-IR spectra
α-helix Triple helix β-sheets β-turns Unordered
tI-C 18.6±0.9 17.7±0.4 27.7±1.1 24.4±0.7 11.6±0.9
tIV-C 15.6±0.6** 15.7±1.0* 31.7±2.5* 25.0±1.2 12.0±1.9
*Significantly different from tI-C, P<0.05; **P<0.01. Absorption bands used for secondary structure calculation: α-helix (ca. 1,656 cm−1 ),
β-sheet (ca. 1,691, 1,679, and 1,626 cm−1 ), β-turn (ca. 1,669 and 1,608 cm−1 ), triple helix (ca. 1,638 cm−1 ), and unordered structure
(ca. 1,647 cm−1 ). n=10 spectra for each protein
Anal Bioanal Chem (2006) 386:1961–1966 1963
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each collagen type) with no more than 2 cm−1 shift at
maximal intensities. As previously described in the literature
[8, 13, 20–22], absorption features could be attributed as
follows: ca. 1,690 cm−1 (parallel β-sheets), ca. 1,680 cm−1
(anti-parallel β-sheets), ca. 1,668 cm−1 (β-turns), ca.
1,658 cm−1 (α-helix), ca. 1,647 cm−1 (unordered),
1,638 cm−1 (triple helix), ca. 1625 cm−1 (parallel β-sheets),
and ca. 1,612 cm−1 (β-turns). It was found that both tI-C and
tIV-C exhibited very close absorptions, which only varied
significantly in intensity. Spectral area per band was used for
secondary structure calculation. Absorption bands belonging
to β-sheets (3 bands) or β-turns (2 bands) were added. As
described in Table 1, it was found that tI-C presented
significantly higher α-helix and triple helix contents than
tIV-C, while β-sheet content was lower (P<0.05). Contents
in β-turns and unordered structure were found similar
between collagen types. This higher content in α-helix and
triple helix for tI-C could be explained by the lack of globular
domains in the protein. As a consequence, the relative amount
of α-helix and triple helix is increased in tI-C, while the
amount of β-sheets is lowered [30, 31]. The results obtained
in this study show for the first time that spectral curve-fitting
allows differentiation of collagen types on the basis of their
secondary structure. Further studies might be envisaged for
differentiating other collagen types (e.g., type VI), which
notably play a role in pathologies implying connective tissue
alterations [5]. This differentiation of collagen types is also
the basis of a functional infrared imaging of connective
tissue in skeletal muscle, since endomysium and perimysium
are mostly composed of tIV-C and tI-C, respectively [5, 6].
FT-IR images of skeletal muscle tissue
An example of tissue analysis by FT-IR imaging is
provided in Fig. 3. Once a tissue section was found to
present skeletal muscle fibers arranged in the vertical plan,
an area in which perimysium and endomysium could be
distinguished was selected to perform visible and FT-IR
image acquisitions. Typically, 400×400-μm tissue areas
could be analyzed in 6–8 min. As shown in Fig. 3, 4 to 6
spectra belonging to endomysium and perimysium were
selected and averaged for every tissue section (n=10) and
used for determining secondary structure of protein content
(Table 2; Fig. 4). The same differences were found between
Fig. 3 Visible (left) and full
spectral FT-IR (right) images of
skeletal muscle tissue section
(16 μm) exhibiting a vertical
arrangement of fibers. + and ×
in FT-IR image show selected
positions to obtain FT-IR spectra
of perimysium and endomy-
sium, respectively
Table 2 Secondary structure calculation from perimysium and endomysium FT-IR spectra
α-helix Triple helix β-sheets β-turns Unordered
Perimysium 18.9±0.4a 17.6±0.8a 28.3±1.5a 22.6±2.2 12.6±0.8
Endomysium 16.0±0.5*b 15.4±0.6*b 31.6±1.1*b 24.9±1.6b 13.0±0.6
*Significantly different from perimysium, P<0.05
a Significant correlation with tI-C secondary structure parameters, P<0.05
b Significant correlation with tIV-C secondary structure parameters, P<0.05 (see Table 1 for details). n=10 spectra for each sample
1964 Anal Bioanal Chem (2006) 386:1961–1966
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perimysium and endomysium as for tI-C and tIV-C,
respectively, i.e., perimysium secondary structure presented
higher amounts of α-helix and triple helix (P<0.05), while
the proportion of β-sheets was lower (P<0.05) than for
endomysium. Again, as for collagen types, relative amounts
of β-turns and unordered structure were found to be similar.
It is also noteworthy that several features of secondary
structure of perimysium protein contents were found
significantly correlated to the results obtained for tI-C:
relative amounts of α-helix, triple helix, and β-sheets were
found to be very similar (P<0.05). The same level of
correlation was found between secondary structures of
tIV-C and endomysium protein contents (P<0.05). These
results clearly indicate that skeletal muscle perimysium and
endomysium may be analyzed by FT-IR spectroscopy and
imaging on the basis of the contents of their main collagen
type. A further step in this functional FT-IR imaging of
connective tissue will be the ability to differentiate other
collagen types, thus allowing determination of the relative
amount of each one. Alterations in amounts of collagen
type are currently investigated to explain connective tissue
degeneration in many skeletal muscle pathologies [6].
Conclusion
This study has shown that type I and IV collagens may be
differentiated by using several secondary structure parame-
ters revealed by curve-fitting the amide I spectral interval of
FT-IR spectra. Moreover, FT-IR imaging allows differenti-
ation of the main connective tissue compartments of skeletal
muscle, perimysium and endomysium, on the basis of these
secondary structure parameters. An enhancement of this
analytical tool might be the development of a software sub-
routine able to determine the secondary structure of protein
contents found under every pixel of an FT-IR image.
Moreover, it can be expected that future FT-IR imaging
systems will rapidly use higher spatial resolution (currently
ca. 6 μm), thus allowing more detailed analysis of the
junctions between collagen types in the different compart-
ments of connective tissue. These perspectives open the
route to a functional FT-IR imaging of tissues on the basis of
molecular features considered as characteristic of a given
physiological situation (e.g., pathology or necrosis), which
may be named a molecular histopathology.
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Effect of tumor phenotype in the formation of blood capillaries: 
molecular analysis by FTIR spectral imaging 
 
 
Purpose: The aim of this study was to use FTIR spectral imaging to investigate 
whereas different angiogenic phenotype derived tumors induce different angiogenic 
stress levels altering the chemical compositions of blood vessels. Two cell-derived 
tumors, obtained with either C6 (rat) or U87 (human) glioma cell lines, were used for 
this purpose. Glioma cells have been implanted onto the chorio-allantoic membrane 
(CAM) of the chicken embryo to develop highly vascularized solid tumors 7 days after 
implantation. The CAM is a densely vascularized extra-embryonic tissue of the chick 
embryo, which allows nutrients and oxygen intake. FTIR imaging was used to 
analyze blood capillaries spectral features and differences between tumor 
phenotypes. 
 
Background: Generally, solid tumor growth may induce a local increase in free 
radicals, leading to the alteration of normal cellular processes through peroxidation of 
lipids, proteins, and nucleic acids. Tumors also differ widely in their energy 
requirement, depending on the cell types considered, tumor grade and tissue 
locations. The rat C6 glioma cell line is widely used as a model mimicking the growth 
of human glioblastoma multiforme. The U87 cell line is a human phenotype known to 
develop a highly vascularized tumor similar to those occurring naturally in human glia 
(glioblastoma or astrocytoma). 
 
Main results: The two cell phenotypes produced highly vascularized solid tumors, 
highlightling the high angiogenic properties of C6 and U87 cells. Variations in the 
ν=(CH), νas(CH3), and νas(CH2) IR absorptions (3050–2800 cm-1 spectral interval) 
were analyzed for determining fatty acyl chain length and unsaturation level in cells of 
blood capillaries, pericytes and endothelial cells. The results obtained from the curve 
fitting of the 3050 - 2800 cm-1 spectral interval revealed that the ν=(CH)/νas(CH3) ratio 
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was higher in C6 tumor capillaries with respect to U87 tumor capillaries, and an 
opposite results was obtained for the νas(CH2)/νas(CH3) ratio. We might hypothesize 
that these absorption changes could result from tumor cell aggressiveness because 
they mainly arise from the lipid content of cell membranes in blood capillaries. 
However, the biological interpretation of this result is not possible using only this 
spectral information. Oxidative stress effects on fatty acyl chain contents of 
membrane phospholipids would require further determinations to study the balance 
between reactive oxygen species and antioxidants, which is not envisageable on 
dried tissue sections. Nevertheless, the aim of this study was to determine spectral 
markers discriminating between tumor phenotypes effects on blood capillary 
formation. These spectral markers based on fatty acyl chain absorptions might be 
considered for discriminating between cell phenotypes in brain tumors. 
 
Moreover, we could observe another spectral difference of capillaries between the 
two phenotypes for absorptions in the 1200-950 cm-1 spectral interval, which is 
attributed mainly to sugars. Second derivative spectra showed that the absorption 
band at 1056 cm-1 in U87 was shifted to 1051 cm-1 and the band centered at 1041 
cm-1 was not found in C6 tumor blood capillaries. Hierarchical analysis of first 
derivative FTIR spectra of blood vessels based on the 1200-950 cm-1 spectral 
interval discriminated clearly between the two populations of blood capillaries. This 
other spectral marker could not be linked to the previous one on fatty acyl chains, but 
this double differentiation between two tumor cell phenotypes suggest two possible 
interpretations: 1- if these two spectral changes are interdependent, i.e., they belong 
to  same molecules, then a glycolipidic marker may show changes between tumor 
phenotypes; 2- if these two spectral changes are not interdependent, then at least 
two molecular markers should allow the differentiation between tumor phenotypes. 
Further studies are required to address this point, but this study has clearly 
demonstrated that spectral markers of differentiation might be used for identifying the 
cell phenotype involved in the tumor formation by FTIR imaging. 
 
Contribution to a “molecular histology of brain glioma”: The high level of 
heterogeneity encountered in gliomas does not facilitate the use and the 
interpretation of routine histological markers. Sometimes, low-grade astrocytomas 
have a tendency to develop over time into anaplasic or even malignant neoplasms. 
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Glioblastoma and ganglioglioma may look like meningioma or metastasis in computer 
tomography or magnetic resonance imaging images, as well as ex vivo after surgical 
excision. Histological examination is not always suitable for identifying these different 
types of tumors with precision. Therefore, the results obtained in this research 
suggest that modifications of membrane lipids, according with the phenotype of the 
tumor, can be responsible for functional variations connected with neoplastic growth. 
These IR markers combined with the changes of band shapes in the carbohydrates 
spectral interval constitute valuable biochemical parameters which may be useful, 
together with histological studies, in the diagnosis of brain tumors. 
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Effect of tumor phenotype in the formation of blood capillaries: 
molecular analysis by FTIR spectral imaging 
 
Abstract 
 
The aim of this study was to use FTIR spectral imaging for determining chemical 
markers of discrimination between two glioma cell phenotypes derived tumors on the 
basis of their blood capillaries. U87 human glioma and C6 murine glioma cells were 
implanted onto the chorio-allantoic membrane (CAM) of the chicken embryo to 
develop highly angiogenic solid tumors. Infrared spectra of tumor blood capillaries 
found in C6-derived tumors indicated a higher unsaturation level of membrane 
phospholipids than those from U87-derived tumors. This was demonstrated by a 
curve fitting procedure of the fatty acyl chain spectral interval (3050-2800 cm-1) 
showing higher ν=(CH)/νas(CH3) and lower νas(CH2)/νas(CH3) ratios (C6 vs. U87, 
respectively). Moreover, hierarchical analysis of first derivative FTIR spectra of blood 
vessels in the carbohydrates spectral interval (1200-950 cm-1) differentiated spectra 
into two clusters, one per tumor phenotype, and with high heterogeneity level. Our 
results show that tumor phenotype must be taken into account in the analysis of 
gliomas and that FTIR imaging is able to reveal subtle changes in molecular 
parameters belonging to blood capillaries of these tumors. 
 
Abbreviations 
 
CAM: chorioallantoic membrane; DMEM: Dulbecco’s modified eagle medium; FBS: 
Fetal bovine serum; FTIR: Fourier Transform Infrared; HA: Hierarchical analysis 
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Materials and methods 
 
Cell culture 
U87 and C6 human and murine glioma cells, respectively, were selected for the study 
as malignant glioma models that form highly vascularized tumors. Cells were 
maintained in DMEM, with 10% FBS, antibiotics, and L-glutamine, and then 
incubated in a 37°C-incubator in 5% CO2. Cells were grown to confluence, harvested 
after trypsinization, and re-suspended in serum free DMEM for injection. 
 
In vivo CAM assay 
The chorioallantoic membrane (CAM) of the chick embryo appears on day 4–5 and 
its vessels subsequently spread over the surface of the yolk sac, totally covering it 
[1]. Fertilized chicken eggs (Gallus gallus) (EARL Morizeau, Dangers, France) were 
handled as previously described [2]. Eggs were incubated at 37°C and 80% 
humidified atmosphere. On day 4 of incubation a window was made in the eggshell 
after removal of 2–3 mL of albumin so as to detach the developing CAM from the 
shell. The window was sealed with Durapore® tape and the eggs were returned to 
the incubator. On embryonic day 10, a plastic ring was placed on the CAM, and 5 
million of U87 or C6 cells in 20 µl of medium were deposited after gentle laceration of 
the surface. Digital photos were taken under a stereomicroscope (Nikon SMZ800). 
Tumors were removed after 7 days of injection (embryonic day 17), placed in tubes 
without fixatives before to be frozen in liquid N2 and stored at -80°C until required. 
 
Histology and Immunohistochemistry procedures 
CAM tumors were covered by cooled glue (polyvinyl alcohol for cryostat, -20°C). 
Serial sections (Cryostat 3050-TM, Leica-Microsystems, France) of 20 µm in 
thickness were transferred, respectively, onto a glass slide (SuperFrost) for 
immunohistochemistry assessment, and onto a Zinc Selenide (ZnSe) windows for 
FTIR spectro-imaging. All tissue sections were dried on air before further processing. 
In order to get more precision and reproducibility of data, we preferred to do immuno-
histochemistry also on the same sections of ZnSe windows after image acquisition 
for each CAM sample. Immunohistochemistry was used to highlight all blood vessels 
of tumor sections and for further comparisons with FTIR analyses. For this, the 20 
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µm sections were fixed in paraformaldehyde 4% for 10 minutes, then washed with 
PBS containing 0.1% Triton X-100 (PBS-T; Sigma). Slides were incubated with 
biotinylated Sambucus Nigra lectin (SNA-lectin) antibody (1:500; Vector 
Laboratories), for 45 minutes at room temperature in a humidified chamber. After 
washing with PBS, sections were then incubated with standard avidin–biotin complex 
(Vectastain Elite kit ABC, Vector Laboratories) for 30 min for routine signal 
amplification. Antibody binding was revealed using H2O2 as a substrate and 
diaminobenzidine as chromogen. Counterstaining was performed with hematoxylin 
only on superfrost slide sections but not for the ZnSe sections [3].  
 
FTIR spectral imaging acquisition 
Spectral images were collected in transmission mode using a Spotlight 300 FTIR 
imaging system, equipped with a Spectrum One spectrometer (Perkin-Elmer, 
France). The imaging system was equipped with a liquid N2-cooled MCT linear 
detector comprising 16 pixel elements. FTIR images were collected from CAM tumor 
sections, in the 4000-720 cm-1 range using 8 scans with 4 cm-1 as spectral resolution 
and 6.25*6.25 µm spatial resolution per pixel. Highly vascularized areas were 
selected referring to the immunohistochemical sections on slides. After image 
acquisition, we also performed immunohistochemistry for ZnSe sections. 
 
Data processing and analysis 
Referring to immunohistochemistry, we obtained 90 spectra for capillary blood 
vessels for each tumor phenotype. After baseline correction, data treatments were 
performed using OPUS 4.2 software (Bruker, Germany). FTIR spectra representing 
blood capillaries for each group were averaged to form model spectra (called “MS-
group” U87 and “MS-group” C6, respectively). The second derivative spectrum of 
every MS was used to determine the position of all absorption bands within the 3050-
2800 cm-1 spectral interval, with a 9-point smoothing and 0.44% sensitivity 
(subroutine of OPUS 4.2 software, Bruker). The minimum values yielded absorption 
bands at 3030, 3012, 2981, 2959, 2921, 2894, 2872, 2852, and 2811 cm-1 and were 
all found in the two MS models. Spectral curve fitting procedure could thus be 
performed after fixing bands at these values to obtain a “Report”. For every FTIR 
spectrum corresponding to a blood capillary, all absorptions bands were modeled by 
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the curve fitting procedure based on Lorentzian function, by applying the “Report” 
obtained from MS given by the curve-fitting toolbox. 
 
Statistics 
Data used for comparison between the two groups, were expressed as mean ± SD. A 
paired Student’s t-test was used to determine differences between series of data 
between the two groups. P-values were fixed at .05 to consider the significance level 
of differences between series of data. 
 
Results 
 
Phenotypic changes of tumor tissues 
Glioma cells deposited on the CAM surface form solid tumors that exhibit 
characteristic features of malignant progression. Phenotypic changes of C6 and U87 
cell derived tumors were checked 4 and 7 days after implantation. U87 cell derived 
tumors grew rapidly and formed a compact tumor mass at day 4 more expanded at 
day 7. These tumors presented a structured vascular network into the whole tumor 
mass at day 7. C6 cell-derived tumors have shown to be more expanded than U87 at 
day 4 and they were likely to be exploded at day 7. They were more edematous and 
sometimes showed necrotic and hemorrhagic areas with different patterns of 
vascularization (Figure 1). To get a similar behavior of glial cells during malignant 
glioma grade, we only analyzed day-7 tumors for data treatment and statistics. 
 
FTIR data analysis 
Careful examination of spectra indicates that most of the variability between the two 
cell-derived tumor blood capillaries is in the fatty acyl and carbohydrates spectral 
intervals (i.e., 3050–2800 and 1200–950 cm-1). 
 
1. Fatty acyl chain spectral interval 
Spectra exhibited significant differences between their profiles. In order to interpret 
these spectral differences and to understand the biochemical variations in tumor 
blood vessels for each angiogenic phenotype, we used the curve fitting procedure for 
the spectral interval of 3050-2800 cm-1. Using this procedure to every FTIR spectrum 
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of each capillary blood vessel, we analyzed the variations of the absorption bands at 
3012 cm-1 for ν=(CH), 2959 cm-1 for νas(CH3) and 2921 cm-1 for νas(CH2), identified 
from the second derivative spectra of averaged capillary for each tumor phenotype 
(Figure 2). These absorptions are mainly due to the asymmetric stretching vibrations 
mode of the fatty acyl moieties of membrane phospholipids for determining the level 
of phospholipid unsaturation in blood vessel membranes. The results obtained from 
the curve fitting of the 3050–2800 cm-1 spectral interval (Figure 3) revealed that the 
ν=(CH)/νas(CH3) ratio is higher in C6 tumor BV than U87 tumor BV (17.7% increase). 
However, the νas(CH2)/νas(CH3) ratio (8.7% decrease) was lower in C6 than in U87 
tumor BV. Only the ν=(CH)/νas(CH3) ratio shows a significant difference (P< 0.05) 
between the two populations (see Table 1 for more details).  
 
2. Carbohydrates spectral interval 
Figure 4 shows the second derivative of the averaged capillary spectra for each 
tumor phenotype within the carbohydrates spectral interval (1200-950 cm-1). As we 
can see, the main difference is situated between the 1020 and 1080 cm-1 spectral 
interval. Obviously, the absorption band at 1056 in U87 is shifted to 1051 cm-1 and 
the band at 1041 cm-1 is not present in C6 tumor BV. Moreover, in order to see if 
these differences are able to separate the two sets of blood vessels, we performed a 
hierarchical analysis (HA). HA was used to classify spectra of blood vessels issued 
from the two cell-derived tumors using the first derivatives of the spectra with 5-point 
smoothing. Based on the carbohydrates spectral interval (1200-950 cm-1), we got a 
good discrimination between the two sets of data. As we can see in Figure 5, the two 
sets of data were correctly classified without any overlapping. 
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Tables 
 
Table 1: Curve fitting results showing the different values of ratios in the fatty acyl 
chain spectral interval for the two tumor cell phenotypes.  
 
Asymmetric stretching bands 
 ν=(CH)/νas(CH3) νas(CH2)/νas(CH3) 
C6 0.73 ± 0.47 1.72 ± 0.75 
U87 0.62 ± 0.31 1.87 ± 0.72 
t test  0.044 * 0.088 
C6 vs. U87 17.7 % - 8.7 % 
 
 
Average values ± SD for ratios of the fatty acyl chains in the two cell derived tumors. 
n=90 blood capillary spectra for each tumor phenotype. An increase in the 
percentage of ν=(CH)/νas(CH3) versus a decrease in the percentage of 
νas(CH2)/νas(CH3) are shown in the last line of this table. We assigned a “ ‒ “ to 
mention the decrease in the percentage. The student t test performed shows a 
significant difference (*) between the two populations for the first ratio (P< 0.05). 
 
Figures 
 
Figure 1: A: Tumor cells were deposited onto the CAM of embryonated chicken eggs 
at day 17 of development.  B and C: U87 and C6 cell derived tumors, respectively, 
after 7 days of implantation. We can obviously see that C6 tumors were more 
edematous than U87. D: From the left to the right, tumor sections with 
immunohistochemistry (IHC) on slide, visible image by Spotlight, visible image after 
IHC on ZnSe window to locate all blood capillaries marked with SNA-lectin (brown). 
FTIR image was realized using 8 scans with a spectral resolution of 4 cm-1 and a 
spatial resolution of 6.25 µm. Spectra were chosen according to the IHC section.  
Scale bar represents 200 µm. 
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Figure 2: Second derivative averaged spectra of each tumor phenotype blood 
capillary model within the 3050-2800 cm-1 spectral interval. Minimum values at 3012, 
2959, and 2921 cm-1 represent asymmetric stretching vibrations of fatty acyl 
moieties. 
 
Figure 3: Spectral curve fitting performed within the 3050-2800 cm-1 spectral interval. 
Absorption bands at 3012 cm-1 for ν=(CH), 2959 cm-1 for νas(CH3), and 2922 cm-1 for 
νas(CH2) were used to calculate the ν=(CH)/νas(CH3) and νas(CH2)/νas(CH3) ratios.  
 
Figure 4: Second derivative spectra of each tumor phenotype blood capillary model 
within the 1200-950 cm-1 spectral interval for carbohydrates determination. As we can 
see, the absorption band at 1056 in U87 is shifted to 1051 cm-1 and the band at 1041 
cm-1   is not present in C6 tumor BV.  
 
Figure 5: Hierarchical analysis of 1st derivative spectra of each tumor phenotype 
blood capillaries (n=90 for each phenotype) within the carbohydrates spectral interval 
(1200-950 cm-1).  
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FTIR spectral imaging of blood vessels reveals protein secondary 
structure deviations induced by tumor growth 
 
 
Anal Bioanal Chem. 2008 Sep; 392(1-2):129-35. 
 
 
Purpose: The aim of this study was to analyze the molecular structures of blood 
capillaries of astrocytic tumors at different stages of the tumor growth by FTIR 
spectral imaging. A reproducible animal model (Rag-gamma mice) was used to 
assess the potential of FTIR spectral imaging for determining structural features in 
vascular basement membrane (VBM) protein contents 14 and 21 days after 
implantation. 
 
Background: Vascular basement membrane remodeling is involved in tumor 
angiogenesis to enable tumor invasion and growth. During angiogenesis, VBM is 
degraded and disassembled to be finally reorganized to a native state around a 
newly formed capillary. Collagens (especially type IV) are the main components of 
BM proteins (at least 50%). The VBM of tumor capillaries is characterized by variable 
diameter, swelling, vacuolization, and degeneration. These changes in collagen 
assembly and disposition in VBM exposed to the tumor angiogenic stress are now 
regarded as sub-molecular targets for tumor imaging and diagnosis. 
 
Main results: To analyze capillary blood vessels by FTIR spectral imaging, a curve-
fitting procedure (method already used for data treatments in the first publication) 
was proposed to determine changes in the secondary structure of protein contents of 
VBM at the two stages of tumor growth. For largest blood capillaries of a diameter 
>20 microns, tumor growth had induced a decrease in triple-helix content (1638 cm−1; 
P<0.05) and an increase in beta turns (1666 and 1615 cm−1; P<0.01). These protein 
structure alterations, resulting from type IV collagen loss, reflected the high 
angiogenic stress of growing tumors. We could note also that for blood capillaries of 
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small diameter, < 20 µm, these differences were not observed. Therefore, our results 
clearly show that FTIR imaging has the potential to reveal the steps effects of tumor 
growth on blood capillaries formation. We thus propose to use these molecular 
markers of VBM protein alterations for gradation of solid tumors by FTIR spectral 
imaging. 
 
Contribution to a “molecular histology of brain glioma”: C6 tumors obviously 
mimick human glioma tumor phenotype. The subcutaneous (s.c.) space is essentially 
avascular. s.c. tumors will therefore be artificially selected to grow in an 
angiogenesis-dependent fashion. Tumor cells rapidly grow and form angiogenic 
tumor by presenting the histopathological features of human GBM. Our results 
support previous studies that reported the presence of collagen fibers irregularly 
disposed in blood capillaries of brain tumors. The collagen decrease may support the 
hypothesis that the angiogenesis stress increases with tumor growth. This study has 
shown that the triple helix and β-turn contents of the secondary structure of VBM 
proteins might be used as molecular markers for a functional FTIR spectral imaging 
of tumors. The result opens the way to the development of a molecular 
histopathology, which might become a useful analytical tool for neurosurgeons. 
Therefore, we later proposed to use these molecular markers on human glioma 
sections in order to see if same deviations will be obtained.  
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Abstract Vascular basement membrane remodeling is
involved in tumor angiogenesis to enable tumor invasion
and growth. FT-IR spectral imaging was used to determine
changes in tumor blood vessels to reveal protein secondary
structure in Rag-gamma immuno-deficient mice sacrificed
14 and 21 days after subcutaneous glioma implantation. For
the oldest blood capillaries (diameter >20 microns), tumor
growth induced a decrease in triple-helix content
(1638 cm−1; −7.3%; P<0.05) and an increase in beta turns
(1666 and 1615 cm−1; +4%; P<0.01). These protein-
structure alterations, mainly from type IV collagen,
reflected the high angiogenic stress of growing tumors.
We propose to use these molecular markers of vascular
basement membrane protein alterations for gradation of
solid tumors by FT-IR spectral imaging.
Keywords FT-IR spectral imaging . Cancer . Angiogenesis .
Basement membrane proteins
Abbreviations
BM Basement membrane
DMEM Dulbecco’s modified Eagle’s medium
FBS Fetal bovine serum
FT-IR Fourier-transform infrared
MRI Magnetic resonance imaging
PET Positron-emission tomography
VBM Vascular basement membrane
Introduction
Malignant gliomas, the most common primary brain
tumors, are very aggressive and highly invasive tumors
which diffuse heterogeneously into the surrounding paren-
chyma [1]. To date, the “gold standard” for brain cancer
diagnosis is histopathological examination, by experienced
pathologists, using standard light microscopy-based tech-
niques. In many cases, histopathologic examination is unable
to provide a firm diagnosis because of tissue heterogeneity
[2]. Thus, despite various therapeutic and diagnostic efforts,
high-grade gliomas (grades III and IV) still represent an
unsolved problem for neuro-oncologists [1].
Glioblastoma (GB) tumors can be difficult to remove
due to the lack of defined tumor limits. The tumor may
extend into normal-looking brain tissue and/or can be
localized near critical areas of the brain. Determination of
tumor limits and assessment of tumor grade is of clinical
importance in improving patient prognosis. Imaging tech-
niques such as PET or MRI can be helpful in diagnosing
brain tumor occurrence [1] but are also characterized by a
spatial resolution at the millimeter scale and/or mmol L−1
sensitivity [3]. Thus, with respect to human brain glioblas-
toma volumes, i.e. a few mm3, these imaging modalities
suffer from limitations.
Therefore, new approaches are required for rapid and
objective classification of brain tumors and it is believed
that ex vivo imaging techniques still have a critical role to
play in the development of new molecular histopathology
tools. Among the methods recently developed for disease
pattern recognition in the field of cancer diagnosis,
vibrational spectroscopy, mainly Fourier-transform infrared
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(FT-IR) spectroscopy, could be applied with success, owing
to the possibility of performing quantitative analysis of
molecular composition of healthy and pathological tissues
[4]. When applied to biological specimens, this technique
reveals the vibrational modes of functional groups within
the biomolecules present, i.e., mainly proteins, nucleic
acids, lipids, and carbohydrates. Data-treatment methods
enable correlation of the chemical information with
biological features, enabling functional interpretation of
histological structures [5]. Thus, changes in cell or tissue
composition induced by any pathological process can be
revealed by the chemical information contained in FT-IR
spectra [6]. FT-IR spectroscopy may now be coupled to an
optical microscope and a 2D array IR camera to enable FT-
IR spectral imaging.
The advantage of using FT-IR spectral imaging to
characterize biological substances lies in the very simple
sample preparation [7], i.e., it does not require sample
staining or fixation, and full spectral acquisition is done
within only a few minutes for a 1-mm2 tissue area. FT-IR
spectral imaging may thus be used for examining extem-
poraneous biopsies to help give an answer to the neuro-
oncologist with delays compatible with subsequent surgery.
Using this technique, the metabolic status of cells has been
analyzed within glioblastoma tissue sections [8], providing
evidence that glucose content decreased linearly with the
distance from blood vessels while lactic acid increased [9].
This metabolic pattern of change is representative of the
ischemic condition of cells within the tumor mass and
highlights the critical role played by tumor blood vascula-
ture in this kind of tumor.
Recent experimental evidence has shown that angiogen-
esis is an essential phenomenon in tumor growth and
progression beyond a few cubic millimeters in size [10].
Angiogenesis is the development of new blood vessels
from preexisting ones [11]. The vascular basement mem-
brane (VBM) is an amorphous, dense, sheet-like structure
of 50–100 nm in thickness [12] that constitutes an insoluble
structural wall of newly formed capillaries and undergoes
sub-molecular changes during tumor-induced angiogenesis.
Most of these protein structural changes are due to the
unfolding, degradation, and refolding of collagen contents
during the capillary sprouting process of angiogenesis.
Collagen proteins (especially type-IV) are the main com-
ponents of BM, comprising 50% of all BM proteins [12].
The triple helix forms 85% of the collagen IV sequence
[13] and exhibits a characteristic IR band in the amide
spectral range (1700–1500 cm−1) [14]. On this basis, it has
recently been proposed to use FT-IR spectral imaging to
analyze molecular changes in BM of capillary blood vessels
exposed to the angiogenic stress of growing tumors.
The aim of this study was to analyze the molecular
structures of blood capillaries of astrocytic tumors at
different stages by FT-IR spectral imaging. A reproducible
animal model (Rag-gamma mice) was used to assess the
potential of FT-IR spectral imaging for determining
structural features in VBM protein contents at different
moments of tumor growth (14 and 21 days). This approach
offers the prospect of non-subjective grading of tumor
malignancy.
Materials and methods
Cell culture
Rat C6 glioma cells were selected for the study as an
established model for malignant gliomas that form highly
vascularized tumors. Rat C6 glioma cells (ATCC, passage
24) were maintained in culture using Dulbecco’s modified
Eagle’s medium (DMEM) with 10% FBS, l-glutamine
(2 mmol L−1), and antibiotics (penicillin 50 UI mL−1, strep-
tomycin 50 μg mL−1). Cell culture was performed in a 37°C
incubator with humidified atmosphere and 5% CO2. Cells
were grown to confluence, harvested after trypsinization, and
re-suspended in serum-free DMEM for injection.
Animals
Six week-old male Rag-gamma immuno-deficient mice (n=
12) were randomly divided into two groups of six animals
each with an average weight of 24 g. Animals were
anesthetized using Imalgene 1000 (Ketamin 10 g/100 mL)
injected intraperitoneally. C6 rat glioma cells (5×105 cells
per animal) were suspended in 100 μL medium and
implanted subcutaneously (s.c.) into the flanks of mice. S.
c. xenografted tumors were removed from mice 14 and
21 days post-implantation (named Group-14 and Group-21,
respectively). Tumor volume was determined for every
animal. Because all tumors exhibited ellipsoid form, the
formula used for volume (cm3) determination was:
Volume ¼ 4 3 p 0:5 W 0:5 L 0:5 Hð Þ= ð1Þ
where all axes are measured in cm, “W” is the width axis,
“L” is the length axis, and “H” is the height axis. All
tumors were washed in PBS solution and placed in tubes
without fixatives before freezing in liquid N2 and storage
at –80°C until required.
Tissue samples
For every tumor specimen, frozen tissue was deposited on
cooled glue (poly(vinyl alcohol) for cryostat, –20°C) to
avoid tissue embedding. Additional glue was used to
homogenize the sample intended for cryosections (Cryostat
3050-TM, Leica-Microsystems, France). Serial frozen
130 K. Wehbe et al.
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sections 10 and 20 μm thick (seven sections per tumor)
were transferred, respectively, on to glass slides (Super-
Frost) for immunohistochemistry assessment and on to
ZnSe windows for FT-IR spectral imaging. All tissue
sections were dried in air before further processing.
Immunohistochemistry
Immunohistochemistry was used to highlight all blood
vessels of tumor sections and for further comparisons with
FT-IR analyses. The antibody used for this technique was
CD31 also designated PECAM-1 (platelet endothelial cell
adhesion molecule 1). The 10-μm sections were fixed in
paraformaldehyde 4%. Endogenous peroxidase was
inhibited using 3% H2O2 in distilled water. Sections were
then washed in phosphate-buffered saline (PBS 1× solu-
tion). Slides were incubated first with the primary antibody
(purified rat anti-mouse monoclonal antibody; Pharmingen
BD Biosciences), for CD31 (1:100 v/v). Incubation was
performed for 2 h at room temperature in a humidified
chamber. After washing, the slides were incubated with
goat anti-rat biotinylated polyclonal antibody (1:200 v/v;
Pharmingen BD Biosciences) for 1 h at room temperature.
Sections were then washed and incubated with standard
avidin-biotin complex (Vectastain Elite kit ABC; Vector
Laboratories) for 30 min. Antibody binding was revealed
using H2O2 as substrate and diaminobenzidine as chromo-
gen. Counterstaining was performed with hematoxylin.
Negative control slides were obtained by omitting the
primary antibody.
FT-IR spectral imaging acquisition
Tumor sections 20 μm thick consecutive to immunohisto-
logical sections were used for FT-IR analyses using a
Spotlight 300 FT-IR spectral imaging system equipped with
a Spectrum One spectrometer (Perkin-Elmer, France). ZnSe
windows were used for tissue section deposition. Once the
visible image was obtained, capillary blood vessels were
sought for spectral image acquisition, referring to the
immunohistochemistry sections to locate all capillaries.
Transmittance FT-IR spectra were obtained in image mode
(spatial resolution of rebuilt image 6.25 μm, 16 pixels)
using eight scans (4000–720 cm−1) and a 4 cm−1 spectral
resolution. All data acquisition, post-processing (atmo-
spheric and baseline corrections, and normalization), and
image construction were performed using sub-routines of
Spotlight 1.0 (Perkin-Elmer, France).
Spectral data treatment
For every FT-IR image of blood capillary, the FT-IR spectra
corresponding to the pixels covering the basal membrane
were averaged and saved for further data treatment. All
spectra representing all blood capillaries for each group were
averaged to form model spectra (MS-group-14 and MS-
group-21). The second-derivative spectrum of every MS was
used to determine all absorption bands within the 1750–
1480 cm−1 spectral range, with nine-point smoothing and
0.4% sensitivity (subroutine of Opus 4.2 software; Bruker).
This spectral range shows the two major absorbance bands
of proteins (1655 and 1545 cm−1 for amide I and II
absorption, respectively) and may be used to determine the
secondary structure of proteins. This step led to the
generation of a calculation frame called “Report” which
allows fixing of two kinds of data—the type of function
(Lorentzian) and the wavenumbers corresponding to the
maximum intensities for every band revealed from second
derivative of MS. For every FT-IR spectrum corresponding
to a blood capillary, all absorption bands were determined by
100 µm 100 µm 50 µm
CBA
Fig. 1 A Optical image of
immunohistochemistry section
(10 μm) in which all blood
vessels revealing tumor angio-
genesis are marked with CD31
(brown). B Visible image of the
consecutive tumor section
(20 μm). Corresponding capil-
lary blood vessels are shown
(arrows). C Full spectral inten-
sity (total absorbance for the
4000–720 cm−1 spectral range)
image of capillaries in the se-
lected area (red square)
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a curve-fitting procedure (another subroutine of Opus 4.2
software), by applying the “Report” obtained from MS given
by the curve-fitting toolbox [15–18]. Each band was finally
expressed as a percentage of the total amide I absorption
area (covered by the bands between 1690 and 1615 cm−1).
Protein secondary structure parameters were further assessed
using absorption bands assigned as α-helix, triple helix, β-
sheets, β-turns, and unordered structure (% of total amide I
absorption) as previously described [8, 14–17].
Statistics
All data (amide I absorption bands and secondary structure
parameters) were used for comparisons between groups. All
data were expressed as mean ± SD. A paired Student’s t-test
was used to determine differences between series of data
between the two groups. P-values fixed at 0.01 and 0.05
were used to assess the significance of differences between
series of data.
Results
Tumor description and data acquisition
All tumors were observed to grow rapidly after 10 to
13 days post-implantation. After resection, tumor volume of
Group-21 mice (1.10±0.88 cm3) was found to be five times
larger than for Group-14 (0.22±0.19 cm3; P<0.05).
Xenografted tumors were removed and analyzed by FT-IR
spectral imaging. Serial frozen sections of 20 μm thickness
were used for FT-IR analyses.
Several capillary blood vessel locations were selected on
every tissue section for FT-IR image acquisition referring to
the immunohistochemistry sections (Fig. 1). Finally, 116
and 125 FT-IR images of capillary blood vessels, for
Group-14 and Group-21 mice tissue sections, respectively,
provided averaged spectra of sufficient quality for further
data treatment (Supplementary material; Fig. S1).
Using second-derivative spectra to reveal all absorption
bands within the 1750–1480 cm−1 spectral range, the curve-
fitting procedure could be applied to every averaged FT-IR
spectrum of each capillary blood vessel (Fig. 2). The
absorption band exhibiting the highest intensity (Fig. 3)
20 µm
Fig. 2 Gray-scale representation of the full spectral image of a
capillary blood vessel. The white circle in the center represents the
vascular basement membrane (VBM) with the endothelial cells and
pericytes. In the inside is the blood vessel lumen (BVL) and outside is
the surrounding tissue (ST). Note the selected positions of different
FT-IR spectra (crosses) to obtain an averaged FT-IR spectrum of the
basal membrane
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Fig. 3 Averaged FT-IR spectra of capillaries for group-14 and group-
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was found to be centered at ∼1655 cm−1 (amide I), which
arises primarily from the ν(C=O) stretching vibrations of
the amide groups of the protein backbone, while the
absorption band centered at ∼1545 cm−1 arises from the
δ(N-H) bending vibrations (see also supplementary materi-
al, Fig. S1). Second-derivative MS (Fig. 4) of each group
showed that all absorption bands within the amide I spectral
range have very close wavenumbers (<2 cm−1 between
groups), with differences only for maximum intensities per
absorption band. The minimum values on second derivative
spectra were at 1690, 1680, 1666, 1655, 1645, 1638, 1628,
and 1615 cm−1 for the amide I spectral range. Spectral
curve fitting could thus be performed after fixing bands at
these values (Supplementary material; Table S1). To
determine secondary structure parameters, as previously
described [15, 16, 18], we assigned the bands centered at
1690 and 1625 cm−1 to parallel β-sheets, at 1680 cm−1 to
anti-parallel β-sheets, and bands at 1666 and 1615 cm−1
were attributed to β-turns. The dominant band centered at
1655 cm−1 was assigned to the α-helix, the band centered at
1645 cm−1 was assigned to unordered structure, and the
band centered at 1638 cm−1 to the triple helix of collagen
(Fig. 5). Percentages of the three β-sheets bands were
added together, and for the two β-turn bands.
Secondary structure of protein contents
Using the whole set of capillaries, curve fitting results
showed that Group-21 had a higher percentage of the
1666 cm−1 absorption band (one of the β-turn absorption
bands; 14.2±2.28 vs. 13.7±2.03%; P<0.05) but a lower
percentage of the 1638 cm−1 absorption band (triple helix;
13.7±2.55 vs. 14.5±2.41; P<0.05). Capillary blood vessels
were further divided into two groups, with respect to their
diameter (∅ < and > 20 μm), to search for the category of
capillary (“young” if ∅ < 20 μm; “old” if ∅ > 20 μm) that
could be responsible for the differences obtained between
groups. Sixty-four and fifty-one blood capillaries with
diameter <20 μm were obtained for Group-14 and Group-
21, respectively, and 52 vs. 74, respectively, for ∅ >
20 μm. For capillaries with ∅ < 20 μm, only the band at
1680 cm−1 (one of the three β-sheet bands) was signifi-
cantly higher for group-21 than for group-14 (7.7±1.76 vs.
7.1±1.14; P<0.05). For capillaries with ∅ > 20 μm, only
the percentage of the 1638 cm−1 absorption band was higher
in Group-14 than Group-21 (15.1±2.41 vs. 14.0±2.64; P<
0.05; see also Tables S3 and S4 in online supplementary
material).
Secondary structure parameters for the whole set of capil-
laries (Table 1) showed that no significant difference (P>
0.05) could be found for α-helix, β-sheets, and unordered
structure. However, the percentage of β-turns was found to
be significantly higher for Group-21 (28.8±3.21%) than for
Group-14 (27.7±2.79%; P<0.01). This significant increase in
β-turn content was ∼4%. Conversely, the triple-helix content
was lower for Group-21 than for Group-14 by ∼−5.5%.
Only the capillaries of ∅ > 20 μm were significantly dif-
ferent between groups, for β-turn (27.3±2.84% vs. 28.8±
3.24%; P<0.01; ∼4% increase) and triple-helix (15.1±2.41%
vs. 14.0±2.64%; P<0.05; ∼7.3% decrease) content of second-
ary structure (Tables 2 and 3).
Finally, the secondary structure of proteins was com-
pared with regard to tissue section location within the tumor
(periphery vs. center). When considering the whole set of
capillaries (all diameters), no significant difference could be
Fig. 5 Spectral curve fitting of the averaged spectrum of Fig. 2
showing the 1750–1480 cm−1 spectral range. Absorption bands of
amide I are used for secondary structure determination: α-helix
(1655 cm−1), β-sheets (1690, 1680, and 1628 cm−1), β-turns (1666
and 1615 cm−1), unordered structure (1645 cm−1), and triple helix
(1638 cm−1)
Table 1 Secondary structure determination of VBM protein contents for Group-14 and Group-21 mice
α-Helix β-Sheets β-Turns Unordered Triple helix Capillary diameter
Group-14 26.2±4.35 21.2±3.31 27.7±2.79 10.5±2.56 14.5±2.41 21.7±5.36
Group-21 25.6±4.10 21.2±3.11 28.8±3.21 10.7±2.44 13.7±2.55 22.9±5.02
t-test 0.244 0.942 0.005** 0.479 0.024* 0.067
Significant differences between groups: *P<0.05; **P<0.01. Absorption bands used for protein secondary structure determination: α-helix
(1655 cm−1 ), β-sheets (1690, 1680, and 1628 cm−1 ), β-turns (1666 and 1615 cm−1 ), unordered structure (1645 cm−1 ), and triple helix
(1638 cm−1 ). n=116 and 125 spectra for Group-14 and Group-21 mice, respectively
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found with regard to tissue section location (P>0.05 for all
comparisons; data not shown). Again, no significant
difference could be found when considering capillaries
with ∅ < or > 20 μm (P>0.05 for all comparisons).
Discussion
Previous studies demonstrated that FT-IR spectroscopy is a
useful complement to established histopathology methods
for identification and classification of tumors [19]. It is now
believed that FT-IR spectral imaging might play a central
role in this context because ex-vivo analytical methods are
still lacking to help neurosurgeons in the extemporaneous
examination of tumor resection [17].
In recent studies, the metabolic status of cells could be
determined by FT-IR spectral imaging within glioblastoma
tissue sections [9]. Metabolic changes in tumors were due
to the ischemic condition of cells within the tumor mass
and highlighted high angiogenic stress [9]. However, the
high heterogeneity of gliomas requires that other molecular
markers are used to improve the diagnostic performance of
FT-IR spectral imaging for such tumors. Thus, the aim of this
study was to assess the potential of FT-IR spectral imaging as a
molecular probe of tumor progression in highly angiogenic
tumor specimens. It was used to analyze changes in capillary
(probably VBM) protein content with tumor growth. We
compared tumors removed on days 14 and 21 after tumor cell
implantation from two groups of six mice. In every tumor
approximately 20 blood capillaries were analyzed.
During angiogenesis, VBM is degraded and disassembled
to be finally reorganized to a native state around a newly
formed capillary. Collagens (especially type IV) are the main
components of BM proteins (at least 50%) [12]. The VBM of
tumor capillaries is characterized by variable diameter,
swelling, vacuolization, and degeneration. These changes in
collagen assembly and disposition in VBM exposed to the
cancer angiogenic stress are now regarded as sub-molecular
targets for tumor imaging and diagnostic [17].
To analyze capillary blood vessels by FT-IR spectral
imaging, a curve-fitting procedure was proposed to deter-
mine the changes in the secondary structure of proteins at
two moments of tumor growth (14 and 21 days). The
second-derivative spectrum was used for positioning of
amide I absorption bands, which were further fixed on the
curve-fitting process. Furthermore, as collagen remodeling
occurs through changes in their structure, more biological
sense could be given to the data obtained by comparing the
secondary structure results between tumor groups rather
than by comparing results for every absorption band of the
amide I spectral range. As an example, only one of the two
β-turn absorption bands (1666 cm−1) exhibited a significant
difference between groups while comparing the whole set
of capillaries. However, biological interpretation of this
single β-turn absorption band change is not possible. One
may also consider that “statistical” significance has no
systematic biological sense. Conversely, when secondary
structure results were used, i.e., with the combination of the
two β-turn absorption bands, a significant difference (∼4%
increase) could be found between groups for capillaries
with diameter >20 μm. This example illustrates the use-
fulness of using secondary structure parameters rather than
individual bands of the amide I spectral range. A converse
example was found for β-sheets absorption bands. Among
the three bands of this secondary structure parameter, only
one (1680 cm−1) exhibited a significant difference between
groups for capillaries with diameter <20 μm. One may
question this peculiar (artifact?) result, because no other
significant difference in the amide I absorptions counter-
balanced this higher β-sheet content. Again, no result
reinforced this β-sheet absorption difference while com-
paring groups using results in terms of secondary structure
Table 2 Secondary structure determination of VBM protein contents for Group-14 and Group-21 mice for all capillaries of diameter <20 μm
α-Helix β-Sheets β-Turns Unordered Triple helix
Group-14 26.9±4.62 20.9±3.51 28.0±2.74 10.2±2.70 14.0±2.32
Group-21 26.9±3.55 20.6±3.09 28.7±3.20 10.4±2.27 13.4±2.40
t-test 0.988 0.546 0.182 0.739 0.234
n=64 and 51 spectra for Group-14 and Group-21 mice, respectively
Table 3 Secondary structure determination of VBM protein contents for Group-14 and Group-21 mice for all capillaries of diameter >20 μm
α-Helix β-Sheets β-Turns Unordered Triple helix
Group-14 25.3±3.88 21.5±3.06 27.3±2.84 10.8±2.37 15.1±2.41
Group-21 24.6±4.21 21.7±3.05 28.8±3.24 10.9±2.54 14.0±2.64
t-test 0.343 0.746 0.007** 0.755 0.015*
Significant differences between groups: *P<0.05; **P<0.01. n=52 and 74 spectra for Group-14 and Group-21 mice, respectively
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parameters. Finally, from the biological point-of-view, there
is circumstantial evidence that young blood capillaries are
globally comparable in structure and maturation, and this
whatever the “age” of the tumor. It is usually on bigger
blood capillaries that structural alterations appear due to
angiogenic stress and ischemia [20].
Our results also showed a significant decrease in the
1638 cm−1 centered absorption with tumor growth. The
triple-helix is certainly a major contribution to this band
[14, 21], but the possibility that other structural motifs, for
example β-turns, also contribute within this spectral range
cannot be ruled out [13]. The decrease in triple helix
absorption suggested the unfolding or degradation of
collagen contents during the capillary sprouting process of
angiogenesis and tumor growth. Thus, a decrease in the
1638 cm−1 absorption might be regarded as a molecular
marker for functional FT-IR spectral imaging of angiogenic
tumors. Conversely, a significant increase in β-turns con-
tents was also found along tumor growth which counter-
balanced the decrease in triple helix.
These results support previous studies [22] that reported
the presence of collagen fibers irregularly disposed in blood
capillaries of astrocytic tumors. This collagen decrease may
support two hypotheses:
1. tumor necrosis induced degradation of proteins, or
2. the angiogenesis stress increased with tumor stage.
The decrease in triple helix content was not likely to be
because of the formation of necrotic areas, because there
was no significant difference in triple helix content for
capillaries found at the center of the tumor, which area
should also have been the most subject to necrosis.
Besides, a 5.5% reduced level was found for the whole
set of capillaries and 7.3% for “old” capillaries (diameter
>20 μm). There is thus circumstantial evidence to support
the hypothesis that angiogenic stress of tumors induced a
high rate of degradation/remodeling of VBM proteins [12],
which could be detected only on the biggest capillaries.
One may also consider that, in biology, subtle changes in
protein structure (a few percent in given conformational
parameters) may result in major functional changes.
However, these small, although significant, differences
observed between the two experimental groups in this work
open two commentaries. First, these slight changes in VBM
protein content with tumor growth could explain the lack of
analytical studies on collagen structure changes during
angiogenesis. Second, and as a consequence of the first
commentary, FT-IR spectral imaging offers a unique opportu-
nity to detect very subtle changes in protein structure during
tumor formation.More analyses and comparisons with healthy
capillaries, certainly with the same phenotypes of cells, could
be useful to confirm the assumption and to assess these subtle
changes detected in our study. Therefore, by combination of
protein secondary structure markers with other molecular
markers of tumor physiological status, notably metabolic [9],
this functional imaging technique might be proposed as a
useful diagnostic tool for surgeons and histologists. Although
chemometric methods and data treatment are limited, because
we cannot treat all the spectra of an image, methods based on
FT-IR spectroscopy have emerged and developed rapidly
during recent decades.
Conclusion
This study has shown that the triple helix and β-turn content
of the secondary structure of VBM proteins might be used as
molecular markers for functional FT-IR spectral imaging of
tumor growth. This functional imaging appears as a promis-
ing technique to rapidly generate multi-parametric informa-
tion on tumors, and opens the way to the development of a
molecular histopathology, which might become a useful
analytical tool for neurosurgeons.
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Differentiation between normal and tumor blood vessels in 
xenografted brain tumors by FTIR spectral imaging 
 
 
To be submitted 
 
 
Purpose: FTIR spectral imaging was envisaged to get reliable molecular markers to 
differentiate between normal and tumor blood vessels. U87 pcDNA3 and U87 IRE1 
DN human glioma cells were selected for the study as an established model for 
malignant glioma that form highly vs. poorly vascularized tumors, respectively. They 
were implanted intracranially in Rag-gamma mice for 28 days. Classical pathological 
examination and immunohistochemistry were performed in parallel to the FTIR 
imaging of brain tissues (with both healthy and tumor parts) for validation of FTIR 
results. 
 
Background: Brain tumor formation and growth is accompanied by the sprouting 
and proliferation of blood capillaries towards the tumor cells for ensuring their 
nutrients and oxygen intake. Structural and functional abnormalities of the vascular 
microenvironment are contributory to pathophysiological characteristics of gliomas. 
Angiogenesis and functions of resultant vessels differ significantly between the same 
tumors grown in different host organs. With the presence of the blood brain barrier, a 
significantly higher amount of VEGF is required to induce vascular hyperpermeability 
in normal vessels in the cranial window than in the dorsal skin chamber. On the other 
hand, the cranial environment is more angiogenic and forms new vessels faster than 
the subcutaneous tissue in response to a given angiogenic factor. Therefore, for this 
study, we preferred to test intracranially implanted tumors to better present the 
histopathological environment of the human GB. 
 
109
Main results: FTIR spectral imaging of tissues was followed by a hierarchical 
analysis (HA) of spectra corresponding to pixels covering blood capillaries. Two 
combined spectral intervals of fatty acyl (3020-2800 cm-1) and carbohydrates (1180-
950 cm-1) of first derivative FTIR spectra allowed to obtain classification of blood 
capillaries, with one cluster of spectra corresponding to the healthy blood vessels and 
another cluster for the tumor blood vessels. High heterogeneity level (H = 2.22) could 
be obtained between clusters (h = 0.2 for cluster of healthy blood vessels and h = 0.1 
for cluster of tumor blood vessels). The results outlined by the use of these spectral 
intervals in classification also suggest a higher unsaturation level of fatty acyl chains 
contained in phospholipids and a lower level of saccharidic residues than for normal 
BV. As an example, the ν=(CH)/νas(CH3) ratio was increased for tumor BV with 
respect to normal ones, while a concomitant decrease was found for the 
νas(CH2)/νas(CH3) ratio, thus providing evidence of larger unsaturation of fatty acyl 
chains in the cells of tumor BV. Concerning the carbohydrates spectral interval 
(1180-950 cm-1) that also differentiated BV, an absorption band at ~ 1068 cm-1 was 
observed in normal BV spectra but not in tumor ones. Furthermore, we tested spectra 
from human endothelial cells from two different origins (cerebral and umbilical vein), 
and we confirmed the presence of the band in the first type. We have temptatively 
assigned this absorption band to the presence of mannosyl residues since 
comparison with spectra of some sugars pure products showed that only the 
mannose FTIR spectrum presents this absorption band. Moreover when this 
classification was applied on the invasive phenotype of tumors, it allowed define the 
tumor area by indicating the positions of tumor BV. So we can conclude that these 
two spectral intervals of BV FTIR spectra contain discriminant markers to distinguish 
healthy and tumor areas of brain tissues and thus to define the tumor limits. 
 
Contribution to a “molecular histology of brain glioma”: These findings 
demonstrate that FTIR spectral imaging was able to detect changes on a molecular 
level between healthy and pathological BV. Thus, it might become a valuable 
analytical method in molecular histopathology for brain tumor diagnosis.  
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Abstract 
 
Brain tumor growth is accompanied by the sprouting of new blood vessels (BV). 
Structural and functional abnormalities of the vascular microenvironment are 
contributory to pathophysiological characteristics of gliomas. Imaging the differences 
between healthy and tumor tissues on the basis of blood vessels would be helpful for 
a clear diagnosis and therapeutic follow-up of brain cancers. In this study, we used 
FTIR spectral imaging to differentiate between normal and tumor blood vessels from 
intracranialy xenografted tumors in Rag-gamma mice 28 days after implantation. 
Classification of the spectra corresponding to pixels covering the capillary blood 
vessels succeeded by using spectral intervals of fatty acyl (3050-2800 cm-1) and 
carbohydrates (1180-950 cm-1) absorptions, with the formation of two clusters. 
Heterogeneity between clusters (H = 2.22) was significantly higher than for every 
population of spectra (h = 0.2 and 0.1 for healthy and tumor BV spectra, 
respectively). Data treatment based on these two spectral intervals provided 
interpretative information about molecular contents involved in the differentiation 
between healthy and tumor BV, the later presenting higher fatty acyl chain 
unsaturation from phospholipids and an unexpected loss of absorption from 
saccharidic residues. These findings demonstrate that FTIR imaging could potentially 
serve to highlight molecular probes for differentiation between normal and tumor 
blood vessels, and might thus become a valuable tool for pathologic examination of 
brain tumors. 
 
Abbreviations 
 
FTIR: Fourier Transform Infrared ; BV : blood vessels ; DN : dominant negative ; HA : 
Hierarchical analysis 
 
Keywords 
 
FTIR spectral imaging, gliomas, angiogenesis, molecular markers, hierarchical 
analysis 
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Introduction 
 
Many brain tumors are characterized by rapid growth and infiltration of healthy tissue 
[1]. Remodeling of the tumor microvasculature is essential for adequate tumor tissue 
oxygenation and nutrients supply. Thus, the vascular environment determines 
pathophysiology of gliomas, such as edema formation, and tumor cell invasiveness 
[2]. The resulting vessels are structurally and functionally abnormal, and contribute to 
a hostile microenvironment (low oxygen tension and high interstitial fluid pressure), 
leading to a more malignant phenotype with increased morbidity and mortality [3]. 
Moreover, the effectiveness of radiotherapy, chemotherapy, or immunotherapy 
critically depends upon the successful drugs delivery by blood transporters [2]. Thus, 
a better understanding of the molecular basis of vascular normalization may 
ultimately lead to more effective therapeutic follow-up not only for cancer but also for 
diseases with abnormal vasculature, in which the goal is to maintain a functionally 
normal vasculature [4]. Nevertheless, whatever the objective of the clinician’s 
intervention, being able to image blood capillaries for discriminating healthy and 
tumor tissues is a major issue of brain cancer research.  
 
Many articles have  described and illustrated ultrastructural abnormalities in brain 
tumors such as fenestrations, endothelial gaps, pinocytotic vesicles, and trans-
endothelial channels, but only a few have attempted to quantitate these changes in 
either experimental or human brain tumors, and only recently has anyone attempted 
to interrelate structure and function. The glioma vessel morphology is highly 
heterogeneous and different from the physiological microvasculature in brain tissue. 
Gliomas contain tortuous and sinusoidal vessels. Concerning their size, cerebral 
capillaries (~3–5 µm in diameter) are smaller than, those in gliomas (diameters 
ranging between 3 and 40 µm) due to endothelial cell hyperplasia [2, 5]. Pericytes 
and the basement membrane of tumor vessels also reveal significant abnormalities 
versus cerebral vessels. 
  
Actually, the histological study of brain exereses uses conventional light microscopic 
studies and immunohistochemical staining for endothelial cell markers, such as factor 
VIII-related antigen (von Willebrand factor), as well as CD31 (PECAM) or CD34, 
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which allowed identifying high-grade gliomas as one of the most intensively 
vascularized tumors reflecting a high angiogenic activity of these tumors [2]. Although 
not usable in the clinical routine for diagnostic purposes, transmission electron 
microscopic analyses have also gained further insight into ultrastructural alterations 
of the glioma vessel wall and potential transvascular transport mechanisms [6, 7]. In 
vivo phage display was also used to analyze differences between the normal and 
diseased microvasculature in order to identify and localize novel vascular markers in 
cancer, and to characterize changes that occur during tumor progression [8]. All 
these techniques are limited for routine use, time consuming and also expensive. 
Moreover, they lack of molecular markers of tumor blood vessels. There is thus no 
reliable molecular marker to differentiate between normal and tumor blood vessels. 
Recently, Fourier transform infrared (FTIR) micro-spectroscopy has been proposed 
for the non-destructive determination of structural and chemical/physical properties of 
biological systems at the molecular level. In particular, new methodologies have been 
developed to examine and distinguish between normal and pathological tissues by 
FTIR means, spectroscopy, microscopy or imaging. Main advantages of this method 
include the global information provided about the sample molecular contents, its 
great sensitivity and reproducibility, and no sample contents modification is required 
before analysis. 
 
A number of studies have utilized FTIR spectroscopy and chemometric based 
spectral data treatments for tumor detection and classification of tissue samples, 
including cervical [9], skin [10], prostate [11], colon [12], lung [13], and breast [14]. 
However, only a few studies focused on the brain tissue [15-18]. To our knowledge, 
there is no report of study on blood vessels characterization by FTIR spectral 
imaging. In this study, FTIR spectral imaging was used to differentiate between 
normal and tumor blood vessels of xenografted brain tumors in Rag-gamma mice 28 
days after intracranial implantation. Two cell phenotypes were compared by FTIR 
spectroscopy after cell culture and also by FTIR spectral imaging after intracranial 
tumor formation. 
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Materials and methods 
 
Cell culture 
U87 pcDNA3 and U87 IRE1 DN human glioma cells were selected for the study as 
an established model for malignant glioma that form highly vs. poorly vascularized 
tumors, respectively [19]. Cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM), 1g/L glucose supplemented with 10% FBS, L-glutamine, and antibiotics. 
Cell culture was performed in a 37°C-incubator with humidified atmosphere and 5% 
CO2. Cells were grown to confluence, centrifuged after trypsinization, and re-
suspended in serum free DMEM for injection. 
 
Endothelial cells (HCMEC and HUVEC) were grown on plastic tissue culture flasks in 
EGM-2 growth medium containing FBS and growth supplements. [20] EBM-2 
medium was supplemented with VEGF, IGF-1, EGF, basic FGF, hydrocortisone, 
ascorbate, gentamycin and 2.5% fetal bovine serum (FBS) as recommended by the 
manufacturer. The cultures were maintained at 37°C in 5% CO2 and EGM-2 medium 
was replaced every 3 days until the cells reached confluence. After trypsinization and 
centrifugation, the pellets of cells were diluted 10 times in distilled water for lysates 
preparation in order to be analyzed by FTIR spectroscopy. 
 
Intracranial tumors 
Six to eight week-old male Rag-gamma immunodeficient mice (n=8) with an average 
weight of 26 g were used for this experiment (n=6 for the U87 pcDNA3 and n=2 for 
U87 IRE1 DN). Animals were anesthetized using Imalgene 1000 (Ketamin 10 g/100 
ml) injected intraperitoneally. Their head was mounted into a stereotactic head holder 
in a flat-skull position. Cell implantations (in the left hemisphere) were at 2.2 mm 
lateral to the bregma and 3 mm in depth using U87 cells. U87 glioma cells (5.6x105 
cells per animal) were suspended in 3 µl of free DMEM media. Twenty-eight days 
post-injection (average weight of mice was about 22 g), animals were sacrificed by 
cervical dislocation. Brains of the sacrificed mice were dissected from the cranial 
cavity and washed in PBS solution. Then, brains were placed individually in tubes 
without fixatives before to be frozen in liquid N2 and stored at -80°C until analyses. 
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Tissue samples 
Frozen brains were covered by cooled glue (polyvinyl alcohol for cryostat, -20°C) 
before slicing. Serial coronal sections (Cryostat 3050-TM, Leica-Microsystems, 
France) of 20 µm in thickness were transferred onto a ZnSe windows for FTIR 
spectro-imaging. All tissue sections were dried on air before further processing. For 
obtaining the highest comparison level of data, immunohistochemistry was performed 
on the same tissue sections (on ZnSe windows) after FTIR image acquisition. Finally, 
5 tumors out of 6 samples were found to be formed for the U87 pcDNA3 phenotype 
were developed, and 2 sections per sample were analyzed. Comparisons were 
performed on formed tumors only. 
 
FTIR spectral imaging acquisition 
Spectral images were collected in transmission mode using a Spotlight 300 FTIR 
imaging system, equipped with a Spectrum One spectrometer (Perkin-Elmer). The 
imaging system was equipped with a liquid N2-cooled MCT linear detector comprising 
16 pixel elements. FTIR images were collected from samples in normal and tumor 
areas, in the 4000-720 cm-1 range using 8 scans with a spectral resolution of 4 cm-1 
and a spatial resolution of 6.25*6.25 µm per pixel (4X magnification of the physical 
25*25 µm dimension of detectors). Spectral intervals of interest in the tissue sections 
were selected referring to the immunohistochemical sections on slides. 
 
Immunohistochemistry 
Immunohistochemistry was used to highlight all blood vessels of tumor sections and 
for further comparisons with FTIR analyses. We used CD31 also designated as 
PECAM-1 (platelet endothelial cell adhesion molecule 1) as a marker for benign and 
malignant vascular tumors. The 20 µm sections were fixed in paraformaldehyde 4%. 
Endogenous peroxidase was inhibited using 3% H2O2 in distilled water. The sections 
were then washed in phosphate buffered saline. Slides were incubated first with the 
primary antibody (purified rat anti-mouse monoclonal antibody, pharmingen BD 
Biosciences), for CD31 (1:100). Incubation was performed for 2 hours at room 
temperature in a humidified chamber. After washing, the slides were then incubated 
with goat anti-rat biotinylated polyclonal antibody (1:200, pharmingen BD 
Biosciences) for one hour at room temperature. Sections were then washed and 
incubated with standard avidin–biotin complex (Vectastain Elite kit ABC, Vector 
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Laboratories) for 30 min. Antibody binding was revealed using H2O2 as a substrate 
and diaminobenzidine as chromogen. 
 
Data processing and analysis 
Once the visible image of the same area of IR images done on ZnSe windows was 
obtained after immunohistochemistry, capillary blood vessels were searched and one 
averaged spectrum was obtained per capillary. For each sample, 40 spectra were 
chosen from the 2 sections (20 spectra for normal blood vessels from cerebral cortex 
and 20 for tumor vessels from tumor region). After baseline correction, spectra were 
subjected to hierarchical analysis (HA) using Ward’s algorithms of OPUS 4.2 
software (Bruker, Germany). In such a classification method, all data points 
(absorbance values) from individual spectra are compared based on their Euclidean 
distance to the average of spectra included in the database. Calculation of distances 
leads to the classification of spectra under the form of a dendrogram, with the 
formation of clusters containing the most comparable spectra and heterogeneity 
levels between clusters. To be significant, heterogeneity value (referred to as H) 
between two clusters must be above the sum of the clusters’ heterogeneity (referred 
to as h) values [21]. Classification was performed on the first derivatives of the 
spectra with 5-point smoothing on different spectral intervals. 
 
FTIR spectrometry for cell lysates 
Cells lysates were homogenized with an agitator. 35 µL of each was deposited on 
96-well silicon-microplate (sample deposition area 7 mm in ∅). The microplate was 
placed in a drying vaccum to evaporate water (45 min), then it was finally put into the 
analysis compartment of a Bruker Tensor 27 spectrometer combined to a HTS-XT 
sample compartment and equipped with a Globar (MIR) source (7 V), a KBr 
beamsplitter, and a DTGS/B detector (18–28 °C). We used a resolution of 2.0 cm-1, 
and acquisitions were performed using 32 scans. All analyses were performed in 
triplicate and spectra were averaged before data treatments [22]. 
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Results 
 
Spectra classification 
For every brain sample, two tissue sections were used to select 20 healthy blood 
capillaries and 20 tumor blood capillaries (Figure 1). 15 out of 20 blood capillaries 
were randomly selected within each group for the classification and the 5 remaining 
blood capillaries were used to test and validate our method. Spectra classification 
with Ward’s algorithm was used for data analysis on the first derivatives of the 
spectra with a 5-point smoothing. Classification was tested for the spectral intervals 
presenting the most important heterogeneity of absorbances between spectra, which 
could be selected using the second derivative of spectra. The spectral intervals used 
included absorptions of fatty acyl chains (3020-2800 cm-1), lipid esters (1776-1720 
cm-1), proteins amide I and II (1712-1500 cm-1), and carbohydrates (1180-950 cm-1). 
Spectra classification was performed for every sample (n = 15 healthy + 15 tumor 
blood capillaries) and for the whole set of spectra (n = 5 samples; n = 75 healthy + 75 
tumor blood capillaries). Spectra classification was found to provide two distinct 
clusters between healthy and tumor blood capillaries using fatty acyl chain (3020-
2800 cm-1) and carbohydrates (1180-950 cm-1) spectral intervals with high 
hetereogeneity level between clusters (Table 1). To test the classification method, we 
used the left 10 spectra for each sample (5 normal and 5 tumor blood capillaries), so 
in the global classification of all samples 50 spectra were added to the previous 150 
spectra (as total, n = 100 healthy + 100 tumor blood capillaries) These added spectra 
were found to be inserted in their respective cluster, thus demonstrating the 
robustness of the classification method with an increase in heterogeneity level 
between clusters (Figures 2A, 2B, 3A and 3B). 
 
Fatty acyl spectral interval 
In order to interpret the spectral differences revealed by the spectra classification for 
fatty acyl chain absorptions, spectra were curve fitted for the spectral interval 3050-
2800 cm-1. The positions of each absorption band were determined using the second 
derivative spectrum corresponding for every blood capillary (Figure 4). The minimum 
values on second derivative spectra allowed to determine absorption bands at 3033, 
3012, 2959, 2921, 2899, 2871, and  2851 cm-1. Spectral curve fitting procedure could 
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thus be performed after fixing bands at these values (Figure 5). A model of curve 
fitting was first obtained for this spectral interval from the average of all spectra (n = 
200). This model was then used to analyze all individual spectra. Spectral areas of 
the following absorption bands were extracted from curve fitting procedure: 3012 cm-1 
for ν=(CH), 2959 cm-1 for νas(CH3), and 2921 cm-1 for νas(CH2). These absorptions 
are mainly due to the asymmetric stretching mode of the fatty acyl moieties of 
membrane phospholipids. Fatty acyl chain unsaturation may be appreciated using 
the following absorption band ratios: ν=(CH)/νas(CH3) and νas(CH2)/νas(CH3) [23]. The 
ν=(CH)/νas(CH3) ratio increased in the tumor with respect to normal blood vessels 
(49% increase), a concomitant decrease being observed for the νas(CH2)/νas(CH3) 
ratio (28% decrease; Tables 2 and 3). A verification of this result was obtained by 
using also the symmetric bands of methyl νs(CH3) and methylene νs(CH2) groups 
(Table 4). 
 
Carbohydrates spectral interval 
Spectra classification based on this spectral interval gave two clear clusters. Second 
derivatives of spectra highlighted a difference between healthy and tumor blood 
vessels for  an absorption band centered at ~1068 cm-1, which was not found in the 
spectra of tumor blood capillaries, and the band centered at 1025 cm-1 was found 
with reduced intensity with respect to spectra of healthy blood capillaries (Figure 6). 
As shown in table 1, the absorption of the band centered at 1068 cm-1 provided about 
most of the heterogeneity level in classification while using the carbohydrates 
spectral interval. Moreover, when combined with the fatty acyl chain spectral interval, 
the same heterogeneity level was obtained for each sample (n = 40 spectra) and for 
the whole set of samples (n = 200 spectra). 
 
Application of the spectra classification model to a second type of tumors 
U87 IRE1 DN tumors were characterized by their invasiveness and poor 
vascularization, so it was difficult to differentiate between healthy and tumor 
capillaries. After choosing randomly 100 BV spectra of U87 IRE1 DN derived tumors, 
they were inserted in the model of classification established on the first type of 
tumors (U87 pcDNA3 derived tumors) to be tested whereas they are normal or tumor. 
34 and 26 spectra out of 100 for each of the two tumors of U87 IRE1 DN were 
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classified with the tumor class respectively. Referring to tissue sections of each 
tumor, the positions of capillaries for these spectra were exactly around the tumor 
area or inside the tumor (Figure 7).  
 
Endothelial cells lysates spectra 
Cell lysates were analyzed by FTIR spectroscopy to determine if endothelial cells of 
brain blood capillaries could be specific of the differentiation found between healthy 
and tumor blood capillaries by FTIR imaging. Second derivative spectra of cell 
lysates (Figure 8) revealed the presence of the band at 1068 cm-1 (carbohydrates 
region) in the HCMEC (brain phenotype) and its absence in HUVEC (umbilical 
phenotype). 
 
Discussion 
 
Most tumor capillaries have an irregular diameter and random branching, and they do 
not fit well into the usual classification of arterioles, capillaries or venules [24]. They 
show structural and functional abnormalities in all components of the blood vessel 
wall. These abnormalities, which are the product of soluble and matrix-associated 
factors from tumor and stromal cells, have physiological consequences. Much 
excitement has been generated by the idea of attacking and destroying tumors by 
exploiting abnormalities of their blood capillaries. More studies are necessary to 
better understand differences between normal and tumor blood capillaries at the 
molecular level; because this could provide the opportunity to destroy tumor 
vasculature without destroying that of normal tissues [3].  
 
We suggested [25] that FTIR spectral imaging could be taken into consideration for 
the development of new molecular histopathology tools. The results obtained in this 
study using FTIR spectral imaging and spectroscopy allowed to highlight potential 
molecular markers differentiating healthy and tumor blood capillaries.  
 
Spectra classification based on spectral region of lipids (1776-1720 cm-1) 
discriminated healthy and tumor blood capillaries into two distinct clusters for several 
samples and with higher heterogeneity level than using the carbohydrate spectral 
120
interval (0.81 vs. 0.31, respectively). However, this spectral interval exhibits very 
weak absorption intensity, and may be found null for spectra presenting small 
absorbance level. Thus, this spectral interval was not taken into consideration for 
establishing a classification model. 
 
Spectra classification based on amide spectral interval (1712-1500 cm-1) did not 
allow for a good discrimination between blood capillaries. We could expect that such 
result could not be obtained on this spectra classification, although it was previously 
demonstrated that this spectral interval could contain spectral markers for 
differentiating tumor blood capillaries at different tumor stages. These markers were 
mainly based on the secondary structure of protein contents found in vascular 
basement membranes and changed during  angiogenesis [26]. They accounted for 
no more than a few % in terms of repartition between α-helix, β-sheets, triple 
helix…etc. contents. These changes were mainly due to different repartitions 
between collagen types I and IV [27]. Therefore, the classification using the whole 
spectral interval covered by amide absorptions is too large to distinguish between 
healthy and tumor blood capillaries on the sole basis of these subtle differences. 
 
The spectra classification using the spectral interval 3020-2800 cm-1, alone or 
combined with the carbohydrates spectral interval, provided the highest 
heterogeneity levels between the two spectra populations. The two clusters obtained 
did not presented overlap between spectra. Adding the carbohydrate spectral interval 
(1180-950 cm-1) led also to the formation of two clusters with a comparable 
heterogeneity level. From the curve-fitting of the 3020–2800 cm-1 spectral interval, we 
could find that ν=(CH)/νas(CH3) ratio increased for tumor blood capillaries spectra 
with a parallel decrease in the νas(CH2)/νas(CH3) ratio. These changes in fatty acyl 
chain absorptions revealed that phospholipids of vascular cells (the most important 
source of fatty acyl chains in blood capillaries) could be more unsaturated in tumors 
than in healthy tissues. Therefore, one may consider that fatty acyl chain 
differentiation between healthy and tumor blood capillaries, is a valuable molecular 
and spectral marker for further functional FTIR imaging of brain tumors. 
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The molecular interpretation of classification model was also valid for the 
carbohydrates spectral interval (1180-950 cm-1). In this spectral region, we found two 
discriminating bands especially that at 1068 cm-1. This absorption band may be 
attributed to a saccharidic moiety, but comparison between pure product FTIR 
spectra of glucose, lactate, mannose, galactose, and glycogen would suggest that 
the bands centered at ~ 1068 and 1025 cm-1 should belong to a mannosyl residue 
[22]. Mannose considered as a free hexose is physiologically present in weak 
concentration in the brain. It is thus unlikely that the clear difference in the 1068 cm-1 
absorption band intensity, would be due to the presence or not of mannose in this 
chemical form. It is also known that tumor cells are embedded in a network of 
protein-protein and protein-carbohydrate interactions mediated by a wide variety of 
glycoproteins, glycolipids, lectins and proteoglycans. Glycohistochemical analyses 
have shown that the binding capacity to saccharide epitopes in astrocytic tumors 
change protein-carbohydrate interactions in tumors [28]. This study has mentioned 
that markedly the level of binding site expression for α-D mannose decreases in the 
tumors, the perivascular tumor areas and the vessel walls.  Moreover, the mannose 
receptor is a transmembrane glycoprotein mainly expressed by macrophages, 
dendritic cells, and endothelial cells that specifically binds to mannosylated molecules 
and mediates their endocytosis. Expression of the mannose receptor has recently 
been demonstrated in the brain. Astrocytes and microglia, two types of glial cells that 
can be turned into immune-competent cells, are the main sites of expression in vivo 
and in vitro.  In a recent study, mannosylation of molecules and targeting of the 
mannose receptor have been used and tried successfully in antitumor response [29, 
30]. Immunohistochemical studies revealed also a regional distribution of the 
mannose receptor varying with age, the site of the highest expression being the 
meninges and the cerebral cortex [30]. This may also explain the presence of 
mannosyl residues in normal cerebral capillaries and their absence in tumor blood 
capillaries. Furthermore, when cells lysates of two types of endothelial cells were 
studied by FTIR spectrometry, this discriminant band at 1068 cm-1 was present in the 
HCMEC originated from human cerebral microvasculature and absent in HUVEC 
originated from human umbilical vein, thus confirming the results obtained from brain 
tumors. Therefore, our results suggest that the absence of the band centered at 1068 
cm-1 is another molecular and spectral marker of brain tumor blood capillaries with 
respect to their healthy counterpart. 
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In conclusion, our study has demonstrated that FTIR spectral imaging is a valuable 
analytical tool for determining the spectral and molecular differences between healthy 
and tumor blood capillaries. A classification model based on fatty acyl chain and 
carbohydrate absorptions could be obtained for discriminating 100% of the spectra 
representative of tumor and healthy blood capillaries. A basic molecular interpretation 
of these results could be obtained after curve fitting these spectral intervals. We 
could determine that fatty acyl chains of cell membranes phospholipids were 
probably more unsaturated in tumor samples. The absence of the 1068 cm-1 
absorption band is probably related to the lack of a mannosyl residue in vascular 
endothelial cells of tumor blood capillaries. This study demonstrated that FTIR 
spectral imaging is a suitable imaging modality for developing molecular histology 
tools for brain tumor diagnostic purposes. 
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Tables 
 
 
Table 1. Heterogeneity levels of dendrograms done by hierarchical analyses (HA) for 
each sample using each band alone or combined 
 
Sample (1)  3020-2800 
(2) 
1776-1720 
(3)
1712-1500
(4)
1180-950 
(5)
1076-1056 (1)+(2) (1)+(3) (1)+(4) (1)+(5)
S1 (n=30) 0.39 0.14 - 0.07 0.04 0.41 0.46 0.38 0.38 
S2 (n=30) 0.35 0.13 - 0.04 0.02 0.38 0.41 0.35 0.35 
S3 (n=30) 0.25 0.11 - 0.04 0.02 0.27 - 0.25 0.25 
S4 (n=30) 0.40 0.14 0.34 0.05 0.03 0.42 0.52 0.39 0.39 
S5 (n=30) 0.37 0.14 - 0.06 0.03 0.39 0.46 0.37 0.37 
    n=150 1.68 0.61 - 0.23 0.13 1.80 - 1.68 1.68 
 n=200 2.22 0.81 - 0.31 0.17 2.35 - 2.22 2.22 
 
n=30 for each of the 5 samples (15 normal and 15 tumor BV); For all samples joined 
together, n=150.  Then 50 spectra were added to the 150 spectra to test the 
classification. Five spectral interval were used for this HA, each interval alone and 
combination (mentioned as “+”) of the first one of fatty acyl moieties with each of the 
other four. Spectral intervals are designated by a number: (1): 3020-2800 cm-1, (2): 
1776-1720 cm-1, etc… 
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Table 2. Curve fitting results of fatty acyl chains spectral interval (3050-2800 cm-1; 
n=100 for each set of BV). 
 
  3012 cm
-1 
ν=(CH) 
2959 cm-1 
νas(CH3) 
2921 cm-1 
 νas(CH2) ν=(CH)/νas(CH3) νas(CH2)/νas(CH3)
Normal BV 
(NBV) 7.57 ± 1.41 17.91 ± 2.21 16.23 ± 1.90 0.43 ± 0.11 0.92 ± 0.13 
Tumor BV 
(TBV) 8.16 ± 2.41 13.00 ± 2.80  8.33 ± 1.54 0.64 ± 0.17 0.66 ± 0.12 
TBV % NBV +8 -27 -49 +49 -28 
 
 
Values are designated by means ± SD. The percentage of variations between tumor 
blood vessels (TBV) versus normal BV (NBV) in the last line is mentioned by “+” if 
increase and “-“ if decrease occurs.  
  
 
Table 3. Ratios of asymmetric absorptions bands of the fatty acyl chains spectral 
interval for each tumor sample (n=40 for each sample, 20 NBV and 20 TBV) 
 
 ν=(CH)/νas(CH3) νas(CH2)/νas(CH3) % variation (tumor/normal) 
Samples Normal BV Tumor BV Normal BV Tumor BV ν=(CH)/νas(CH3) νas(CH2)/νas(CH3)
S1 0.37 0.63 0.87 0.66 72.9 -23.5 
S2 0.47 0.69 0.96 0.70 47.4 -27.6 
S3 0.44 0.67 0.87 0.67 49.8 -22.9 
S4 0.47 0.57 0.98 0.69 20.9 -29.0 
S5 0.41 0.62 0.91 0.57 51.9 -37.5 
Average 0.43 ±  0.04 0.64 ± 0.05 0.92 ± 0.05 0.66 ± 0.05 49 ± 18.5 -28± 5.8 
 
 
 
Table 4. Curve fitting results of fatty acyl chains spectral interval with total symmetric 
and asymmetric absorptions bands (n=20 for each set of BV so 20% of the 
population).  
 Asymmetric Total (asymmetric+symmetric) 
20% of the total ν=(CH)/νas(CH3) νas(CH2)/νas(CH3) ν=(CH)/νas+νs(CH3) νas+νs(CH2)/νas+νs(CH3)
Normal BV 0.42 ± 0.13 0.87 ± 0.13 0.31 ± 0.09 0.82 ± 0.11 
Tumor BV 0.63 ± 0.23 0.66 ± 0.15 0.45 ± 0.15 0.59 ± 0.13 
Tumor % normal 51 -24 47 -28 
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Figures legends 
 
Figure 1 
U87 pcDNA3 tumor shown in different ways: with immunohistochemistry (IHC) on 
slide, visible image by Spotlight, visible image after IHC on ZnSe window to locate all 
blood capillaries marked with CD31 (brown), FTIR image using 8 scans with a 
spectral resolution of 4 cm-1 and a spatial resolution of 6.25 µm /pixel. Scale bar 
represents 200 µm.   
 
Figure 2  
2A: Example of a dendrogram of a HA for one sample using the combination of the 
fatty acyl and carbohydrates spectral interval. N=30 where 15 are healthy blood 
capillaries (C) and 15 are tumor blood capillaries (T). Two clear clusters are shown 
separating the two populations. 
2B: The same dendrogram of figure 2A when another 10 blood capillaries (marked 
with – for healthy and + for tumor blood capillaries) were added to test the 
classification. HA was performed using Ward’s algorithms of OPUS 4.2 software. 
 
Figure 3  
3A: Dendrogram of the HA of all samples using the combination of the fatty acyl and 
carbohydrates regions. N=150 spectra where 75 are cerebral blood capillaries (.) and 
75 are tumor blood capillaries (-). Two clear clusters are shown separating the two 
populations. 
3B: The same dendrogram of figure 3A when 50 blood capillaries were added to test 
the classification. Totally we have 200 spectra in two clear clusters differentiating the 
two populations of the blood capillaries.  
 
Figure 4 
Second derivative of the average spectra of normal and tumor blood capillaries within 
the 3050-2800 cm-1 spectral interval. Minimum values at 3012, 2959, and 2921 cm-1 
represent asymmetric bands of fatty acyl moieties. 
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Figure 5 
Spectral curve fitting performed within the 3050-2850 cm-1 spectral interval. 
Absorption bands at 3012 cm-1 for ν=(CH), 2959 cm-1 for νas(CH3), and 2921 cm-1 for 
νas(CH2) were used to calculate the ν=(CH)/ νas(CH3) and νas(CH2)/ νas(CH3) ratios.  
 
Figure 6 
Second derivative of the average spectra of normal and tumor blood capillaries within 
the 1180-950 cm-1 spectral interval for carbohydrates determination. We can see the 
absence of the bands at 1068 and 1025 cm-1 which have been attributed to mannosyl 
residues.                       
  
Figure 7 
Visible image of a U87 IRE1DN tumor after immunohistochemistry on ZnSe window. 
Crosses represent spectra chosen to test the classification method done with 
U87pcDNA3 sample. Arrows mark capillaries that were classified with tumor 
samples. The positions of those capillaries, shown precisely inside the tumor or 
around it, delimit very well the tumor area. Scale bar represents 100 µm. 
 
Figure 8 
Second derivative spectra of endothelial cells lysates spectra in the 1200-950 cm-1 
region. The band at 1068 cm-1 was observed in HCMEC and not in HUVEC average 
spectrum. 
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Figure 2.A 
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Figure 3.A 
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Figure 7 
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Figure 8 
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Application of FTIR spectral imaging to study alterations of blood 
vessels in human glioma   
 
 
 
 
Purpose: The aim of the present work was to use FTIR spectral imaging to study 
biochemical changes in blood vessels from tissue sections of human glioma with 
different grades. Brain tumor specimens were obtained by the Service of 
Anatomopathology from patients undergoing neurosurgery. We applied the data 
treatment methods developed in previous studies (research report and papers) to test 
their transferability form animal models to human tissues. 
 
Main results: Secondary structure of proteins was determined by using the curve-
fitting of the amide I spectral interval (1700-1600 cm-1). Changes in protein secondary 
structure of blood vessels could be identified between blood capillary spectra of 
healthy and tumor areas, with a decrease in triple helix content (∼ 9 % decrease; P < 
0.01) observed for tumor BV. This change in protein secondary structure was likely to 
be due to the abnormal arrangement (crosslinks) of collagen fibers in the vascular 
basement membrane during tumor growth. Moreover, hierarchical analysis of BV 
spectra based on two combined regions of fatty acyl (3020-2800 cm-1) and 
carbohydrates (1200-900 cm-1) formed two clusters discriminating normal and tumor 
BV with a small percentage of misclassification (5 and 18.2 %, respectively). Our 
study demonstrated that FTIR spectra of BV may reveal discriminant spectral 
markers to distinguish between healthy and tumor areas of brain tissues and thus 
may define the tumor limits. However, no correlation could be found between FTIR 
classification and pathological grading of grade III and IV tumors, i.e., no 
classification model could discriminate between grade III and IV sample FTIR 
spectra. This might be attributed to the high morphological heterogeneity usually 
observed in grade III and IV gliomas, thus potentially leading to misclassifications in 
pathological examinations. 
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 In conclusion, FTIR imaging allowed establishing different molecular markers in the 
proteins, lipids, and carbohydrates spectral intervals to differentiate between tumor 
and normal blood vessels in human brain tissues. These markers should be 
developed and validated in further work by using a larger collection of human 
samples in order to help neurosurgeons to define tumor margins during glioma 
surgery. Nevertheless, the results obtained in this study indicate that FTIR imaging 
allows discriminating healthy and pathological features for discriminating tissue 
areas. Therefore, this work opens the way to a functional FTIR imaging for the 
development of a molecular anatomopathology of brain tumors. 
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Application of FTIR spectral imaging to study alterations of blood 
vessels in human glioma 
 
Abstract 
 
Distinction between tumor and normal brain blood vessels (BV) may be particularly 
important in neurosurgery to maximally resect tumor margins without affecting brain 
function. In the present work we used FTIR spectral imaging to study biochemical 
changes in blood vessels in human glioma sections of different grades. FTIR imaging 
was able to detect changes in protein secondary structure of blood vessels from 
healthy and tumor areas, a decrease in triple helix content (∼ 9 % decrease; P < 
0.01) was observed for tumor BV. Moreover, hierarchical analysis of BV spectra 
based on two combined regions of fatty acyl (3020-2800 cm-1) and carbohydrates 
(1200-900 cm-1) gives two clusters corresponding one to normal BV and the other to 
tumor BV with a little percentage of misclassification. The results outlined a lower 
level of lipids and saccharidic residues for tumor BV. Our study shows that FTIR 
spectra of BV contain discriminant markers to distinguish healthy and tumor areas of 
brain tissues and thus may define the tumor limits. 
 
Abbreviations 
 
BV: blood vessels; FTIR: Fourier Transform Infrared; GBM: glioblastoma multiforme; 
IHC: Immunohistochemistry; MPV: microvascular proliferation; VBM: Vascular 
basement membrane 
 
Keywords 
 
FTIR spectral imaging, gliomas, angiogenesis, blood vessels  
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Materials and methods 
 
Tissue samples 
Brain tumor specimens were obtained from 29 patients undergoing neurosurgery in 
the period going from November 2005 to October 2007. All specimens were provided 
from Bordeaux Hospital Center (CHU Pellegrin; Bordeaux) through the collaboration 
of the Department of Anatomy and Cytological Pathology. Samples were divided as 
follow: 1 specimen grade I, 1 astrocytoma grade II, 4 astrocytomas grade III, 17 
glioblastomas grade IV, and 6 metastasis. Fresh samples were frozen in liquid 
nitrogen immediately after tumor resection without fixatives to perform cryosectioning. 
For each sample, a 10 μm tissue section was transferred onto a glass slide for 
immunohistochemistry assessment to be stained with CD34 (1:50 dilution, 
Immunotech, France). This antibody recognizes a cell surface antigen expressed on 
human vascular endothelium. A 20 µm following section was deposited onto an IR 
transparent silicon window for FTIR imaging in transmission mode. All tissue sections 
were dried on air before further processing. Pathological diagnosis was also obtained 
from experienced pathologists’ observations of additional formalin-fixed and paraffin-
embedded tissue sections using standard histological H&E staining. 
 
Spectral data acquisition and processing 
FTIR spectral imaging data were acquired in transmission mode using a Spotlight 
300 FTIR imaging system, equipped with a Spectrum One spectrometer (Perkin-
Elmer, France). The imaging system was equipped with a liquid nitrogen cooled 
Mercury Cadmium Telluride (MCT) linear detector of 16 pixel elements. FTIR images 
were collected from samples in the mid IR range (4000-720 cm-1) using a spectral 
resolution of 4 cm-1 accumulating 8 scans for each data point. The spatial resolution 
used was 6.25 µm for each pixel. Regions of interest in the tissue sections were 
selected referring to the immunohistochemical and histological sections on slides to 
locate blood vessels. All data acquisition, post-processing (atmospheric and baseline 
corrections), and image construction were performed using sub-routines of the 
Spotlight 1.0 (Perkin Elmer, France). Then all data were analysed using OPUS 4.2 
software (Bruker, Germany). 
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Spectral data analysis and treatments 
For every FTIR image of a blood vessel, the FTIR spectra corresponding to the pixels 
covering the basal membrane were averaged and saved for further data treatment. A 
model spectrum for curve fitting procedure (previously described in [1]) was applied 
to each blood vessel averaged spectrum, for the determination of protein secondary 
structure changes between samples. Absorption bands within the 1750-1480 cm-1 
spectral interval were localized from second derivative spectra with a 9-point 
smoothing (subroutine of OPUS 4.2 software, Bruker). This spectral interval shows 
the two major absorbance bands of proteins (1655 and 1545 cm-1 for amide I and II 
absorptions, respectively) and may be used to determine the secondary structure of 
proteins. Protein secondary structure parameters were assessed using absorption 
bands assigned as α-helix (centered at 1655 cm−1), triple helix (centered at 1638 
cm−1), β-sheets (1690 and 1628 cm-1 to parallel β-sheets, and 1680 cm-1 to anti-
parallel β-sheets), β-turns (1666 and 1615 cm−1), and unordered structure (at 1645 
cm−1). Each band was calculated as a percentage of the total amide I absorption as 
we previously described [1, 2]. 
 
Moreover, spectra were subjected to hierarchical analysis (HA) using Ward’s 
algorithms of OPUS 4.2 software (Bruker, Germany). In this analysis, data points 
from spectra were compared based on the Euclidean distances between them. 
These distances allowed the classification of all spectra within clusters creating a 
dendrogram giving a heterogeneity level between the two populations. As we 
demonstrated in a previous work that HA was able to differentiate between normal 
and tumor blood vessels using the fatty acyl and carbohydrate regions, we tried to 
apply this method on those human samples. HA was performed on the first 
derivatives of the spectra with 5-point smoothing of different blood vessels from 
normal areas and grade III and IV tumor areas. 
      
Statistics 
Data of protein secondary structure parameters were used for comparisons between 
grades. All data were expressed as mean ± SD. A paired Student’s t-test was used to 
determine differences between series of data between groups. P-values were fixed at 
0.01 and 0.05 to consider the significance level of differences. 
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Results and Discussion  
 
Secondary structure of protein contents 
After choosing blood vessels in visible images referring to the immunohistochemical 
section, (Figure 1) FTIR spectra corresponding to the pixels covering the basal 
membrane were averaged and one averaged spectrum was taken for each blood 
vessel. Using the whole set of blood vessels, 48, 125, and 73 blood vessels were 
analyzed for grade III, grade IV and metastasis sections groups, respectively. We 
exclude samples of Grade I and II since there was an insufficient number for the 
study. Secondary structure parameters obtained from the curve fitting procedure of 
the amide I region (Figure 2) were compared between each 2 of 3 groups (see Table 
1 for more information). Comparison between all blood vessel spectra of grade III 
and grade IV tumor sections showed a significant decrease in α-helix and increase in 
unordered structure in grade IV with respect to grade III. No significant differences 
were shown between grade III and metastasis or between grade IV and metastasis. 
These results may not be very informative because all blood vessels were taken 
together mixed between normal and tumor for the different grades.  
 
In other term, we divided blood vessels in tumor and normal groups according to the 
diagnosis made by the pathologists when identifying tumor and healthy regions in 
tissue sections. For these statistics we only took into consideration samples where 
these regions were clearly identified in the two consecutive sections of IHC and IR to 
be more accurate in choosing blood vessels. For tumor blood vessels, we add 
spectra from grade III and grade IV samples together (n=66) to differentiate their 
protein secondary structure with normal blood vessels from healthy regions (n=40). 
Results showed that only significant difference (P < 0.01) could be found in triple 
helix secondary structure, it decreases in tumor BV with respect to normal BV (14.5 ± 
2.31 % vs. 13.2 ± 2.24 %; P < 0.01; ∼ 9 % decrease) (Table 2). These results on 
human samples agreed well with our previous work obtained on animal model [1]. 
We have already described this change as a molecular marker that may be due to 
the conformational changes of collagen fibers in the vascular basement membrane 
(VBM) during tumor growth; since the collagen (especially collagen IV) is a main 
component of the VBM and it is mainly constituted of triple helix. 
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 Moreover, when we divided the tumor blood vessel group to compare the protein 
secondary structure between grade III and grade IV, we found significant differences 
in α-helix and β-sheets amounts. There was a decrease in the percentage of α-helix 
in grade IV with respect to grade III (30.7 ± 2.43 vs. 27.1 ± 3.46 %; P < 0.01). 
Inversely, there was an increase in the percentage of β-sheets in grade IV with 
respect to grade III (18.6 ± 2.36 % vs. 21.5 ± 2.70; P < 0.01) (Table 3). Here again, 
we couldn’t be certain of this deviation since we haven’t sufficient number of data for 
interpretation.  
 
Hierarchical analysis 
HA was used for data analysis to classify normal and tumor blood vessels using the 
first derivatives of the spectra with 5-point smoothing. We used the two spectral 
regions of fatty acyl chains (3020-2800 cm-1) and carbohydrates (1180-950 cm-1) in 
order to get a better discrimination between the two sets of data. In a first time, we 
made a classification between normal (15 BV spectra from one sample) and tumor 
(18 BV spectra from one sample of glioblastoma G IV) based on these two spectral 
regions. As we can see in Figure 3, the two sets of data were correctly classified 
without any overlapping. After collecting all data we tried the same IR based 
classification to see the robustness of the method if we increase the number of 
samples. As total data we had 40 spectra of normal blood vessels (issued from 
different samples in healthy regions identified by histological observations) and 66 
spectra of tumor blood vessels (from grade III and IV samples). We obtained two 
clusters with a misclassification of a few spectra (Figure 4). Only 5 % of normal BV 
spectra were misclassified with tumor and 18.2 % of tumor BV spectra misclassified 
with normal.  
 
We should also note that a comparison between grade III and grade IV samples 
show an apparent disagreement between the IR-predicted classification and the 
histopathological grade (results not shown). This could be attributed to the high 
heterogeneity within glioblastoma multiforme of grade IV. Although the IR based 
classification was not entirely consistent with conventional histopathology in grading 
the tumors of grade III and IV, the IR based classification shows no great confusion 
between tumor and normal blood vessels even with a little percentage of 
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misclassification. This may be due to the invasiveness of gliomas into the 
surrounding tissue, where on these limits we can confuse between normal and tumor; 
hence the idea to search for molecular markers able to differentiate between normal 
and tumor blood vessels in these areas to help neurosurgeons for defining the tumor 
margins. 
 
Second derivatives comparison 
Moreover, a careful examination of second derivative of the averaged spectra of 
normal, grade III and grade IV samples indicates that most of the variability is in the 
regions of fatty acyl and carbohydrates (3050–2800 and 1200–950 cm-1 respectively) 
(Figures 5 and 6). Concerning the fatty acyl chain regions, there is a clear difference 
in peaks on 3012 cm-1, 2959 cm-1 and 2921 cm-1 corresponding respectively to the 
asymmetric stretching vibrations of ν=(CH), νas(CH3) and νas(CH2). These peaks are 
of smaller intensities in tumor BV spectra than in normal. The absorptions in question 
arise from the lipid constituents (e.g., phospholipids and possibly others). The 
observed trend is in accordance with studies suggesting that an increase in 
malignancy is accompanied by a reduction of total lipids and that normal tissue 
contains more components of long-chain C-H and C=O bonds that decrease and 
even disappear in the spectra of malignant tissues. This difference may be 
interpreted by the fact that fat in the region of malignant tissue is consumed because 
of the necessary nutritional and energy requirement in the development of carcinoma 
(because triglyceride contains a large proportion of methyl, methylene and carbonyl).  
 
A second prominent spectral trend is the difference in certain absorptions in the 
1200–950 cm-1 region.  Figure 6 shows the second derivative of the average spectra 
of the three tissue classes (normal, tumor of grade III and grade IV). In this region 
occur absorption bands due to sugar moieties as well as to deoxyribose C–O and 
PO2_ groups of DNA. We can obviously see the difference between the averaged 
spectra especially in the region of 1050–1085 cm-1. Moreover, we, in the previous 
work, found a discriminating band in the carbohydrates region at 1068 cm-1 present in 
normal murine BV and absent in tumor BV. This band was also present in spectra of 
endothelial cells of human cerebral origin. Here again in this study this absorption 
band is present only in normal BV although shifted to 1072 cm-1.  
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Tables 
 
Table 1: Secondary structure determination of VBM protein contents for all blood 
vessels (BV) of Grade III, Grade IV and metastasis sections 
 
 α helix β sheets β turns Unord. Struc Triple helix 
Grade III (G III) 28.7 ± 5.95 20.1 ± 4.78 28.9 ± 5.43 8.7± 4.20 13.6 ± 4.25 
Grade IV (G IV) 26.9 ± 4.40 21.3 ± 3.64 27.7 ± 3.50 10.0 ± 3.03 13.9 ± 2.73 
Metastasis (M) 27.1 ± 5.44 21.1 ± 3.69 27.8 ± 3.39 10.0 ± 3.52 14.0 ± 2.32 
t test G III vs. IV   0.032 * 0.066 0.115   0.025 * 0.564 
t test G III vs. M 0.137 0.172 0.177 0.076 0.578 
t test G IV vs. M 0.745 0.712 0.963 0.927 0.966 
 
* P<0.05: Significant difference between groups. n = 48, 125 and 73 BV spectra for 
Grade III (G III), Grade IV (G IV) and metastasis (M) sections, respectively. 
Absorption bands used for proteins secondary structure determination: α-helix (1655 
cm-1), β-sheets (1690, 1680, and 1628 cm-1), β-turns (1666 and 1615 cm-1), 
unordered structure (1645 cm-1), and triple helix (1638 cm-1)  
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Table 2: Secondary structure determination of VBM protein contents for normal and 
tumor blood vessels (BV) of Grade III and IV together 
 
 
  α helix β sheets β turns Unord. Struc Triple helix 
Normal BV 25.6 ± 6.45 21.2 ± 4.85 28.2 ± 3.88 10.5 ± 4.00 14.5 ± 2.31 
Tumor BV 
 G III + G IV 27.5 ± 3.54 21.2 ± 2.81 28.7 ± 3.15 9.4 ± 2.31 13.2 ± 2.24 
t test Tumor BV 
vs. Normal BV 0.051 0.982 0.460 0.066 0.005 ** 
 
** P<0.01: Significant difference between groups. n = 40 and 66 spectra for normal 
and tumor BV, respectively.  
 
 
 
Table 3: Secondary structure determination of VBM protein contents for Grade III 
and Grade IV blood vessels 
 
  α helix β sheets β turns Unord. Struc Triple helix 
Grade III BV 30.7 ± 2.43 18.6 ± 2.36 29.6 ± 2.87 8.7 ± 2.86 12.4 ± 1.62 
Grade IV BV 27.1 ± 3.46 21.5 ± 2.70 28.6 ± 3.20 9.5 ± 2.23 13.3 ± 2.30 
t test Grade IV 
vs. Grade III 0.006 ** 0.006 ** 0.410 0.343 0.302 
 
** P<0.01: Significant difference between groups. n = 8 and 58 spectra for Grade III 
and Grade IV blood vessels, respectively.  
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Figures Legends 
 
Figure 1: A: optical image of immunohistochemistry section (10 µm) where blood 
vessels were marked with CD34 (brown). B: visible image of the consecutive tumor 
section (20 µm) deposited on silicon window where corresponding blood vessels are 
shown. C: full spectral image of blood vessels done with a spatial resolution of 6.25 
µm corresponding to the size of a pixel. Scale bar represents 100 µm.  
 
Figure 2: Spectral curve fitting for the 1750-1500 cm-1 spectral interval. Absorption 
bands of amide I are used for the protein secondary structure determination: α-helix 
(at 1655 cm-1), β-sheets (1690, 1680, and 1628 cm-1), β-turns (1666 and 1615 cm-1), 
unordered structure (1645 cm-1), and triple helix (1638 cm-1). 
 
Figure 3: Classification between normal (15 BV spectra from one sample) and tumor 
(18 BV spectra of G IV from one sample) based on fatty acyl (3020-2800 cm-1) and 
carbohydrates (1200-900 cm-1) spectral regions. 
 
Figure 4: Classification between normal (40 spectra) and tumor (66 spectra from G 
IV and G III) blood vessels based on fatty acyl (3020-2800 cm-1) and carbohydrates 
(1200-900 cm-1) spectral regions. The percentage of normal BV spectra misclassified 
with tumor is 5 %, and the percentage of tumor BV spectra misclassified with normal 
is 18.2 %. 
 
Figure 5: Second derivative spectra of normal, grade III and grade IV averaged 
blood vessel (used for the classification in figure 4) within the 3050-2800 cm-1 
spectral interval. Absorption bands at 3012 cm-1, 2959 cm-1 and 2921 cm-1 
correspond to the stretching vibrations of ν=(CH), νas(CH3) and νas(CH2), 
respectively. 
 
Figure 6: Second derivative spectra of normal, grade III and grade IV averaged 
blood vessel within the 1200-950 cm-1 spectral interval for carbohydrates 
determination. As we can see, the absorption band at 1072 cm-1 is present only in 
normal BV.                      
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Figure 1  
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         Dans ce travail nous avons exploré une nouvelle méthodologie pour étudier les 
vaisseaux sanguins angiogéniques des tumeurs cérébrales (en particulier des 
gliomes). Ces tumeurs richement vascularisées et agressives s’infiltrent dans le 
parenchyme cérébral sain, ce qui rend difficile l’exérèse complète de la tumeur 
malgré les outils de diagnostic actuels. Cette méthodologie a été fondée sur 
l’imagerie fonctionnelle infrarouge à transformée de Fourier (IRTF). L’utilisation de 
cette spectro-imagerie vibrationnelle peut trouver un intérêt dans de nombreuses 
pathologies tel que le cancer et plus particulièrement les gliomes. En tenant compte 
du rôle de l'angiogenèse dans les gliomes, des limites des techniques actuelles 
d'imagerie, et des informations moléculaires disponibles par le biais de l’IRTF, nous 
avons effectué cette recherche pour apporter une comparaison moléculaire aux 
techniques histologiques utilisées pour le diagnostic des gliomes. 
 
         La comparaison de cette technique avec les modalités d'imagerie de routine 
met en évidence de nombreux avantages : (i) c’est une technique caractérisée par sa 
haute résolution spatiale (~6 µm) ce qui en fait une modalité d’imagerie ex vivo très 
performante, (ii) elle est rapide vis-à-vis de l’acquisition des données spectrales qui 
peuvent être collectées et interprétées en quelques minutes ; (iii) elle exige un 
minimum de préparation des échantillons, vu sa capacité en tant que spectroscopie 
vibrationnelle d’identifier la composition chimique des tissus sans l’utilisation de 
marqueurs ; et (iiii) elle est non destructive, de sorte que l'échantillon puisse être 
soumis à d'autres analyses telle que l'immunohistochimie dans le but de confirmer 
les conclusions. De plus tous les moyens actuels d'identification moléculaire de 
l’angiogenèse sont laborieux en comparaison avec la spectro-imagerie infrarouge qui 
présente à la fois un gain du temps et d'argent. 
 
         La plupart des paramètres pertinents qui ont été mis en évidence lors de cette 
étude sont les suivants: 
  
         - La détermination des altérations de la structure secondaire des protéines  des 
vaisseaux sanguins au cours de la croissance de la tumeur. Ces protéines contenues 
dans la membrane vasculaire (tel le collagène) ont été modifiées au cours de la 
progression tumorale lors du stress angiogénique. La modification au niveau de la 
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triple hélice, par exemple, pourrait être utilisée comme un marqueur moléculaire de la 
gradation tumorale.  
 
         - L’évaluation des modifications des phospholipides membranaires dans les 
vaisseaux sanguins. Ceci a été traduit par un niveau plus haut d’insaturation des 
chaînes d’acides gras dans les vaisseaux tumoraux et plus particulièrement dans les 
tumeurs plus agressives.  
 
        - La discrimination rigoureuse entre une vasculature saine et tumorale. Celle ci 
a été basée sur une méthode efficace de classification (algorithme de Ward) qui a 
permis de différencier les capillaires sanguins cérébraux de souris des capillaires 
angiogéniques de la tumeur après une implantation intracrânienne de cellules 
tumorales de gliomes. Cette classification fondée sur les contenus moléculaires du 
tissu, notamment glucidiques et lipidiques, a permis de bien délimiter la zone 
tumorale dans un autre phénotype invasif imitant l’infiltration des gliomes humains 
dans le tissu sain.    
 
         Une combinaison de ces paramètres a été mise à profit pour assurer une 
histopathologie moléculaire solide pour l’étude angiogénique des gliomes dans des 
tumeurs de xénogreffe. Par conséquent, nous avons ensuite utilisé ces marqueurs 
moléculaires sur des échantillons de gliomes humains afin de valider leur application. 
En prenant un seul grade de tumeur, les vaisseaux ont été parfaitement classés; par 
contre en prenant un nombre d’échantillons plus grand avec deux grades différents, il 
y a eu un faible pourcentage d’erreur de classification (mais inférieur à celui de 
l’histopathologie). Ceci est probablement dû à la forte hétérogénéité des gliomes ou 
au problème de reproductibilité de la classification anatomopathologique de l’OMS. 
Malgré ce faible pourcentage d’erreur, les résultats ont démontré la faisabilité de 
différencier la vasculature tumorale de la vasculature saine sur ces gliomes humains. 
Ce qui pourrait être utilisable pour délimiter la zone tumorale vis-à-vis de la zone 
saine lors d’une intervention chirurgicale. Les résultats ouvrent alors la voie à 
l'élaboration d'une histopathologie moléculaire, qui pourrait devenir un outil 
analytique rapide, fiable et utile pour les neurochirurgiens avec une durée compatible 
avec la chirurgie.  
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         Nous avons ainsi montré que la spectro-imagerie IRTF est une technique 
prometteuse qui pourrait servir comme un outil clinique de diagnostic des gliomes 
afin de compléter les méthodes existantes. En raison de son potentiel d’étudier les 
tissus au niveau moléculaire, et sa capacité d’étudier les variations chimiques entre 
l’état physiologique et pathologique, cette technique a mis en évidence plusieurs 
marqueurs spectraux des vaisseaux sanguins. Un plus grand nombre d’échantillons 
et une amélioration des techniques de traitement de données spectrales permettront 
ensuite de valider cette méthodologie. Aussi, il serait approprié d’étudier d’une 
manière approfondie les modifications identifiées lors de cette étude comme les 
altérations glucidiques et lipidiques des vaisseaux liées aux facteurs angiogéniques ; 
ce qui pourrait mettre en place des outils thérapeutiques pour l’angiogenèse 
tumorale. 
 
         Le développement de cette méthodologie, pour la rendre plus avantageuse vis-
à-vis d’autres techniques de diagnostic et notamment compatible avec la durée de 
l’acte chirurgical, necessitera la conception de logiciels experts pour une optimisation 
automatique de différenciation et plus de rapidité d’acquisition des images. A terme, il 
sera alors envisageable de l’appliquer sur d’autres types de tumeurs malignes.  
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Résumé 
 
 
Utilisation de la spectro-imagerie IR-TF pour le développement d’une anatomo-
pathologie moléculaire des tumeurs cérébrales 
 
Les gliomes sont des tumeurs agressives de mauvais pronostic, très angiogéniques et 
infiltrantes ce qui rend leur exérèse particulièrement difficile. Vu les limites des techniques 
actuelles d’imagerie, nous avons proposé la spectro-imagerie Infrarouge à Transformée de 
Fourier (IRTF), d’une résolution spatiale de 6 µm, pour apporter une information moléculaire 
à l’examen histologique actuel des gliomes. Nos travaux ont été fondés sur la recherche de 
paramètres moléculaires des vaisseaux sanguins, notamment sur la base des contenus de 
leur membrane basale. Celle-ci subit des altérations dûes au stress angiogénique tumoral. 
Nous avons mis en évidence des altérations de la structure secondaire des protéines (tels 
les collagènes) des vaisseaux sanguins au cours de la croissance de la tumeur. Nous avons 
aussi évalué les modifications des chaines d’acides gras des phospholipides membranaires, 
qui révélent un degré d’insaturation plus important pour les vaisseaux tumoraux. Ensuite, sur 
un modèle de gliome murin, nous avons établi une méthode efficace de classification des 
capillaires sanguins sur la base d’absorptions de leurs contenus glucidiques et lipidiques, 
permettant de discriminer totalement les capillaires sains et tumoraux. La combinaison de 
ces paramètres a été mise à profit pour assurer une histopathologie moléculaire des gliomes 
humains. Nos résultats ont démontré qu’il est possible de différencier entre la vasculature 
saine et tumorale sur ces gliomes humains, ce qui permet une bonne délimitation des zones 
tissulaires correspondantes. Cette technique pourrait devenir un outil analytique fiable, 
rapide d’une durée compatible avec la chirurgie et donc très utile pour les neurochirurgiens. 
 
 
Mots Clés : Imagerie IRTF, Gliomes, Angiogenèse, Marqueurs moléculaires, Classification  
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identified alterations of the secondary structure of proteins (such as collagen) in blood 
vessels during tumor growth. We have also assessed the changes in fatty acyl chains of 
membrane phospholipids, which revealed a higher unsaturation level in tumor vessels. Then, 
on a murine glioma model, we have established an efficient method of blood vessels 
classification based on their carbohydrates and fats contents, allowing the differentiation 
between healthy and tumor blood vessels. The combination of these parameters was used to 
provide a molecular histopathology for the study of human gliomas. Our results have 
demonstrated the feasibility of differentiating between healthy and tumor vasculature in these 
human gliomas, which help delimitating areas of corresponding tissue. This technique could 
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